<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://m2.mtmt.hu/xsl/gui3.xsl" ?>
<myciteResult>
  <serverUrl>https://m2.mtmt.hu/</serverUrl>
  <labelLang>hun</labelLang>
  <responseDate>2026-09-20 22:40</responseDate>
  <content>
    <publication>
      <otype>JournalArticle</otype>
      <mtid>36252484</mtid>
      <status>VALIDATED</status>
      <published>true</published>
      <unhandledTickets>0</unhandledTickets>
      <deleted>false</deleted>
      <lastRefresh>2026-09-08T08:44:24.718+0000</lastRefresh>
      <lastModified>2026-07-10T08:31:30.182+0000</lastModified>
      <created>2025-07-16T13:10:17.024+0000</created>
      <creator>
        <snippet>true</snippet>
        <mtid>10090082</mtid>
        <familyName>Gomaa</familyName>
        <givenName>Nariman Essmat Mohamed Abdeltawab</givenName>
        <link>/api/author/10090082</link>
        <otype>Author</otype>
        <label>Gomaa Nariman Essmat Mohamed Abdeltawab (In vivo and in vitro pain assessment)</label>
        <published>true</published>
      </creator>
      <lastDuplumOK>2026-09-07T07:52:05.333+0000</lastDuplumOK>
      <lastDuplumSearch>2026-09-07T07:52:05.333+0000</lastDuplumSearch>
      <validated>2026-01-21T10:31:16.280+0000</validated>
      <validator>
        <snippet>true</snippet>
        <mtid>10015546</mtid>
        <familyName>Berhidi</familyName>
        <givenName>Anna</givenName>
        <link>/api/admin/10015546</link>
        <otype>Admin</otype>
        <label>Berhidi Anna (SE_KK_Admin5_BA, admin)</label>
        <published>true</published>
        <oldId>10015546</oldId>
      </validator>
      <tempLockers>
        <otype>Admin</otype>
        <mtid>10025544</mtid>
        <link>/api/admin/10025544</link>
        <label>Lévayné Deseő Katalin (MTMT Központi admin)</label>
        <familyName>Lévayné Deseő</familyName>
        <givenName>Katalin</givenName>
        <published>true</published>
        <oldId>10025544</oldId>
        <snippet>true</snippet>
      </tempLockers>
      <tempLocked>2026-05-20T07:50:23.018+0000</tempLocked>
      <core>true</core>
      <publicationPending>false</publicationPending>
      <type>
        <snippet>true</snippet>
        <mtid>24</mtid>
        <code>24</code>
        <link>/api/publicationtype/24</link>
        <otype>PublicationType</otype>
        <label>Folyóiratcikk</label>
        <listPosition>1</listPosition>
        <published>true</published>
        <oldId>24</oldId>
        <otypeName>JournalArticle</otypeName>
      </type>
      <subType>
        <snippet>true</snippet>
        <mtid>1134514</mtid>
        <nameEng>Survey paper</nameEng>
        <docType>
          <snippet>true</snippet>
          <mtid>24</mtid>
          <code>24</code>
          <link>/api/publicationtype/24</link>
          <otype>PublicationType</otype>
          <label>Folyóiratcikk</label>
          <listPosition>1</listPosition>
          <published>true</published>
          <oldId>24</oldId>
          <otypeName>JournalArticle</otypeName>
        </docType>
        <link>/api/subtype/1134514</link>
        <name>Összefoglaló cikk</name>
        <otype>SubType</otype>
        <label>Összefoglaló cikk (Folyóiratcikk)</label>
        <listPosition>102</listPosition>
        <published>true</published>
        <oldId>1134514</oldId>
      </subType>
      <category>
        <snippet>true</snippet>
        <mtid>1</mtid>
        <link>/api/category/1</link>
        <otype>Category</otype>
        <label>Tudományos</label>
        <published>true</published>
        <oldId>1</oldId>
      </category>
      <firstAuthor>Al-Khrasani, Mahmoud</firstAuthor>
      <title>Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?</title>
      <journal>
        <snippet>true</snippet>
        <sciIndexed>true</sciIndexed>
        <link>/api/journal/732</link>
        <reviewType>REVIEWED</reviewType>
        <label>BIOMEDICINE &amp; PHARMACOTHERAPY 0753-3322 1950-6007</label>
        <published>true</published>
        <hungarian>false</hungarian>
        <oldId>732</oldId>
        <noIF>false</noIF>
        <mtid>732</mtid>
        <scopusIndexed>true</scopusIndexed>
        <pIssn>0753-3322</pIssn>
        <eIssn>1950-6007</eIssn>
        <otype>Journal</otype>
        <lang>FOREIGN</lang>
      </journal>
      <volume>189</volume>
      <internalId>118346</internalId>
      <firstPageOrInternalIdForSort>118346</firstPageOrInternalIdForSort>
      <pageLength>38</pageLength>
      <publishedYear>2025</publishedYear>
      <abstractText>Neuropathic pain (NP), a disease affecting the somatosensory nervous system, causes a high socioeconomic burden on healthcare systems and society; yet, its management has not been fully solved. Post COVID-19, with sequelae of the somatosensory system, further increases the number of individuals with chronic pain, thus further exacerbating the social burden related to NP. The pro-inflammatory mediators, such as TNF-α, IL-1β, and IL-6, are massively released in patients with COVID-19 and are known to be involved in the pathomechanisms of NP, particularly in relation to neuronal sensitization. Specifically, the release of large amounts of these pro-inflammatory cytokines from immune and non-immune effector cells during the acute and post COVID-19 phases prone to have substantial involvement in the development of post COVID-19 NP. Several preclinical and clinical studies have shown that vitamins’ supplementation, namely vitamins A, B1, B2, B3, B5, B6, B7, B9, B12, C, D, E, and K can attenuate the enhanced release of TNF-α, IL-1β, and IL-6. The early supplementation of these vitamins may mitigate the neuronal sensitization evoked by cytokine storm due to COVID-19 or other viruses. This strategy may provide a novel approach to prevent the development of post COVID-19 NP. This review highlights the mechanisms by which COVID-19 can induce NP and how vitamins may help to alleviate these post COVID-19 sequelae. © 2025 The Authors</abstractText>
      <fundings>
        <funding>
          <otype>Funding</otype>
          <mtid>2055447</mtid>
          <link>/api/funding/2055447</link>
          <label>(TKP2021-EGA-25)</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2055448</mtid>
          <link>/api/funding/2055448</link>
          <label>(RRF-2.3.1-21-2022-00003)</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
        <funding>
          <otype>Funding</otype>
          <mtid>2055449</mtid>
          <link>/api/funding/2055449</link>
          <label>Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH</label>
          <published>false</published>
          <snippet>true</snippet>
        </funding>
      </fundings>
      <digital/>
      <printed>true</printed>
      <collaboration>INTERNATIONAL</collaboration>
      <sourceYear>2025</sourceYear>
      <foreignEdition>true</foreignEdition>
      <foreignLanguage>true</foreignLanguage>
      <fullPublication>true</fullPublication>
      <conferencePublication>false</conferencePublication>
      <nationalOrigin>true</nationalOrigin>
      <missingAuthor>false</missingAuthor>
      <oaType>GOLD</oaType>
      <oaCheckDate>2026-09-08</oaCheckDate>
      <oaFree>true</oaFree>
      <oaLink>https://doi.org/10.1016/j.biopha.2025.118346</oaLink>
      <citationCount>7</citationCount>
      <citationCountUnpublished>0</citationCountUnpublished>
      <citationCountWoOther>7</citationCountWoOther>
      <independentCitCountWoOther>5</independentCitCountWoOther>
      <nationalOriginCitationCount>2</nationalOriginCitationCount>
      <foreignEditionCitationCount>7</foreignEditionCitationCount>
      <doiCitationCount>7</doiCitationCount>
      <wosCitationCount>7</wosCitationCount>
      <scopusCitationCount>7</scopusCitationCount>
      <wosScopusCitationCount>7</wosScopusCitationCount>
      <wosScopusCitationCountWoOther>7</wosScopusCitationCountWoOther>
      <wosScopusIndependentCitationCount>5</wosScopusIndependentCitationCount>
      <wosScopusIndependentCitationCountWoOther>5</wosScopusIndependentCitationCountWoOther>
      <independentCitationCount>5</independentCitationCount>
      <selfCitationCount>2</selfCitationCount>
      <unhandledCitationCount>0</unhandledCitationCount>
      <citingPubCount>7</citingPubCount>
      <independentCitingPubCount>5</independentCitingPubCount>
      <citingPubCountWoOther>7</citingPubCountWoOther>
      <independentCitingPubCountWoOther>5</independentCitingPubCountWoOther>
      <unhandledCitingPubCount>0</unhandledCitingPubCount>
      <citedPubCount>9</citedPubCount>
      <citedCount>9</citedCount>
      <pubStats>
        <types>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <count>7</count>
        </types>
        <types>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <count>0</count>
        </types>
        <types>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <count>0</count>
        </types>
        <types>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <count>0</count>
        </types>
        <types>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <count>0</count>
        </types>
        <types>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <count>0</count>
        </types>
        <types>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <count>0</count>
        </types>
        <types>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <count>0</count>
        </types>
        <citationTypes>
          <type>Folyóiratcikk</type>
          <typeEng>Journal Article</typeEng>
          <code>24</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyvrészlet</type>
          <typeEng>Chapter in Book</typeEng>
          <code>25</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Könyv</type>
          <typeEng>Book</typeEng>
          <code>23</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciaközlemény</type>
          <typeEng>Conference paper</typeEng>
          <code>31</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb konferenciakötet</type>
          <typeEng>Conference proceedings</typeEng>
          <code>32</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Oltalmi formák</type>
          <typeEng>Protection forms</typeEng>
          <code>26</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Disszertáció</type>
          <typeEng>Thesis</typeEng>
          <code>28</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Egyéb</type>
          <typeEng>Miscellaneous</typeEng>
          <code>29</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Alkotás</type>
          <typeEng>Achievement</typeEng>
          <code>22</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <citationTypes>
          <type>Kutatási adat</type>
          <typeEng>Research data</typeEng>
          <code>33</code>
          <countUnknown>0</countUnknown>
          <countIndependent>0</countIndependent>
          <countSelfCitation>0</countSelfCitation>
        </citationTypes>
        <years>
          <year>2026</year>
          <publicationCount>0</publicationCount>
          <citationCount>7</citationCount>
          <independentCitationCount>5</independentCitationCount>
          <citingPubCount>7</citingPubCount>
          <independentCitingPubCount>5</independentCitingPubCount>
          <oaStats/>
          <oaStats2/>
        </years>
      </pubStats>
      <ratingsForSort>D1</ratingsForSort>
      <predatorRatingsForSort>340575</predatorRatingsForSort>
      <hasCitationDuplums>false</hasCitationDuplums>
      <importDuplum>false</importDuplum>
      <importOverwritten>false</importOverwritten>
      <importSkipped>false</importSkipped>
      <userChangeableUntil>2025-07-18T15:15:47.285+0000</userChangeableUntil>
      <directInstitutesForSort>Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI)</directInstitutesForSort>
      <ownerAuthorCount>18</ownerAuthorCount>
      <ownerInstituteCount>41</ownerInstituteCount>
      <directInstituteCount>3</directInstituteCount>
      <authorCount>20</authorCount>
      <contributorCount>0</contributorCount>
      <hasQualityFactor>false</hasQualityFactor>
      <tempLockerIds>10025544</tempLockerIds>
      <languages>
        <language>
          <otype>Language</otype>
          <mtid>10002</mtid>
          <link>/api/language/10002</link>
          <label>Angol</label>
          <name>Angol</name>
          <nameEng>English</nameEng>
          <published>true</published>
          <oldId>2</oldId>
          <snippet>true</snippet>
        </language>
      </languages>
      <authorships>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310109</mtid>
          <link>/api/authorship/127310109</link>
          <label>Al-Khrasani, Mahmoud ✉ [Al-Khrasani, Mahmoud (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>1</listPosition>
          <share>0.05</share>
          <first>true</first>
          <last>false</last>
          <corresponding>true</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10015484</mtid>
            <link>/api/author/10015484</link>
            <label>Al-Khrasani Mahmoud (Farmakológia)</label>
            <familyName>Al-Khrasani</familyName>
            <givenName>Mahmoud</givenName>
            <published>true</published>
            <oldId>10015484</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Al-Khrasani</familyName>
          <givenName>Mahmoud</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310110</mtid>
          <link>/api/authorship/127310110</link>
          <label>Essmat, Nariman [Gomaa, Nariman Essmat Mohamed Abdeltawab (In vivo and in vi...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>2</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10090082</mtid>
            <link>/api/author/10090082</link>
            <label>Gomaa Nariman Essmat Mohamed Abdeltawab (In vivo and in vitro pain assessment)</label>
            <familyName>Gomaa</familyName>
            <givenName>Nariman Essmat Mohamed Abdeltawab</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Essmat</familyName>
          <givenName>Nariman</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310111</mtid>
          <link>/api/authorship/127310111</link>
          <label>Boldizsár, Imre [Boldizsár Jr, Imre (farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>3</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10096971</mtid>
            <link>/api/author/10096971</link>
            <label>Boldizsár Jr Imre (farmakológia)</label>
            <familyName>Boldizsár Jr</familyName>
            <givenName>Imre</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Boldizsár</familyName>
          <givenName>Imre</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310112</mtid>
          <link>/api/authorship/127310112</link>
          <label>Varga, Bence Tamás [Varga, Bence Tamás (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>4</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10075565</mtid>
            <link>/api/author/10075565</link>
            <label>Varga Bence Tamás (Farmakológia)</label>
            <familyName>Varga</familyName>
            <givenName>Bence Tamás</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Varga</familyName>
          <givenName>Bence Tamás</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310113</mtid>
          <link>/api/authorship/127310113</link>
          <label>Chalabiani, Yashar [Chalabiani, Yashar (neuropsychopharma...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>5</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10101816</mtid>
            <link>/api/author/10101816</link>
            <label>Chalabiani Yashar (neuropsychopharmacology)</label>
            <familyName>Chalabiani</familyName>
            <givenName>Yashar</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Chalabiani</familyName>
          <givenName>Yashar</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310114</mtid>
          <link>/api/authorship/127310114</link>
          <label>Abbood, Sarah Kadhim [Abbood, Sarah Kadhim (In vivo AND In vi...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>6</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10090125</mtid>
            <link>/api/author/10090125</link>
            <label>Abbood Sarah Kadhim (In vivo AND In vitro pain assessment)</label>
            <familyName>Abbood</familyName>
            <givenName>Sarah Kadhim</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Abbood</familyName>
          <givenName>Sarah Kadhim</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310115</mtid>
          <link>/api/authorship/127310115</link>
          <label>Ernyey, Aliz Judit [Ernyey, Alíz Judit (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>7</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10052997</mtid>
            <link>/api/author/10052997</link>
            <label>Ernyey Alíz Judit (Farmakológia)</label>
            <familyName>Ernyey</familyName>
            <givenName>Alíz Judit</givenName>
            <published>true</published>
            <oldId>10052997</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Ernyey</familyName>
          <givenName>Aliz Judit</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310116</mtid>
          <link>/api/authorship/127310116</link>
          <label>Király, Kornél [Király, Kornél P (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>8</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10015480</mtid>
            <link>/api/author/10015480</link>
            <label>Király Kornél P (Farmakológia)</label>
            <familyName>Király</familyName>
            <givenName>Kornél P</givenName>
            <published>true</published>
            <oldId>10015480</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Király</familyName>
          <givenName>Kornél</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310117</mtid>
          <link>/api/authorship/127310117</link>
          <label>Máté, Attila [Máté, Attila (Alvásmedicina, di...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>9</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10065644</mtid>
            <link>/api/author/10065644</link>
            <label>Máté Attila (Alvásmedicina, diabetes)</label>
            <familyName>Máté</familyName>
            <givenName>Attila</givenName>
            <published>true</published>
            <snippet>true</snippet>
          </author>
          <familyName>Máté</familyName>
          <givenName>Attila</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310118</mtid>
          <link>/api/authorship/127310118</link>
          <label>Riba, Pál [Riba, Pál (Farmakológia, opi...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>10</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10000721</mtid>
            <link>/api/author/10000721</link>
            <label>Riba Pál (Farmakológia, opioid fájdalomcsillapítás)</label>
            <familyName>Riba</familyName>
            <givenName>Pál</givenName>
            <published>true</published>
            <oldId>10000721</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Riba</familyName>
          <givenName>Pál</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310119</mtid>
          <link>/api/authorship/127310119</link>
          <label>Timár, Julia [Timár, Júlia (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I)</label>
          <listPosition>11</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10006033</mtid>
            <link>/api/author/10006033</link>
            <label>Timár Júlia (Farmakológia)</label>
            <familyName>Timár</familyName>
            <givenName>Júlia</givenName>
            <published>true</published>
            <oldId>10006033</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Timár</familyName>
          <givenName>Julia</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310120</mtid>
          <link>/api/authorship/127310120</link>
          <label>Gyertyán, István [Gyertyán, István (Viselkedésfarmako...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>12</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10009109</mtid>
            <link>/api/author/10009109</link>
            <label>Gyertyán István (Viselkedésfarmakológia)</label>
            <familyName>Gyertyán</familyName>
            <givenName>István</givenName>
            <published>true</published>
            <oldId>10009109</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Gyertyán</familyName>
          <givenName>István</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310121</mtid>
          <link>/api/authorship/127310121</link>
          <label>Miklya, Ildikó [Miklya, Ildikó (Neuropszichofarma...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>13</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10011448</mtid>
            <link>/api/author/10011448</link>
            <label>Miklya Ildikó (Neuropszichofarmakológia)</label>
            <familyName>Miklya</familyName>
            <givenName>Ildikó</givenName>
            <published>true</published>
            <oldId>10011448</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Miklya</familyName>
          <givenName>Ildikó</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310122</mtid>
          <link>/api/authorship/127310122</link>
          <label>Parenti, Carmela</label>
          <listPosition>14</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Parenti</familyName>
          <givenName>Carmela</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310123</mtid>
          <link>/api/authorship/127310123</link>
          <label>Pasquinucci, Lorella</label>
          <listPosition>15</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <familyName>Pasquinucci</familyName>
          <givenName>Lorella</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310124</mtid>
          <link>/api/authorship/127310124</link>
          <label>Ágg, Bence [Ágg, Bence (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>16</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10057401</mtid>
            <link>/api/author/10057401</link>
            <label>Ágg Bence (Farmakológia)</label>
            <familyName>Ágg</familyName>
            <givenName>Bence</givenName>
            <published>true</published>
            <oldId>10057401</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Ágg</familyName>
          <givenName>Bence</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310125</mtid>
          <link>/api/authorship/127310125</link>
          <label>Fürst, Susanna [Fürst, Zsuzsanna (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>17</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10005121</mtid>
            <link>/api/author/10005121</link>
            <label>Fürst Zsuzsanna (Farmakológia)</label>
            <familyName>Fürst</familyName>
            <givenName>Zsuzsanna</givenName>
            <published>true</published>
            <oldId>10005121</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Fürst</familyName>
          <givenName>Susanna</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310126</mtid>
          <link>/api/authorship/127310126</link>
          <label>Ferdinandy, Péter [Ferdinandy, Péter (Farmakológia, mol...), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>18</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10010125</mtid>
            <link>/api/author/10010125</link>
            <label>Ferdinandy Péter (Farmakológia, molekuláris medicina)</label>
            <familyName>Ferdinandy</familyName>
            <givenName>Péter</givenName>
            <published>true</published>
            <oldId>10010125</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Ferdinandy</familyName>
          <givenName>Péter</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310127</mtid>
          <link>/api/authorship/127310127</link>
          <label>Vizi, E. Sylvester [Vizi, E. Szilveszter (Neurofarmakológia...), szerző] Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I)</label>
          <listPosition>19</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>false</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10000023</mtid>
            <link>/api/author/10000023</link>
            <label>Vizi E. Szilveszter (Neurofarmakológia, neurokémia)</label>
            <familyName>Vizi</familyName>
            <givenName>E. Szilveszter</givenName>
            <published>true</published>
            <oldId>10000023</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Vizi</familyName>
          <givenName>E. Sylvester</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
        <authorship>
          <otype>PersonAuthorship</otype>
          <mtid>127310128</mtid>
          <link>/api/authorship/127310128</link>
          <label>Harsing, Laszlo G. [Hársing, László Gábor (Farmakológia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); Farmakológiai és Gyógyszerkutatás-fejlesztési K... (SE / KSZE)</label>
          <listPosition>20</listPosition>
          <share>0.05</share>
          <first>false</first>
          <last>true</last>
          <corresponding>false</corresponding>
          <author>
            <otype>Author</otype>
            <mtid>10000022</mtid>
            <link>/api/author/10000022</link>
            <label>Hársing László Gábor (Farmakológia)</label>
            <familyName>Hársing</familyName>
            <givenName>László Gábor</givenName>
            <published>true</published>
            <oldId>10000022</oldId>
            <snippet>true</snippet>
          </author>
          <familyName>Harsing</familyName>
          <givenName>Laszlo G.</givenName>
          <authorTyped>true</authorTyped>
          <editorTyped>false</editorTyped>
          <otherTyped>false</otherTyped>
          <type>
            <otype>AuthorshipType</otype>
            <mtid>1</mtid>
            <link>/api/authorshiptype/1</link>
            <label>Szerző</label>
            <code>0</code>
            <published>true</published>
            <oldId>0</oldId>
            <snippet>true</snippet>
          </type>
          <published>false</published>
          <snippet>true</snippet>
        </authorship>
      </authorships>
      <identifiers>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29611228</mtid>
          <link>/api/publicationidentifier/29611228</link>
          <label>DOI: 10.1016/j.biopha.2025.118346</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>6</mtid>
            <link>/api/publicationsource/6</link>
            <label>DOI</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10001</mtid>
              <link>/api/publicationsourcetype/10001</link>
              <label>DOI</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>DOI</name>
            <nameEng>DOI</nameEng>
            <linkPattern>https://doi.org/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>6</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <validState>IDENTICAL</validState>
          <idValue>10.1016/j.biopha.2025.118346</idValue>
          <realUrl>https://doi.org/10.1016/j.biopha.2025.118346</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29626417</mtid>
          <link>/api/publicationidentifier/29626417</link>
          <label>REAL: 221337</label>
          <source>
            <otype>SwordSource</otype>
            <mtid>36</mtid>
            <link>/api/publicationsource/36</link>
            <label>REAL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10007</mtid>
              <link>/api/publicationsourcetype/10007</link>
              <label>Repozitórium</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>REAL</name>
            <nameEng>REAL</nameEng>
            <linkPattern>https://real.mtak.hu/@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>36</oldId>
            <snippet>true</snippet>
          </source>
          <oaType>GOLD</oaType>
          <oaFree>true</oaFree>
          <validState>IDENTICAL</validState>
          <idValue>221337</idValue>
          <realUrl>https://real.mtak.hu/221337</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29621632</mtid>
          <link>/api/publicationidentifier/29621632</link>
          <label>Scopus: 105010506187</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>3</mtid>
            <link>/api/publicationsource/3</link>
            <label>Scopus</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Scopus</name>
            <nameEng>Scopus</nameEng>
            <linkPattern>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>3</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>105010506187</idValue>
          <realUrl>http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105010506187</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>29611229</mtid>
          <link>/api/publicationidentifier/29611229</link>
          <label>PubMed: 40664036</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>17</mtid>
            <link>/api/publicationsource/17</link>
            <label>PubMed</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10003</mtid>
              <link>/api/publicationsourcetype/10003</link>
              <label>Indexelő adatbázis</label>
              <mayHaveOa>false</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>PubMed</name>
            <nameEng>PubMed</nameEng>
            <linkPattern>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=@@@&amp;dopt=Abstract</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>17</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>40664036</idValue>
          <realUrl>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40664036&amp;dopt=Abstract</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
        <identifier>
          <otype>PublicationIdentifier</otype>
          <mtid>32485862</mtid>
          <link>/api/publicationidentifier/32485862</link>
          <label>Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402</label>
          <source>
            <otype>PlainSource</otype>
            <mtid>40</mtid>
            <link>/api/publicationsource/40</link>
            <label>Egyéb URL</label>
            <type>
              <otype>PublicationSourceType</otype>
              <mtid>10006</mtid>
              <link>/api/publicationsourcetype/10006</link>
              <label>Link</label>
              <mayHaveOa>true</mayHaveOa>
              <published>true</published>
              <snippet>true</snippet>
            </type>
            <name>Egyéb URL</name>
            <nameEng>Other URL</nameEng>
            <linkPattern>@@@</linkPattern>
            <publiclyVisible>true</publiclyVisible>
            <published>true</published>
            <oldId>40</oldId>
            <snippet>true</snippet>
          </source>
          <validState>IDENTICAL</validState>
          <idValue>https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402</idValue>
          <realUrl>https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402</realUrl>
          <published>false</published>
          <snippet>true</snippet>
        </identifier>
      </identifiers>
      <subjects>
        <classification>
          <otype>Classification</otype>
          <mtid>12124</mtid>
          <link>/api/classification/12124</link>
          <label>Orvos- és egészségtudomány</label>
          <published>true</published>
          <snippet>true</snippet>
        </classification>
      </subjects>
      <ratings>
        <rating>
          <otype>PredatorRating</otype>
          <mtid>11737513</mtid>
          <link>/api/predatorrating/11737513</link>
          <label>Norvég listás folyóirat:340575 BIOMEDICINE &amp; PHARMACOTHERAPY 0753-3322 1950-6007</label>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10033</mtid>
            <link>/api/ratingtype/10033</link>
            <label>Norvég listás folyóirat</label>
            <code>norveg</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <val>340575</val>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
        <rating>
          <otype>SjrRating</otype>
          <mtid>11602481</mtid>
          <link>/api/sjrrating/11602481</link>
          <label>sjr:D1 (2025) Scopus - Medicine (miscellaneous) BIOMEDICINE &amp; PHARMACOTHERAPY 0753-3322 1950-6007</label>
          <listPos>138</listPos>
          <rankValue>0.1</rankValue>
          <type>journal</type>
          <ratingType>
            <otype>RatingType</otype>
            <mtid>10002</mtid>
            <link>/api/ratingtype/10002</link>
            <label>sjr</label>
            <code>sjr</code>
            <published>true</published>
            <snippet>true</snippet>
          </ratingType>
          <subject>
            <otype>ClassificationExternal</otype>
            <mtid>2701</mtid>
            <link>/api/classificationexternal/2701</link>
            <label>Scopus - Medicine (miscellaneous)</label>
            <published>true</published>
            <oldId>2701</oldId>
            <snippet>true</snippet>
          </subject>
          <ranking>D1</ranking>
          <calculation>DIRECT</calculation>
          <published>true</published>
          <snippet>true</snippet>
        </rating>
      </ratings>
      <references>
        <reference>
          <otype>Reference</otype>
          <mtid>66923562</mtid>
          <link>/api/reference/66923562</link>
          <label>1. Dong 2020: An interactive web-based dashboard to track COVID-19 in real time., Lancet Infect. Dis., 20, DOI: 10.1016/S1473-3099(20)30120-1</label>
          <listPosition>1</listPosition>
          <doi>10.1016/S1473-3099(20)30120-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923563</mtid>
          <link>/api/reference/66923563</link>
          <label>2. Soriano 2022: A clinical case definition of post-COVID-19 condition by a Delphi consensus., Lancet Infect. Dis., 22, DOI: 10.1016/S1473-3099(21)00703-9</label>
          <listPosition>2</listPosition>
          <doi>10.1016/S1473-3099(21)00703-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923564</mtid>
          <link>/api/reference/66923564</link>
          <label>3. Venkatesan 2021: NICE guideline on long COVID., Lancet Respir. Med, 9, DOI: 10.1016/S2213-2600(21)00031-X</label>
          <listPosition>3</listPosition>
          <doi>10.1016/S2213-2600(21)00031-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923565</mtid>
          <link>/api/reference/66923565</link>
          <label>4. Huerne 2023: Epidemiological and clinical perspectives of long COVID syndrome., Am. J. Med. Open, 9, DOI: 10.1016/j.ajmo.2023.100033</label>
          <listPosition>4</listPosition>
          <doi>10.1016/j.ajmo.2023.100033</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923566</mtid>
          <link>/api/reference/66923566</link>
          <label>5. Ledford 2021: Do vaccines protect against long COVID? What the data say., Nature, 599, DOI: 10.1038/d41586-021-03495-2</label>
          <listPosition>5</listPosition>
          <doi>10.1038/d41586-021-03495-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923567</mtid>
          <link>/api/reference/66923567</link>
          <label>6. Taquet 2022: Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections., Brain Behav. Immun., 103, DOI: 10.1016/j.bbi.2022.04.013</label>
          <listPosition>6</listPosition>
          <doi>10.1016/j.bbi.2022.04.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923568</mtid>
          <link>/api/reference/66923568</link>
          <label>7. Tandon 2024: Unraveling links between chronic inflammation and long COVID: workshop report., J. Immunol., 212, DOI: 10.4049/jimmunol.2300804</label>
          <listPosition>7</listPosition>
          <doi>10.4049/jimmunol.2300804</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923569</mtid>
          <link>/api/reference/66923569</link>
          <label>8. Puelles 2020: Multiorgan and renal tropism of SARS-CoV-2., N. Engl. J. Med., 383, DOI: 10.1056/NEJMc2011400</label>
          <listPosition>8</listPosition>
          <doi>10.1056/NEJMc2011400</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923570</mtid>
          <link>/api/reference/66923570</link>
          <label>9. Louis 2022: Extra-pulmonary complications in SARS-CoV-2 infection: a comprehensive multi organ-system review., Microorganisms, 10, DOI: 10.3390/microorganisms10010153</label>
          <listPosition>9</listPosition>
          <doi>10.3390/microorganisms10010153</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923571</mtid>
          <link>/api/reference/66923571</link>
          <label>10. Pesce 2021: COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart., Cardiovasc Res, 117, DOI: 10.1093/cvr/cvab201</label>
          <listPosition>10</listPosition>
          <doi>10.1093/cvr/cvab201</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923572</mtid>
          <link>/api/reference/66923572</link>
          <label>11. Gyöngyösi 2023: Cardiovasc Res, 119, DOI: 10.1093/cvr/cvac115</label>
          <listPosition>11</listPosition>
          <doi>10.1093/cvr/cvac115</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923573</mtid>
          <link>/api/reference/66923573</link>
          <label>12. Davis 2021: Characterizing long COVID in an international cohort: 7 months of symptoms and their impact., EClinicalMedicine, 38, DOI: 10.1016/j.eclinm.2021.101019</label>
          <listPosition>12</listPosition>
          <doi>10.1016/j.eclinm.2021.101019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923574</mtid>
          <link>/api/reference/66923574</link>
          <label>13. Shanthanna 2022: The COVID-19 pandemic and its consequences for chronic pain: a narrative review., Anaesthesia, 77, DOI: 10.1111/anae.15801</label>
          <listPosition>13</listPosition>
          <doi>10.1111/anae.15801</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923575</mtid>
          <link>/api/reference/66923575</link>
          <label>14. Tabacof 2024: Distinguishing pain profiles among individuals with long COVID., Front. Rehabil. Sci., 5, DOI: 10.3389/fresc.2024.1448816</label>
          <listPosition>14</listPosition>
          <doi>10.3389/fresc.2024.1448816</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923576</mtid>
          <link>/api/reference/66923576</link>
          <label>15. Kabir 2023: Profile of long COVID symptoms needing rehabilitation: a cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh., Arch. Public Health, 81, DOI: 10.1186/s13690-023-01140-0</label>
          <listPosition>15</listPosition>
          <doi>10.1186/s13690-023-01140-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923577</mtid>
          <link>/api/reference/66923577</link>
          <label>16. Barke 2022: Classification of chronic pain for the International classification of diseases (ICD-11): results of the 2017 international world health organization field testing., Pain, 163, DOI: 10.1097/j.pain.0000000000002287</label>
          <listPosition>16</listPosition>
          <doi>10.1097/j.pain.0000000000002287</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923578</mtid>
          <link>/api/reference/66923578</link>
          <label>17. Treede 2019: Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11)., Pain, 160, DOI: 10.1097/j.pain.0000000000001384</label>
          <listPosition>17</listPosition>
          <doi>10.1097/j.pain.0000000000001384</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923579</mtid>
          <link>/api/reference/66923579</link>
          <label>18. Finnerup 2021: Neuropathic pain: frommechanisms to treatment., Physiol. Rev., 101, DOI: 10.1152/physrev.00045.2019</label>
          <listPosition>18</listPosition>
          <doi>10.1152/physrev.00045.2019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923580</mtid>
          <link>/api/reference/66923580</link>
          <label>19. Colloca 2017: Neuropathic pain., Nat. Rev. Dis. Prim., 3</label>
          <listPosition>19</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923581</mtid>
          <link>/api/reference/66923581</link>
          <label>20. Kutzsche 2024: An orally available Cav2.2 calcium channel inhibitor for the treatment of neuropathic pain., Br. J. Pharm., 181, DOI: 10.1111/bph.16309</label>
          <listPosition>20</listPosition>
          <doi>10.1111/bph.16309</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923582</mtid>
          <link>/api/reference/66923582</link>
          <label>21. Kamerman 2012: Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models., J. Peripher. Nerv. Syst., 17, DOI: 10.1111/j.1529-8027.2012.00373.x</label>
          <listPosition>21</listPosition>
          <doi>10.1111/j.1529-8027.2012.00373.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923583</mtid>
          <link>/api/reference/66923583</link>
          <label>22. Xu 2024: Exploring viral neuropathic pain: molecular mechanisms and therapeutic implications., PLoS Pathog., 20, DOI: 10.1371/journal.ppat.1012397</label>
          <listPosition>22</listPosition>
          <doi>10.1371/journal.ppat.1012397</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923584</mtid>
          <link>/api/reference/66923584</link>
          <label>23. Zis 2022: Prevalence and determinants of chronic pain post-COVID; cross-sectional study., J. Clin. Med, 11, DOI: 10.3390/jcm11195569</label>
          <listPosition>23</listPosition>
          <doi>10.3390/jcm11195569</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923585</mtid>
          <link>/api/reference/66923585</link>
          <label>24. Van Hecke 2014: Neuropathic pain in the general population: a systematic review of epidemiological studies., Pain, 155, p. 654, DOI: 10.1016/j.pain.2013.11.013</label>
          <listPosition>24</listPosition>
          <doi>10.1016/j.pain.2013.11.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923586</mtid>
          <link>/api/reference/66923586</link>
          <label>25. Simonin 2023: Neurobiology of long-COVID: hypotheses and unanswered questions., Anaesth. Crit. Care Pain. Med, 42</label>
          <listPosition>25</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923587</mtid>
          <link>/api/reference/66923587</link>
          <label>26. Monje 2022: The neurobiology of long COVID., Neuron, 110, DOI: 10.1016/j.neuron.2022.10.006</label>
          <listPosition>26</listPosition>
          <doi>10.1016/j.neuron.2022.10.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923588</mtid>
          <link>/api/reference/66923588</link>
          <label>27. Scholkmann 2023: COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): similarities and differences., Pathol. Res Pr., 246</label>
          <listPosition>27</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923589</mtid>
          <link>/api/reference/66923589</link>
          <label>28. Nalbandian 2021: Post-acute COVID-19 syndrome., Nat. Med, 27, DOI: 10.1038/s41591-021-01283-z</label>
          <listPosition>28</listPosition>
          <doi>10.1038/s41591-021-01283-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923590</mtid>
          <link>/api/reference/66923590</link>
          <label>29. Williams 2023: COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis., J. Clin. Med, 12, DOI: 10.3390/jcm12041672</label>
          <listPosition>29</listPosition>
          <doi>10.3390/jcm12041672</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923591</mtid>
          <link>/api/reference/66923591</link>
          <label>30. Huang 2020: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China., Lancet, 395, DOI: 10.1016/S0140-6736(20)30183-5</label>
          <listPosition>30</listPosition>
          <doi>10.1016/S0140-6736(20)30183-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923592</mtid>
          <link>/api/reference/66923592</link>
          <label>31. Saxena 2021: Role of interluekin – 6 as a prognostic marker in covid-19 patients in a tertiary care centre in Indore district, STATE M.P.., Int J. Med Biomed. Stud., 5</label>
          <listPosition>31</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923593</mtid>
          <link>/api/reference/66923593</link>
          <label>32. Herold 2020: Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19., J. Allergy Clin. Immunol., 146, DOI: 10.1016/j.jaci.2020.05.008</label>
          <listPosition>32</listPosition>
          <doi>10.1016/j.jaci.2020.05.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923594</mtid>
          <link>/api/reference/66923594</link>
          <label>33. Sayers 2022: The E-utilities In-Depth: Parameters, Syntax and More.Entrez Programming Utilities Help [Internet]</label>
          <listPosition>33</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923595</mtid>
          <link>/api/reference/66923595</link>
          <label>34. Ágg 2019: The EntOptLayout Cytoscape plug-in for the efficient visualization of major protein complexes in protein-protein interaction and signalling networks., Bioinformatics, 35, DOI: 10.1093/bioinformatics/btz257</label>
          <listPosition>34</listPosition>
          <doi>10.1093/bioinformatics/btz257</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923596</mtid>
          <link>/api/reference/66923596</link>
          <label>35. Shannon 2003: Cytoscape: A software Environment for integrated models of biomolecular interaction networks., Genome Res, 13, DOI: 10.1101/gr.1239303</label>
          <listPosition>35</listPosition>
          <doi>10.1101/gr.1239303</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923597</mtid>
          <link>/api/reference/66923597</link>
          <label>36. Ozisik 2022: Overlap of vitamin A and vitamin D target genes with CAKUT-related processes., F1000Res, 10, DOI: 10.12688/f1000research.51018.2</label>
          <listPosition>36</listPosition>
          <doi>10.12688/f1000research.51018.2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923598</mtid>
          <link>/api/reference/66923598</link>
          <label>37. Davis 2025: Comparative toxicogenomics database’s 20th anniversary: update 2025., Nucleic Acids Res, 53, p. D1328, DOI: 10.1093/nar/gkae883</label>
          <listPosition>37</listPosition>
          <doi>10.1093/nar/gkae883</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923599</mtid>
          <link>/api/reference/66923599</link>
          <label>38. Thomas 2022: PANTHER: making genome-scale phylogenetics accessible to all., Protein Sci., 31, DOI: 10.1002/pro.4218</label>
          <listPosition>38</listPosition>
          <doi>10.1002/pro.4218</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923600</mtid>
          <link>/api/reference/66923600</link>
          <label>39. Ashburner 2000: Gene ontology: tool for the unification of biology., Nat. Genet, 25, DOI: 10.1038/75556</label>
          <listPosition>39</listPosition>
          <doi>10.1038/75556</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923601</mtid>
          <link>/api/reference/66923601</link>
          <label>40. Aleksander 2023: The gene ontology knowledgebase in 2023., Genetics, 224</label>
          <listPosition>40</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923602</mtid>
          <link>/api/reference/66923602</link>
          <label>41. McFarland 2021: Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain., Pain. Rep., 6</label>
          <listPosition>41</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923603</mtid>
          <link>/api/reference/66923603</link>
          <label>42. Talkington 2024: Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics., Front Neurol., 15</label>
          <listPosition>42</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923604</mtid>
          <link>/api/reference/66923604</link>
          <label>43. Tavares-Júnior 2024: Long COVID: neurological manifestations — an updated narrative review, Dementia e., Neuropsychologia, 18</label>
          <listPosition>43</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923605</mtid>
          <link>/api/reference/66923605</link>
          <label>44. Siepmann 2020: Neuralgic amyotrophy following infection with SARS-CoV-2., Muscle Nerve, 62, DOI: 10.1002/mus.27035</label>
          <listPosition>44</listPosition>
          <doi>10.1002/mus.27035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923606</mtid>
          <link>/api/reference/66923606</link>
          <label>45. Cao 2020: Herpes zoster and postherpetic neuralgia in an elderly patient with critical COVID-19: A case report., J. Pain. Res, 13, DOI: 10.2147/JPR.S274199</label>
          <listPosition>45</listPosition>
          <doi>10.2147/JPR.S274199</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923607</mtid>
          <link>/api/reference/66923607</link>
          <label>46. Joshi 2022: Neuropathic pain associated with COVID-19: a systematic review of case reports., Curr. Pain. Headache Rep., 26, DOI: 10.1007/s11916-022-01065-3</label>
          <listPosition>46</listPosition>
          <doi>10.1007/s11916-022-01065-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923608</mtid>
          <link>/api/reference/66923608</link>
          <label>47. Needham 2021: Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19., J. Neurol., 268, DOI: 10.1007/s00415-020-10321-8</label>
          <listPosition>47</listPosition>
          <doi>10.1007/s00415-020-10321-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923609</mtid>
          <link>/api/reference/66923609</link>
          <label>48. Herrero-Montes 2022: Prevalence of neuropathic component in post-COVID pain symptoms in previously hospitalized COVID-19 Survivors., Int J. Clin. Pr., 2022</label>
          <listPosition>48</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923610</mtid>
          <link>/api/reference/66923610</link>
          <label>49. Topal 2022: Post-COVID-19 pain syndrome: a descriptive study in Turkish population., Korean J. Pain., 35, DOI: 10.3344/kjp.2022.35.4.468</label>
          <listPosition>49</listPosition>
          <doi>10.3344/kjp.2022.35.4.468</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923611</mtid>
          <link>/api/reference/66923611</link>
          <label>50. Comruk 2023: Y. Ersoy, Neuropathic pain in patients with post-COVID-19., North Clin. Istanb. 10, DOI: 10.14744/nci.2022.31932</label>
          <listPosition>50</listPosition>
          <doi>10.14744/nci.2022.31932</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923612</mtid>
          <link>/api/reference/66923612</link>
          <label>51. Aykaç 2023: An analysis of neuropathic pain, vasomotor manifestations, and sympathetic skin reactions in post-COVID-19 patients relative to healthy individuals., Med. (U. S. ), 102</label>
          <listPosition>51</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923613</mtid>
          <link>/api/reference/66923613</link>
          <label>52. Gümüş Atalay 2024: Neuropathic component of chronic musculoskeletal pain in patients with post-COVID-19: a cross-sectional study., Arch. Rheuma, 39, p. 436, DOI: 10.46497/ArchRheumatol.2024.9990</label>
          <listPosition>52</listPosition>
          <doi>10.46497/ArchRheumatol.2024.9990</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923614</mtid>
          <link>/api/reference/66923614</link>
          <label>53. Fernández-de-las-Peñas 2023: Neuropathic post-COVID pain symptomatology is not associated with serological biomarkers at hospital admission and hospitalization treatment in COVID-19 survivors., Front Med (Lausanne), 10</label>
          <listPosition>53</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923615</mtid>
          <link>/api/reference/66923615</link>
          <label>54. Martinez 2023: Chronic pain characteristics in COVID-19 survivors after an ICU stay. A cross-sectional study., Anaesth. Crit. Care Pain. Med, 42</label>
          <listPosition>54</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923616</mtid>
          <link>/api/reference/66923616</link>
          <label>55. Di Stefano 2023: A systematic review and meta-analysis of neuropathic pain associated with coronavirus disease 2019., Eur. J. Pain. (U. Kingd. ), 27</label>
          <listPosition>55</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923617</mtid>
          <link>/api/reference/66923617</link>
          <label>56. Ocak 2022: Evaluation of neuropatic pain features in COVID-19 patients., Neurol. India, 70, DOI: 10.4103/0028-3886.344625</label>
          <listPosition>56</listPosition>
          <doi>10.4103/0028-3886.344625</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923618</mtid>
          <link>/api/reference/66923618</link>
          <label>57. Petrucci 2022: Pain in critically ill COVID-19 patients: an Italian retrospective study., Open Med. (Pol. ), 17</label>
          <listPosition>57</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923619</mtid>
          <link>/api/reference/66923619</link>
          <label>58. Shil 2023: A clinical approach to the investigation and management of long COVID associated neuropathic pain., Eur. Arch. Psychiatry Clin. Neurosci.</label>
          <listPosition>58</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923620</mtid>
          <link>/api/reference/66923620</link>
          <label>59. Fernández-De-las-peñas 2022: The self-reported leeds assessment of neuropathic symptoms and signs (S-LANSS) and PainDETECT Questionnaires in COVID-19 survivors with post-COVID Pain., Viruses, 14, DOI: 10.3390/v14071486</label>
          <listPosition>59</listPosition>
          <doi>10.3390/v14071486</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923621</mtid>
          <link>/api/reference/66923621</link>
          <label>60. Attal 2021: Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic., Pain. Rep., 6</label>
          <listPosition>60</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923622</mtid>
          <link>/api/reference/66923622</link>
          <label>61. Oaklander 2022: Peripheral neuropathy evaluations of patients with prolonged long COVID., Neurol. Neuroimmunol. Neuroinflamm., 9, DOI: 10.1212/NXI.0000000000001146</label>
          <listPosition>61</listPosition>
          <doi>10.1212/NXI.0000000000001146</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923623</mtid>
          <link>/api/reference/66923623</link>
          <label>62. Magdy 2022: Characteristics and risk factors of persistent neuropathic pain in recovered COVID-19 patients., Pain. Med. (U. S., 23</label>
          <listPosition>62</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923624</mtid>
          <link>/api/reference/66923624</link>
          <label>63. Galambos 2024: Glycine transporter 1 inhibitors: predictions on their possible mechanisms in the development of opioid analgesic tolerance., Biomedicines, 12, DOI: 10.3390/biomedicines12020421</label>
          <listPosition>63</listPosition>
          <doi>10.3390/biomedicines12020421</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923625</mtid>
          <link>/api/reference/66923625</link>
          <label>64. Sivilotti 1994: The contribution of GABA(A) and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord., J. Neurophysiol., 72, DOI: 10.1152/jn.1994.72.1.169</label>
          <listPosition>64</listPosition>
          <doi>10.1152/jn.1994.72.1.169</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923626</mtid>
          <link>/api/reference/66923626</link>
          <label>65. Woolf 1999: Neuropathic pain: aetiology, symptoms, mechanisms, and management., Lancet, 353, p. 1959, DOI: 10.1016/S0140-6736(99)01307-0</label>
          <listPosition>65</listPosition>
          <doi>10.1016/S0140-6736(99)01307-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923627</mtid>
          <link>/api/reference/66923627</link>
          <label>66. Ji 2003: Central sensitization and LTP: do pain and memory share similar mechanisms?., Trends Neurosci., 26, DOI: 10.1016/j.tins.2003.09.017</label>
          <listPosition>66</listPosition>
          <doi>10.1016/j.tins.2003.09.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923628</mtid>
          <link>/api/reference/66923628</link>
          <label>67. Julius 2001: Molecular mechanisms of nociception., Nature, 413, DOI: 10.1038/35093019</label>
          <listPosition>67</listPosition>
          <doi>10.1038/35093019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923629</mtid>
          <link>/api/reference/66923629</link>
          <label>68. Woolf 2000: Neuronal plasticity: increasing the gain in pain., Science, 288, p. 1979, DOI: 10.1126/science.288.5472.1765</label>
          <listPosition>68</listPosition>
          <doi>10.1126/science.288.5472.1765</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923630</mtid>
          <link>/api/reference/66923630</link>
          <label>69. Baron 2013: Peripheral input and its importance for central sensitization., Ann. Neurol., 74, DOI: 10.1002/ana.24017</label>
          <listPosition>69</listPosition>
          <doi>10.1002/ana.24017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923631</mtid>
          <link>/api/reference/66923631</link>
          <label>70. Young 2014: Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels., Pain, 155, DOI: 10.1016/j.pain.2014.05.021</label>
          <listPosition>70</listPosition>
          <doi>10.1016/j.pain.2014.05.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923632</mtid>
          <link>/api/reference/66923632</link>
          <label>71. Tibbs 2016: Voltage-gated ion channels in the PNS: novel therapies for neuropathic pain?., Trends Pharm. Sci., 37, DOI: 10.1016/j.tips.2016.05.002</label>
          <listPosition>71</listPosition>
          <doi>10.1016/j.tips.2016.05.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923633</mtid>
          <link>/api/reference/66923633</link>
          <label>72. Basbaum 2009: Cellular and molecular mechanisms of pain., Cell, 139, DOI: 10.1016/j.cell.2009.09.028</label>
          <listPosition>72</listPosition>
          <doi>10.1016/j.cell.2009.09.028</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923634</mtid>
          <link>/api/reference/66923634</link>
          <label>73. Latremoliere 2009: Central sensitization: a generator of pain hypersensitivity by central neural plasticity., J. Pain., 10, DOI: 10.1016/j.jpain.2009.06.012</label>
          <listPosition>73</listPosition>
          <doi>10.1016/j.jpain.2009.06.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923635</mtid>
          <link>/api/reference/66923635</link>
          <label>74. Al-Khrasani 2019: Glycine transporter inhibitors: a new avenue for managing neuropathic pain., Brain Res Bull., 152, p. 143, DOI: 10.1016/j.brainresbull.2019.07.008</label>
          <listPosition>74</listPosition>
          <doi>10.1016/j.brainresbull.2019.07.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923636</mtid>
          <link>/api/reference/66923636</link>
          <label>75. Baron 2010: Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment., Lancet Neurol., 9, p. 807, DOI: 10.1016/S1474-4422(10)70143-5</label>
          <listPosition>75</listPosition>
          <doi>10.1016/S1474-4422(10)70143-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923637</mtid>
          <link>/api/reference/66923637</link>
          <label>76. Finnerup 2021: Neuropathic pain: frommechanisms to treatment., Physiol. Rev., 101, DOI: 10.1152/physrev.00045.2019</label>
          <listPosition>76</listPosition>
          <doi>10.1152/physrev.00045.2019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923638</mtid>
          <link>/api/reference/66923638</link>
          <label>77. Gabay 2011: Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury., Eur. J. Pain., 15</label>
          <listPosition>77</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923639</mtid>
          <link>/api/reference/66923639</link>
          <label>78. Wolf 2006: Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice., Pain, 120, DOI: 10.1016/j.pain.2005.11.011</label>
          <listPosition>78</listPosition>
          <doi>10.1016/j.pain.2005.11.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923640</mtid>
          <link>/api/reference/66923640</link>
          <label>79. Honore 2006: Interleukin-1αβ gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain., Behav. Brain Res., 167, DOI: 10.1016/j.bbr.2005.09.024</label>
          <listPosition>79</listPosition>
          <doi>10.1016/j.bbr.2005.09.024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923641</mtid>
          <link>/api/reference/66923641</link>
          <label>80. H. Fukuoka, M. Kawatani, T. Hisamitsu, C. Takeshige, Cutaneous hyperalgesia induced by peripheral injection of interleukin-lfl in the rat, 1994., DOI: 10.1016/0006-8993(94)90960-1</label>
          <listPosition>80</listPosition>
          <doi>10.1016/0006-8993(94)90960-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923642</mtid>
          <link>/api/reference/66923642</link>
          <label>81. Ferreira 1988: Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue., Nature, 334, DOI: 10.1038/334698a0</label>
          <listPosition>81</listPosition>
          <doi>10.1038/334698a0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923643</mtid>
          <link>/api/reference/66923643</link>
          <label>82. Watkins 1994: Characterization of cytokine-induced hyperalgesia., Brain Res, 654, DOI: 10.1016/0006-8993(94)91566-0</label>
          <listPosition>82</listPosition>
          <doi>10.1016/0006-8993(94)91566-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923644</mtid>
          <link>/api/reference/66923644</link>
          <label>83. Kleibeuker 2008: IL-1β signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2., Brain Behav. Immun., 22, DOI: 10.1016/j.bbi.2007.07.009</label>
          <listPosition>83</listPosition>
          <doi>10.1016/j.bbi.2007.07.009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923645</mtid>
          <link>/api/reference/66923645</link>
          <label>84. Binshtok 2008: Nociceptors are interleukin-1beta sensors., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.3795-08.2008</label>
          <listPosition>84</listPosition>
          <doi>10.1523/JNEUROSCI.3795-08.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923646</mtid>
          <link>/api/reference/66923646</link>
          <label>85. Rahman 2024: Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management., Life Sci., 355, DOI: 10.1016/j.lfs.2024.122954</label>
          <listPosition>85</listPosition>
          <doi>10.1016/j.lfs.2024.122954</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923647</mtid>
          <link>/api/reference/66923647</link>
          <label>86. Ebbinghaus 2012: The role of interleukin-1β in arthritic pain: main involvement in thermal, but not mechanical, hyperalgesia in rat antigen-induced arthritis., Arthritis Rheum., 64, DOI: 10.1002/art.34675</label>
          <listPosition>86</listPosition>
          <doi>10.1002/art.34675</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923648</mtid>
          <link>/api/reference/66923648</link>
          <label>87. Mika 2008: Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model., Pain, 138, DOI: 10.1016/j.pain.2008.02.015</label>
          <listPosition>87</listPosition>
          <doi>10.1016/j.pain.2008.02.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923649</mtid>
          <link>/api/reference/66923649</link>
          <label>88. Sommer 2001: Etanercept reduces hyperalgesia in experimental painful neuropathy., J. Peripher. Nerv. Syst., 6, DOI: 10.1111/j.1529-8027.2001.01010.x</label>
          <listPosition>88</listPosition>
          <doi>10.1111/j.1529-8027.2001.01010.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923650</mtid>
          <link>/api/reference/66923650</link>
          <label>89. Schäfers 2003: Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons., J. Neurosci., 23</label>
          <listPosition>89</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923651</mtid>
          <link>/api/reference/66923651</link>
          <label>90. Jin 2006: Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-α., J. Neurosci., 26, DOI: 10.1523/JNEUROSCI.3858-05.2006</label>
          <listPosition>90</listPosition>
          <doi>10.1523/JNEUROSCI.3858-05.2006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923652</mtid>
          <link>/api/reference/66923652</link>
          <label>91. Fernandes 2011: A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund’s complete adjuvant-induced monarthritis., Arthritis Rheum., 63, DOI: 10.1002/art.30150</label>
          <listPosition>91</listPosition>
          <doi>10.1002/art.30150</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923653</mtid>
          <link>/api/reference/66923653</link>
          <label>92. Fang 2015: Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: Roles in the development of bone cancer pain in a rat model., Pain, 156, DOI: 10.1097/j.pain.0000000000000158</label>
          <listPosition>92</listPosition>
          <doi>10.1097/j.pain.0000000000000158</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923654</mtid>
          <link>/api/reference/66923654</link>
          <label>93. Malsch 2014: Deletion of interleukin-6 signal transducer gp130 in small sensory neurons attenuates mechanonociception and down-regulates TRPA1 expression., J. Neurosci., 34, DOI: 10.1523/JNEUROSCI.5161-13.2014</label>
          <listPosition>93</listPosition>
          <doi>10.1523/JNEUROSCI.5161-13.2014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923655</mtid>
          <link>/api/reference/66923655</link>
          <label>94. Hsieh 2018: Spinal TNF-α impedes Fbxo45-dependent Munc13-1 ubiquitination to mediate neuropathic allodynia in rats., Cell Death Dis., 9, DOI: 10.1038/s41419-018-0859-4</label>
          <listPosition>94</listPosition>
          <doi>10.1038/s41419-018-0859-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923656</mtid>
          <link>/api/reference/66923656</link>
          <label>95. Woolf 1997: Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α., Br. J. Pharm., 121, DOI: 10.1038/sj.bjp.0701148</label>
          <listPosition>95</listPosition>
          <doi>10.1038/sj.bjp.0701148</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923657</mtid>
          <link>/api/reference/66923657</link>
          <label>96. Morioka 2015: Tumor necrosis factor-mediated downregulation of spinal astrocytic connexin43 leads to increased glutamatergic neurotransmission and neuropathic pain in mice., Brain Behav. Immun., 49, DOI: 10.1016/j.bbi.2015.06.015</label>
          <listPosition>96</listPosition>
          <doi>10.1016/j.bbi.2015.06.015</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923658</mtid>
          <link>/api/reference/66923658</link>
          <label>97. Cunha 1992: The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia., Br. J. Pharm., 107, DOI: 10.1111/j.1476-5381.1992.tb14503.x</label>
          <listPosition>97</listPosition>
          <doi>10.1111/j.1476-5381.1992.tb14503.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923659</mtid>
          <link>/api/reference/66923659</link>
          <label>98. Nicol 1997: Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons., J. Neurosci., 17, DOI: 10.1523/JNEUROSCI.17-03-00975.1997</label>
          <listPosition>98</listPosition>
          <doi>10.1523/JNEUROSCI.17-03-00975.1997</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923660</mtid>
          <link>/api/reference/66923660</link>
          <label>99. Sweitzer 2001: Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain., Neuroscience, 103, DOI: 10.1016/S0306-4522(00)00574-1</label>
          <listPosition>99</listPosition>
          <doi>10.1016/S0306-4522(00)00574-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923661</mtid>
          <link>/api/reference/66923661</link>
          <label>100. Zhou 2016: Interleukin-6: An emerging regulator of pathological pain., J. Neuroinflamm., 13, DOI: 10.1186/s12974-016-0607-6</label>
          <listPosition>100</listPosition>
          <doi>10.1186/s12974-016-0607-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923662</mtid>
          <link>/api/reference/66923662</link>
          <label>101. Avona 2021: Interleukin-6 induces spatially dependent whole-body hypersensitivity in rats: implications for extracephalic hypersensitivity in migraine., J. Headache Pain., 22, DOI: 10.1186/s10194-021-01286-8</label>
          <listPosition>101</listPosition>
          <doi>10.1186/s10194-021-01286-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923663</mtid>
          <link>/api/reference/66923663</link>
          <label>102. Burgos-Vega 2016: Dural stimulation in rats causes brain-derived neurotrophic factor-dependent priming to subthreshold stimuli including a migraine trigger., Pain, 157, DOI: 10.1097/j.pain.0000000000000692</label>
          <listPosition>102</listPosition>
          <doi>10.1097/j.pain.0000000000000692</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923664</mtid>
          <link>/api/reference/66923664</link>
          <label>103. Yang 2022: Red nucleus interleukin-6 evokes tactile allodynia in male rats through modulating spinal pro-inflammatory and anti-inflammatory cytokines., Front Mol. Neurosci., 15, DOI: 10.3389/fnmol.2022.820664</label>
          <listPosition>103</listPosition>
          <doi>10.3389/fnmol.2022.820664</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923665</mtid>
          <link>/api/reference/66923665</link>
          <label>104. Chen 2023: Macrophages in immunoregulation and therapeutics., Signal Transduct. Target Ther., 8</label>
          <listPosition>104</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923666</mtid>
          <link>/api/reference/66923666</link>
          <label>105. Watkins 1995: Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states., Pain, 63, DOI: 10.1016/0304-3959(95)00186-7</label>
          <listPosition>105</listPosition>
          <doi>10.1016/0304-3959(95)00186-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923667</mtid>
          <link>/api/reference/66923667</link>
          <label>106. Watkins 1995: Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia., Brain Res, 692, DOI: 10.1016/0006-8993(95)00715-3</label>
          <listPosition>106</listPosition>
          <doi>10.1016/0006-8993(95)00715-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923668</mtid>
          <link>/api/reference/66923668</link>
          <label>107. Woolf 1997: nerve growth factor and in¯ammatory hyperalgesia: the contribution of tumour necrosis factor a., Cytokines</label>
          <listPosition>107</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923669</mtid>
          <link>/api/reference/66923669</link>
          <label>108. Safieh-Garabedian 1995: Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia., Br. J. Pharm., 115, DOI: 10.1111/j.1476-5381.1995.tb15035.x</label>
          <listPosition>108</listPosition>
          <doi>10.1111/j.1476-5381.1995.tb15035.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923670</mtid>
          <link>/api/reference/66923670</link>
          <label>109. Oka 1995: Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats., Brain Res, 692, DOI: 10.1016/0006-8993(95)00691-I</label>
          <listPosition>109</listPosition>
          <doi>10.1016/0006-8993(95)00691-I</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923671</mtid>
          <link>/api/reference/66923671</link>
          <label>110. Ji 2009: Matrix metalloprotease regulation of neuropathic pain., Trends Pharm. Sci., 30, DOI: 10.1016/j.tips.2009.04.002</label>
          <listPosition>110</listPosition>
          <doi>10.1016/j.tips.2009.04.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923672</mtid>
          <link>/api/reference/66923672</link>
          <label>111. Mohammadhosayni 2021: Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019., Int Immunopharmacol., 100, DOI: 10.1016/j.intimp.2021.108076</label>
          <listPosition>111</listPosition>
          <doi>10.1016/j.intimp.2021.108076</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923673</mtid>
          <link>/api/reference/66923673</link>
          <label>112. Kawasaki 2008: Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.3338-07.2008</label>
          <listPosition>112</listPosition>
          <doi>10.1523/JNEUROSCI.3338-07.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923674</mtid>
          <link>/api/reference/66923674</link>
          <label>113. Zhang 2011: TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2., Pain, 152, DOI: 10.1016/j.pain.2010.11.014</label>
          <listPosition>113</listPosition>
          <doi>10.1016/j.pain.2010.11.014</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923675</mtid>
          <link>/api/reference/66923675</link>
          <label>114. Xu 2010: Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions., Nat. Med, 16, DOI: 10.1038/nm.2123</label>
          <listPosition>114</listPosition>
          <doi>10.1038/nm.2123</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923676</mtid>
          <link>/api/reference/66923676</link>
          <label>115. Choi 2010: Peripheral inflammation induces tumor necrosis factor dependent AMPA receptor trafficking and Akt phosphorylation in spinal cord in addition to pain behavior., Pain, 149, DOI: 10.1016/j.pain.2010.02.008</label>
          <listPosition>115</listPosition>
          <doi>10.1016/j.pain.2010.02.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923677</mtid>
          <link>/api/reference/66923677</link>
          <label>116. Zhang 2010: Ap38 mitogen-activated protein kinase-dependentmechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-α., J. Neurosci., 30, DOI: 10.1523/JNEUROSCI.2437-10.2010</label>
          <listPosition>116</listPosition>
          <doi>10.1523/JNEUROSCI.2437-10.2010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923678</mtid>
          <link>/api/reference/66923678</link>
          <label>117. Park 2011: Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1., J. Neurosci., 31, DOI: 10.1523/JNEUROSCI.2443-11.2011</label>
          <listPosition>117</listPosition>
          <doi>10.1523/JNEUROSCI.2443-11.2011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923679</mtid>
          <link>/api/reference/66923679</link>
          <label>118. X. Yan, H.R. WengEndogenous interleukin-1β in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors, Journal of Biological Chemistry 288 (2013). https://doi.org/10.1074/jbc.M113.495465.., DOI: 10.1074/jbc.M113.495465</label>
          <listPosition>118</listPosition>
          <doi>10.1074/jbc.M113.495465</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923680</mtid>
          <link>/api/reference/66923680</link>
          <label>119. Wei 2008: Supraspinal glial-neuronal interactions contribute to descending pain facilitation., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.3593-08.2008</label>
          <listPosition>119</listPosition>
          <doi>10.1523/JNEUROSCI.3593-08.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923681</mtid>
          <link>/api/reference/66923681</link>
          <label>120. Lee 2010: Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK., Eur. J. Pain., 14, DOI: 10.1016/j.ejpain.2009.10.017</label>
          <listPosition>120</listPosition>
          <doi>10.1016/j.ejpain.2009.10.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923682</mtid>
          <link>/api/reference/66923682</link>
          <label>121. Luo 2019: Interleukin-17 Regulates Neuron-Glial Communications, Synaptic Transmission, and Neuropathic Pain after Chemotherapy., Cell Rep., 29, DOI: 10.1016/j.celrep.2019.10.085</label>
          <listPosition>121</listPosition>
          <doi>10.1016/j.celrep.2019.10.085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923683</mtid>
          <link>/api/reference/66923683</link>
          <label>122. Noma 2011: Interleukin-17 levels in rat models of nerve damage and neuropathic pain., Neurosci. Lett., 493, DOI: 10.1016/j.neulet.2011.01.079</label>
          <listPosition>122</listPosition>
          <doi>10.1016/j.neulet.2011.01.079</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923684</mtid>
          <link>/api/reference/66923684</link>
          <label>123. Kim 2011: Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice., J. Pain., 12, DOI: 10.1016/j.jpain.2010.08.003</label>
          <listPosition>123</listPosition>
          <doi>10.1016/j.jpain.2010.08.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923685</mtid>
          <link>/api/reference/66923685</link>
          <label>124. Malcangio 2020: Role of the immune system in neuropathic pain., Scand. J. Pain., 20</label>
          <listPosition>124</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923686</mtid>
          <link>/api/reference/66923686</link>
          <label>125. Moraes 2020: Participation of CXCL1 in the glial cells during neuropathic pain., Eur. J. Pharm., 875, DOI: 10.1016/j.ejphar.2020.173039</label>
          <listPosition>125</listPosition>
          <doi>10.1016/j.ejphar.2020.173039</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923687</mtid>
          <link>/api/reference/66923687</link>
          <label>126. Loggia 2015: Evidence for brain glial activation in chronic pain patients., Brain, 138, DOI: 10.1093/brain/awu377</label>
          <listPosition>126</listPosition>
          <doi>10.1093/brain/awu377</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923688</mtid>
          <link>/api/reference/66923688</link>
          <label>127. Tsuda 2017: Neuronal and microglial mechanisms for neuropathic pain in the spinal dorsal horn and anterior cingulate cortex., J. Neurochem., 141, DOI: 10.1111/jnc.14001</label>
          <listPosition>127</listPosition>
          <doi>10.1111/jnc.14001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923689</mtid>
          <link>/api/reference/66923689</link>
          <label>128. Zhuo 2011: Neuronal and microglial mechanisms of neuropathic pain., Mol. Brain, 4, DOI: 10.1186/1756-6606-4-31</label>
          <listPosition>128</listPosition>
          <doi>10.1186/1756-6606-4-31</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923690</mtid>
          <link>/api/reference/66923690</link>
          <label>129. Shi 2012: Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients., J. Neurosci., 32, DOI: 10.1523/JNEUROSCI.5628-11.2012</label>
          <listPosition>129</listPosition>
          <doi>10.1523/JNEUROSCI.5628-11.2012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923691</mtid>
          <link>/api/reference/66923691</link>
          <label>130. Tsuda 2003: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury., Nature, 424, DOI: 10.1038/nature01786</label>
          <listPosition>130</listPosition>
          <doi>10.1038/nature01786</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923692</mtid>
          <link>/api/reference/66923692</link>
          <label>131. Pelvig 2008: Neocortical glial cell numbers in human brains., Neurobiol. Aging, 29, DOI: 10.1016/j.neurobiolaging.2007.04.013</label>
          <listPosition>131</listPosition>
          <doi>10.1016/j.neurobiolaging.2007.04.013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923693</mtid>
          <link>/api/reference/66923693</link>
          <label>132. Cheng 2022: The role of astrocytes in neuropathic pain., Front Mol. Neurosci., 15, p. 1007889, DOI: 10.3389/fnmol.2022.1007889</label>
          <listPosition>132</listPosition>
          <doi>10.3389/fnmol.2022.1007889</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923694</mtid>
          <link>/api/reference/66923694</link>
          <label>133. Halassa 2009: Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior., Annu Rev. Physiol., 72</label>
          <listPosition>133</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923695</mtid>
          <link>/api/reference/66923695</link>
          <label>134. Ji 2013: Glia and pain: is chronic pain a gliopathy?., : Pain., DOI: 10.1016/j.pain.2013.06.022</label>
          <listPosition>134</listPosition>
          <doi>10.1016/j.pain.2013.06.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923696</mtid>
          <link>/api/reference/66923696</link>
          <label>135. Zhang 2024: Impact of inflammation and Treg cell regulation on neuropathic pain in spinal cord injury: mechanisms and therapeutic prospects., Front Immunol., 15</label>
          <listPosition>135</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923697</mtid>
          <link>/api/reference/66923697</link>
          <label>136. Colonna 2017: Microglia function in the central nervous system during health and neurodegeneration., Annu Rev. Immunol., 35, DOI: 10.1146/annurev-immunol-051116-052358</label>
          <listPosition>136</listPosition>
          <doi>10.1146/annurev-immunol-051116-052358</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923698</mtid>
          <link>/api/reference/66923698</link>
          <label>137. Pastores 1996: Cytokine production and its manipulation by vasoactive drugs., N. Horiz.: Sci. Pract. Acute Med., 4</label>
          <listPosition>137</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923699</mtid>
          <link>/api/reference/66923699</link>
          <label>138. Nakagawa 2014: Role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases., Pharmaceuticals, 7, DOI: 10.3390/ph7121028</label>
          <listPosition>138</listPosition>
          <doi>10.3390/ph7121028</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923700</mtid>
          <link>/api/reference/66923700</link>
          <label>139. Bent 2018: Interleukin-1 beta—a friend or foe in malignancies?., Int J. Mol. Sci., 19, DOI: 10.3390/ijms19082155</label>
          <listPosition>139</listPosition>
          <doi>10.3390/ijms19082155</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923701</mtid>
          <link>/api/reference/66923701</link>
          <label>140. Recasens 2021: Chronic exposure to IL-6 induces a desensitized phenotype of the microglia., J. Neuroinflamm., 18, DOI: 10.1186/s12974-020-02063-1</label>
          <listPosition>140</listPosition>
          <doi>10.1186/s12974-020-02063-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923702</mtid>
          <link>/api/reference/66923702</link>
          <label>141. Dopp 1997: Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia., J. Neuroimmunol., 75, DOI: 10.1016/S0165-5728(97)00009-X</label>
          <listPosition>141</listPosition>
          <doi>10.1016/S0165-5728(97)00009-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923703</mtid>
          <link>/api/reference/66923703</link>
          <label>142. Taylor 2005: Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α-induced neurotoxicity in concert with microglial-derived Fas ligand., J. Neurosci., 25, DOI: 10.1523/JNEUROSCI.4456-04.2005</label>
          <listPosition>142</listPosition>
          <doi>10.1523/JNEUROSCI.4456-04.2005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923704</mtid>
          <link>/api/reference/66923704</link>
          <label>143. Saijo 2013: Regulation of microglia activation and deactivation by nuclear receptors., Glia, 61, DOI: 10.1002/glia.22423</label>
          <listPosition>143</listPosition>
          <doi>10.1002/glia.22423</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923705</mtid>
          <link>/api/reference/66923705</link>
          <label>144. Gao 2023: Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets., Signal Transduct. Target Ther., 8</label>
          <listPosition>144</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923706</mtid>
          <link>/api/reference/66923706</link>
          <label>145. Choi 2017: M2 phenotype microglia-derived cytokine stimulates proliferation and neuronal differentiation of endogenous stem cells in ischemic brain., Exp. Neurobiol., 26, DOI: 10.5607/en.2017.26.1.33</label>
          <listPosition>145</listPosition>
          <doi>10.5607/en.2017.26.1.33</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923707</mtid>
          <link>/api/reference/66923707</link>
          <label>146. Nakagawa 2007: Intrathecal administration of ATP produces long-lasting allodynia in rats: Differential mechanisms in the phase of the induction and maintenance., Neuroscience, 147, DOI: 10.1016/j.neuroscience.2007.03.045</label>
          <listPosition>146</listPosition>
          <doi>10.1016/j.neuroscience.2007.03.045</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923708</mtid>
          <link>/api/reference/66923708</link>
          <label>147. Inoue 2018: Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential., Nat. Rev. Neurosci., 19, DOI: 10.1038/nrn.2018.2</label>
          <listPosition>147</listPosition>
          <doi>10.1038/nrn.2018.2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923709</mtid>
          <link>/api/reference/66923709</link>
          <label>148. Gu 2016: Spinal microgliosis due to resident microglial proliferation is required for pain hypersensitivity after peripheral nerve injury., Cell Rep., 16, DOI: 10.1016/j.celrep.2016.06.018</label>
          <listPosition>148</listPosition>
          <doi>10.1016/j.celrep.2016.06.018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923710</mtid>
          <link>/api/reference/66923710</link>
          <label>149. Monif 2009: The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore., J. Neurosci., 29, DOI: 10.1523/JNEUROSCI.5512-08.2009</label>
          <listPosition>149</listPosition>
          <doi>10.1523/JNEUROSCI.5512-08.2009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923711</mtid>
          <link>/api/reference/66923711</link>
          <label>150. Sperlágh 1998: ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors., Neurochem. Int, 33, DOI: 10.1016/S0197-0186(98)00025-4</label>
          <listPosition>150</listPosition>
          <doi>10.1016/S0197-0186(98)00025-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923712</mtid>
          <link>/api/reference/66923712</link>
          <label>151. Okubo 2016: Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats., PLoS One, 11, DOI: 10.1371/journal.pone.0153375</label>
          <listPosition>151</listPosition>
          <doi>10.1371/journal.pone.0153375</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923713</mtid>
          <link>/api/reference/66923713</link>
          <label>152. Lim 2017: IKK/NF-B-dependent satellite glia activation induces spinal cord microglia activation and neuropathic pain after nerve injury., Pain, 158, p. 1666, DOI: 10.1097/j.pain.0000000000000959</label>
          <listPosition>152</listPosition>
          <doi>10.1097/j.pain.0000000000000959</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923714</mtid>
          <link>/api/reference/66923714</link>
          <label>153. Li 2020: Microglia induce the transformation of A1/A2 reactive astrocytes via the CXCR7/PI3K/Akt pathway in chronic post-surgical pain., J. Neuroinflamm., 17, DOI: 10.1186/s12974-020-01891-5</label>
          <listPosition>153</listPosition>
          <doi>10.1186/s12974-020-01891-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923715</mtid>
          <link>/api/reference/66923715</link>
          <label>154. Kawasaki 2008: Cytokine mechanisms of central sensitization: Distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.3338-07.2008</label>
          <listPosition>154</listPosition>
          <doi>10.1523/JNEUROSCI.3338-07.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923716</mtid>
          <link>/api/reference/66923716</link>
          <label>155. Molofsky 2015: Astrocyte development: a guide for the perplexed., Glia, 63, DOI: 10.1002/glia.22836</label>
          <listPosition>155</listPosition>
          <doi>10.1002/glia.22836</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923717</mtid>
          <link>/api/reference/66923717</link>
          <label>156. Ji 2019: Astrocytes in chronic pain and itch., Nat. Rev. Neurosci., 20, p. 667, DOI: 10.1038/s41583-019-0218-1</label>
          <listPosition>156</listPosition>
          <doi>10.1038/s41583-019-0218-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923718</mtid>
          <link>/api/reference/66923718</link>
          <label>157. Kang 2008: Connexin 43 hemichannels are permeable to ATP., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.5048-07.2008</label>
          <listPosition>157</listPosition>
          <doi>10.1523/JNEUROSCI.5048-07.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923719</mtid>
          <link>/api/reference/66923719</link>
          <label>158. Garrison 1991: Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury., Brain Res, 565, DOI: 10.1016/0006-8993(91)91729-K</label>
          <listPosition>158</listPosition>
          <doi>10.1016/0006-8993(91)91729-K</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923720</mtid>
          <link>/api/reference/66923720</link>
          <label>159. Garrison 1994: GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801., Exp. Neurol., 129, DOI: 10.1006/exnr.1994.1165</label>
          <listPosition>159</listPosition>
          <doi>10.1006/exnr.1994.1165</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923721</mtid>
          <link>/api/reference/66923721</link>
          <label>160. Sharma 2015: Astrogliosis and axonal regeneration., : Neural Regen., DOI: 10.1016/B978-0-12-801732-6.00011-2</label>
          <listPosition>160</listPosition>
          <doi>10.1016/B978-0-12-801732-6.00011-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923722</mtid>
          <link>/api/reference/66923722</link>
          <label>161. Liddelow 2017: Neurotoxic reactive astrocytes are induced by activated microglia., Nature, 541, p. 481, DOI: 10.1038/nature21029</label>
          <listPosition>161</listPosition>
          <doi>10.1038/nature21029</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923723</mtid>
          <link>/api/reference/66923723</link>
          <label>162. Zhang 2008: IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats., Pain, 135, DOI: 10.1016/j.pain.2007.05.023</label>
          <listPosition>162</listPosition>
          <doi>10.1016/j.pain.2007.05.023</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923724</mtid>
          <link>/api/reference/66923724</link>
          <label>163. Giovannoni 2020: The role of astrocytes in CNS inflammation., Trends Immunol., 41, DOI: 10.1016/j.it.2020.07.007</label>
          <listPosition>163</listPosition>
          <doi>10.1016/j.it.2020.07.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923725</mtid>
          <link>/api/reference/66923725</link>
          <label>164. Chen 2014: Connexin-43 induces chemokine release from spinal cord astrocytes to maintain late-phase neuropathic pain in mice., Brain, 137, DOI: 10.1093/brain/awu140</label>
          <listPosition>164</listPosition>
          <doi>10.1093/brain/awu140</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923726</mtid>
          <link>/api/reference/66923726</link>
          <label>165. Denaro 2024: Sigma-1 receptor targeting inhibits connexin 43 based intercellular communication in chronic neuropathic pain., Inflamm. Res., DOI: 10.1007/s00011-024-01926-0</label>
          <listPosition>165</listPosition>
          <doi>10.1007/s00011-024-01926-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923727</mtid>
          <link>/api/reference/66923727</link>
          <label>166. Zhou 2023: Role of IL-33-ST2 pathway in regulating inflammation: current evidence and future perspectives., J. Transl. Med, 21, DOI: 10.1186/s12967-023-04782-4</label>
          <listPosition>166</listPosition>
          <doi>10.1186/s12967-023-04782-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923728</mtid>
          <link>/api/reference/66923728</link>
          <label>167. Yasuoka 2011: Production and functions of IL-33 in the central nervous system., Brain Res, 1385, DOI: 10.1016/j.brainres.2011.02.045</label>
          <listPosition>167</listPosition>
          <doi>10.1016/j.brainres.2011.02.045</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923729</mtid>
          <link>/api/reference/66923729</link>
          <label>168. Zarpelon 2016: Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain., FASEB J., 30, DOI: 10.1096/fj.14-267146</label>
          <listPosition>168</listPosition>
          <doi>10.1096/fj.14-267146</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923730</mtid>
          <link>/api/reference/66923730</link>
          <label>169. Hanani 2020: Emerging importance of satellite glia in nervous system function and dysfunction., Nat. Rev. Neurosci., 21</label>
          <listPosition>169</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923731</mtid>
          <link>/api/reference/66923731</link>
          <label>170. Avraham 2020: Satellite glial cells promote regenerative growth in sensory neurons., Nat. Commun., 11, DOI: 10.1038/s41467-020-18642-y</label>
          <listPosition>170</listPosition>
          <doi>10.1038/s41467-020-18642-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923732</mtid>
          <link>/api/reference/66923732</link>
          <label>171. Hanani 2002: Glial cell plasticity in sensory ganglia induced by nerve damage., Neuroscience, 114, DOI: 10.1016/S0306-4522(02)00279-8</label>
          <listPosition>171</listPosition>
          <doi>10.1016/S0306-4522(02)00279-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923733</mtid>
          <link>/api/reference/66923733</link>
          <label>172. Takeda 2007: Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation., Pain, 129, DOI: 10.1016/j.pain.2006.10.007</label>
          <listPosition>172</listPosition>
          <doi>10.1016/j.pain.2006.10.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923734</mtid>
          <link>/api/reference/66923734</link>
          <label>173. Xu 2006: The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat., Pain, 123, DOI: 10.1016/j.pain.2006.03.011</label>
          <listPosition>173</listPosition>
          <doi>10.1016/j.pain.2006.03.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923735</mtid>
          <link>/api/reference/66923735</link>
          <label>174. Takeda 2011: Peripheral inflammation suppresses inward rectifying potassium currents of satellite glial cells in the trigeminal ganglia., Pain, 152, DOI: 10.1016/j.pain.2011.05.023</label>
          <listPosition>174</listPosition>
          <doi>10.1016/j.pain.2011.05.023</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923736</mtid>
          <link>/api/reference/66923736</link>
          <label>175. Vit 2008: Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury., J. Neurosci., 28, DOI: 10.1523/JNEUROSCI.5053-07.2008</label>
          <listPosition>175</listPosition>
          <doi>10.1523/JNEUROSCI.5053-07.2008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923737</mtid>
          <link>/api/reference/66923737</link>
          <label>176. Silva 2017: Neuroimmune–glia interactions in the sensory ganglia account for the development of acute herpetic neuralgia., J. Neurosci., 37, DOI: 10.1523/JNEUROSCI.2233-16.2017</label>
          <listPosition>176</listPosition>
          <doi>10.1523/JNEUROSCI.2233-16.2017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923738</mtid>
          <link>/api/reference/66923738</link>
          <label>177. Yunna 2020: Macrophage M1/M2 polarization., Eur. J. Pharm., 877, DOI: 10.1016/j.ejphar.2020.173090</label>
          <listPosition>177</listPosition>
          <doi>10.1016/j.ejphar.2020.173090</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923739</mtid>
          <link>/api/reference/66923739</link>
          <label>178. Wang 2014: Molecular mechanisms that influence the macrophage M1-M2 polarization balance., Front Immunol., 5, DOI: 10.3389/fimmu.2014.00614</label>
          <listPosition>178</listPosition>
          <doi>10.3389/fimmu.2014.00614</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923740</mtid>
          <link>/api/reference/66923740</link>
          <label>179. Strizova 2023: M1/M2 macrophages and their overlaps - myth or reality?., Clin. Sci., 137, DOI: 10.1042/CS20220531</label>
          <listPosition>179</listPosition>
          <doi>10.1042/CS20220531</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923741</mtid>
          <link>/api/reference/66923741</link>
          <label>180. Purcu 2022: Effect of stimulation time on the expression of human macrophage polarization markers., PLoS One, 17</label>
          <listPosition>180</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923742</mtid>
          <link>/api/reference/66923742</link>
          <label>181. Guimarães 2023: Neuron-associated macrophage proliferation in the sensory ganglia is associated with peripheral nerve injury-induced neuropathic pain involving CX3CR1 signaling., Elife, 12, DOI: 10.7554/eLife.78515</label>
          <listPosition>181</listPosition>
          <doi>10.7554/eLife.78515</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923743</mtid>
          <link>/api/reference/66923743</link>
          <label>182. Massier 2015: Effects of differently activated rodent macrophages on sensory neurons: implications for arthritis pain., Arthritis Rheumatol., 67, DOI: 10.1002/art.39134</label>
          <listPosition>182</listPosition>
          <doi>10.1002/art.39134</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923744</mtid>
          <link>/api/reference/66923744</link>
          <label>183. Galvin 2021: The role of T-lymphocytes in neuropathic pain initiation, development of chronicity and treatment., Brain Behav. Immun. Health, 18</label>
          <listPosition>183</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923745</mtid>
          <link>/api/reference/66923745</link>
          <label>184. Rincón 1997: T-cell subsets: Transcriptional control in the TH1/TH2 decision., Curr. Biol., 7, DOI: 10.1016/S0960-9822(06)00368-X</label>
          <listPosition>184</listPosition>
          <doi>10.1016/S0960-9822(06)00368-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923746</mtid>
          <link>/api/reference/66923746</link>
          <label>185. Costigan 2009: T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity., J. Neurosci., 29, DOI: 10.1523/JNEUROSCI.4569-09.2009</label>
          <listPosition>185</listPosition>
          <doi>10.1523/JNEUROSCI.4569-09.2009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923747</mtid>
          <link>/api/reference/66923747</link>
          <label>186. Vicuña 2015: The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase., Nat. Med, 21, DOI: 10.1038/nm.3852</label>
          <listPosition>186</listPosition>
          <doi>10.1038/nm.3852</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923748</mtid>
          <link>/api/reference/66923748</link>
          <label>187. Hu 2002: Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat., Neuroscience, 112, DOI: 10.1016/S0306-4522(02)00065-9</label>
          <listPosition>187</listPosition>
          <doi>10.1016/S0306-4522(02)00065-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923749</mtid>
          <link>/api/reference/66923749</link>
          <label>188. Moalem 2004: T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats., Neuroscience, 129, DOI: 10.1016/j.neuroscience.2004.08.035</label>
          <listPosition>188</listPosition>
          <doi>10.1016/j.neuroscience.2004.08.035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923750</mtid>
          <link>/api/reference/66923750</link>
          <label>189. Cao 2008: CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain., Eur. J. Immunol., 38, DOI: 10.1002/eji.200737485</label>
          <listPosition>189</listPosition>
          <doi>10.1002/eji.200737485</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923751</mtid>
          <link>/api/reference/66923751</link>
          <label>190. Sorge 2015: Different immune cells mediate mechanical pain hypersensitivity in male and female mice., Nat. Neurosci., 18, DOI: 10.1038/nn.4053</label>
          <listPosition>190</listPosition>
          <doi>10.1038/nn.4053</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923752</mtid>
          <link>/api/reference/66923752</link>
          <label>191. Celik 2020: IL-4 induces M2 macrophages to produce sustained analgesia via opioids., JCI Insight, 5, DOI: 10.1172/jci.insight.133093</label>
          <listPosition>191</listPosition>
          <doi>10.1172/jci.insight.133093</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923753</mtid>
          <link>/api/reference/66923753</link>
          <label>192. Gupta 2020: Constitutive inflammatory cytokine storm: a major threat to human health., J. Interferon Cytokine Res., 40, DOI: 10.1089/jir.2019.0085</label>
          <listPosition>192</listPosition>
          <doi>10.1089/jir.2019.0085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923754</mtid>
          <link>/api/reference/66923754</link>
          <label>193. Maiese 2021: SARS-CoV-2 and the brain: a review of the current knowledge on neuropathology in COVID-19., Brain Pathol., 31, DOI: 10.1111/bpa.13013</label>
          <listPosition>193</listPosition>
          <doi>10.1111/bpa.13013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923755</mtid>
          <link>/api/reference/66923755</link>
          <label>194. Del Valle 2020: An inflammatory cytokine signature predicts COVID-19 severity and survival., Nat. Med, 26, DOI: 10.1038/s41591-020-1051-9</label>
          <listPosition>194</listPosition>
          <doi>10.1038/s41591-020-1051-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923756</mtid>
          <link>/api/reference/66923756</link>
          <label>195. López-Hernández 2023: The plasma metabolome of long COVID patients two years after infection., Sci. Rep., 13, DOI: 10.1038/s41598-023-39049-x</label>
          <listPosition>195</listPosition>
          <doi>10.1038/s41598-023-39049-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923757</mtid>
          <link>/api/reference/66923757</link>
          <label>196. Schultheiß 2022: The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19., Cell Rep. Med, 3</label>
          <listPosition>196</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923758</mtid>
          <link>/api/reference/66923758</link>
          <label>197. Yin 2023: Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis., Infect. Dis. Poverty, 12, DOI: 10.1186/s40249-023-01086-z</label>
          <listPosition>197</listPosition>
          <doi>10.1186/s40249-023-01086-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923759</mtid>
          <link>/api/reference/66923759</link>
          <label>198. Holms 2022: Long COVID (PASC) is maintained by a self-sustaining pro-inflammatory TLR4/RAGE-Loop of S100A8/A9 > TLR4/RAGE signalling, inducing chronic expression of IL-1b, IL-6 and TNFa: anti-inflammatory ezrin peptides as potential therapy., Immuno, 2, DOI: 10.3390/immuno2030033</label>
          <listPosition>198</listPosition>
          <doi>10.3390/immuno2030033</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923760</mtid>
          <link>/api/reference/66923760</link>
          <label>199. D. Kempuraj, R. Thangavel, P.A. Natteru, G.P. Selvakumar, D. Saeed, H. Zahoor, S. Zaheer, S.S. Iyer, A. Zaheer, Neuroinflammation Induces Neurodegeneration, n.d.</label>
          <listPosition>199</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923761</mtid>
          <link>/api/reference/66923761</link>
          <label>200. Kostic 2019: Evaluation of IL-1β levels in epilepsy and traumatic brain injury in dogs., BMC Neurosci., 20, DOI: 10.1186/s12868-019-0509-5</label>
          <listPosition>200</listPosition>
          <doi>10.1186/s12868-019-0509-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923762</mtid>
          <link>/api/reference/66923762</link>
          <label>201. Copray 2001: Expression of interleukin-1 beta in rat dorsal root ganglia., J. Neuroimmunol., 118, DOI: 10.1016/S0165-5728(01)00324-1</label>
          <listPosition>201</listPosition>
          <doi>10.1016/S0165-5728(01)00324-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923763</mtid>
          <link>/api/reference/66923763</link>
          <label>202. Shamash 2002: The cytokine network of wallerian degeneration: tumor necrosis factor-α, interleukin-1α, and interleukin-1β., J. Neurosci., 22, DOI: 10.1523/JNEUROSCI.22-08-03052.2002</label>
          <listPosition>202</listPosition>
          <doi>10.1523/JNEUROSCI.22-08-03052.2002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923764</mtid>
          <link>/api/reference/66923764</link>
          <label>203. Sommer 2004: Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia., Neurosci. Lett., 361, DOI: 10.1016/j.neulet.2003.12.007</label>
          <listPosition>203</listPosition>
          <doi>10.1016/j.neulet.2003.12.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923765</mtid>
          <link>/api/reference/66923765</link>
          <label>204. Leung 2010: TNF-α and neuropathic pain - a review., J. Neuroinflamm., 7, DOI: 10.1186/1742-2094-7-27</label>
          <listPosition>204</listPosition>
          <doi>10.1186/1742-2094-7-27</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923766</mtid>
          <link>/api/reference/66923766</link>
          <label>205. SOMMER 2004: Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia*1., Neurosci. Lett., 361, DOI: 10.1016/j.neulet.2003.12.007</label>
          <listPosition>205</listPosition>
          <doi>10.1016/j.neulet.2003.12.007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923767</mtid>
          <link>/api/reference/66923767</link>
          <label>206. Gwak 2010: Gliopathy” maintains persistent hyperexcitability of spinal dorsal horn neurons after spinal cord injury: Substrate of central neuropathic pain., : Horiz. Neurosci. Res.</label>
          <listPosition>206</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923768</mtid>
          <link>/api/reference/66923768</link>
          <label>207. Ren 2010: Neuron, glia and reciprocal relationships in pain processing., Open Pain. J., 3</label>
          <listPosition>207</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923769</mtid>
          <link>/api/reference/66923769</link>
          <label>208. Guo 2007: Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain., J. Neurosci., 27, DOI: 10.1523/JNEUROSCI.0176-07.2007</label>
          <listPosition>208</listPosition>
          <doi>10.1523/JNEUROSCI.0176-07.2007</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923770</mtid>
          <link>/api/reference/66923770</link>
          <label>209. Tsakiri 2008: Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarisation in neurones., Mol. Cell. Neurosci., 37, DOI: 10.1016/j.mcn.2007.09.001</label>
          <listPosition>209</listPosition>
          <doi>10.1016/j.mcn.2007.09.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923771</mtid>
          <link>/api/reference/66923771</link>
          <label>210. Van Wagoner 1999: Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor., J. Neurosci., 19, DOI: 10.1523/JNEUROSCI.19-13-05236.1999</label>
          <listPosition>210</listPosition>
          <doi>10.1523/JNEUROSCI.19-13-05236.1999</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923772</mtid>
          <link>/api/reference/66923772</link>
          <label>211. Di Maio 2023: Mechanisms of transmission and processing of pain: a narrative review., Int J. Environ. Res Public Health, 20, DOI: 10.3390/ijerph20043064</label>
          <listPosition>211</listPosition>
          <doi>10.3390/ijerph20043064</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923773</mtid>
          <link>/api/reference/66923773</link>
          <label>212. E. Song, C. Zhang, B. Israelow, P. Lu, O.-E. Weizman, F. Liu, Y. Dai, K. Szigeti-Buck, Y. Yasumoto, G. Wang, C. Castaldi, J. Heltke, E. Ng, J. Wheeler, M.M. Alfajaro, B. Fontes, N.G. Ravindra, D. van Dijk, S. Mane, M. Gunel, A. Ring, C.B. Wilen, T.L. Horvath, A. Louvi, S.F. Farhadian, K. Bilguvar, A. Iwasaki, Neuroinvasive potential of SARS-CoV-2 revealed in a human brain organoid model, BioRxiv (2020). 〈https://doi.org/10.1101/2020.06.25.169946〉., DOI: 10.1101/2020.06.25.169946</label>
          <listPosition>212</listPosition>
          <doi>10.1101/2020.06.25.169946</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923774</mtid>
          <link>/api/reference/66923774</link>
          <label>213. Rothan 2022: SARS-CoV-2 infects primary neurons from human ACE2 expressing mice and upregulates genes involved in the inflammatory and necroptotic pathways., Pathogens, 11, DOI: 10.3390/pathogens11020257</label>
          <listPosition>213</listPosition>
          <doi>10.3390/pathogens11020257</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923775</mtid>
          <link>/api/reference/66923775</link>
          <label>214. Kumari 2021: Neuroinvasion and encephalitis following intranasal inoculation of sars-cov-2 in k18-hace2 mice., Viruses, 13, DOI: 10.3390/v13010132</label>
          <listPosition>214</listPosition>
          <doi>10.3390/v13010132</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923776</mtid>
          <link>/api/reference/66923776</link>
          <label>215. Septyaningtrias 2021: Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences., Rev. Neurosci., 32, DOI: 10.1515/revneuro-2020-0092</label>
          <listPosition>215</listPosition>
          <doi>10.1515/revneuro-2020-0092</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923777</mtid>
          <link>/api/reference/66923777</link>
          <label>216. Xu 2022: Expression of ACE2 in human neurons supports the neuro-invasive potential of COVID-19 Virus., Cell Mol. Neurobiol., 42, DOI: 10.1007/s10571-020-00915-1</label>
          <listPosition>216</listPosition>
          <doi>10.1007/s10571-020-00915-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923778</mtid>
          <link>/api/reference/66923778</link>
          <label>217. Harrison 2020: Mechanisms of SARS-CoV-2 transmission and pathogenesis., Trends Immunol., 41, DOI: 10.1016/j.it.2020.10.004</label>
          <listPosition>217</listPosition>
          <doi>10.1016/j.it.2020.10.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923779</mtid>
          <link>/api/reference/66923779</link>
          <label>218. Tang 2021: Downregulation of ace2 expression by sars-cov-2 worsens the prognosis of kirc and kirp patients via metabolism and immunoregulation., Int J. Biol. Sci., 17, DOI: 10.7150/ijbs.57802</label>
          <listPosition>218</listPosition>
          <doi>10.7150/ijbs.57802</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923780</mtid>
          <link>/api/reference/66923780</link>
          <label>219. Zalpoor 2022: The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies., Cell Mol. Biol. Lett., 27, DOI: 10.1186/s11658-022-00311-1</label>
          <listPosition>219</listPosition>
          <doi>10.1186/s11658-022-00311-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923781</mtid>
          <link>/api/reference/66923781</link>
          <label>220. Wang 2020: CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells., Signal Transduct. Target Ther., 5</label>
          <listPosition>220</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923782</mtid>
          <link>/api/reference/66923782</link>
          <label>221. Emmi 2023: ACE2 Receptor and TMPRSS2 protein expression patterns in the human brainstem reveal anatomical regions potentially vulnerable to SARS-CoV-2 Infection., ACS Chem. Neurosci., 14, DOI: 10.1021/acschemneuro.3c00101</label>
          <listPosition>221</listPosition>
          <doi>10.1021/acschemneuro.3c00101</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923783</mtid>
          <link>/api/reference/66923783</link>
          <label>222. Peluso 2023: Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for up to 2 years following COVID-19., MedRxiv</label>
          <listPosition>222</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923784</mtid>
          <link>/api/reference/66923784</link>
          <label>223. Zhang 2007: Cytokines, inflammation, and pain., Int Anesth. Clin., 45, p. 27, DOI: 10.1097/AIA.0b013e318034194e</label>
          <listPosition>223</listPosition>
          <doi>10.1097/AIA.0b013e318034194e</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923785</mtid>
          <link>/api/reference/66923785</link>
          <label>224. Albrecht 2018: Neuroinflammation of the spinal cord and nerve roots in chronic radicular pain patients., Pain, 159, DOI: 10.1097/j.pain.0000000000001171</label>
          <listPosition>224</listPosition>
          <doi>10.1097/j.pain.0000000000001171</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923786</mtid>
          <link>/api/reference/66923786</link>
          <label>225. DeLeo 2001: The role of neuroinflammation and neuroimmune activation in persistent pain., Pain, 90, DOI: 10.1016/S0304-3959(00)00490-5</label>
          <listPosition>225</listPosition>
          <doi>10.1016/S0304-3959(00)00490-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923787</mtid>
          <link>/api/reference/66923787</link>
          <label>226. Choy 2020: Translating IL-6 biology into effective treatments., Nat. Rev. Rheuma, 16, DOI: 10.1038/s41584-020-0419-z</label>
          <listPosition>226</listPosition>
          <doi>10.1038/s41584-020-0419-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923788</mtid>
          <link>/api/reference/66923788</link>
          <label>227. Mikkelsen 2017: The effects of vitamin B on the immune/cytokine network and their involvement in depression., Maturitas, 96, DOI: 10.1016/j.maturitas.2016.11.012</label>
          <listPosition>227</listPosition>
          <doi>10.1016/j.maturitas.2016.11.012</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923789</mtid>
          <link>/api/reference/66923789</link>
          <label>228. Nakamura 1999: Influence of preoperative nutritional state on inflammatory response after surgery., Nutrition, 15, DOI: 10.1016/S0899-9007(99)00176-8</label>
          <listPosition>228</listPosition>
          <doi>10.1016/S0899-9007(99)00176-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923790</mtid>
          <link>/api/reference/66923790</link>
          <label>229. Goyal 2023: Current Perspective on Vitamins and SARS-CoV-2 Disease (COVID-19)., Ann. Natl. Acad. Med Sci., 59, DOI: 10.1055/s-0043-1777316</label>
          <listPosition>229</listPosition>
          <doi>10.1055/s-0043-1777316</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923791</mtid>
          <link>/api/reference/66923791</link>
          <label>230. Galmés 2020: Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the COVID-19 pandemic framework., Nutrients, 12, DOI: 10.3390/nu12092738</label>
          <listPosition>230</listPosition>
          <doi>10.3390/nu12092738</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923792</mtid>
          <link>/api/reference/66923792</link>
          <label>231. Galmés 2022: Suboptimal consumption of relevant immune system micronutrients is associated with a worse impact of COVID-19 in Spanish populations., Nutrients, 14, DOI: 10.3390/nu14112254</label>
          <listPosition>231</listPosition>
          <doi>10.3390/nu14112254</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923793</mtid>
          <link>/api/reference/66923793</link>
          <label>232. Sommer 1993: Vitamin A, infectious disease, and childhood mortality: a 2¢ solution?., J. Infect. Dis., 167, DOI: 10.1093/infdis/167.5.1003</label>
          <listPosition>232</listPosition>
          <doi>10.1093/infdis/167.5.1003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923794</mtid>
          <link>/api/reference/66923794</link>
          <label>233. Olson 2010: Significance of vitamin A to brain function, behavior and learning., Mol. Nutr. Food Res, 54, DOI: 10.1002/mnfr.200900246</label>
          <listPosition>233</listPosition>
          <doi>10.1002/mnfr.200900246</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923795</mtid>
          <link>/api/reference/66923795</link>
          <label>234. Amimo 2022: Immune impairment associated with vitamin A deficiency: insights from clinical studies and animal model research., Nutrients, 14, DOI: 10.3390/nu14235038</label>
          <listPosition>234</listPosition>
          <doi>10.3390/nu14235038</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923796</mtid>
          <link>/api/reference/66923796</link>
          <label>235. Calder 2020: Nutrition, immunity and COVID-19., BMJ Nutr. Prev. Health, 3, DOI: 10.1136/bmjnph-2020-000085</label>
          <listPosition>235</listPosition>
          <doi>10.1136/bmjnph-2020-000085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923797</mtid>
          <link>/api/reference/66923797</link>
          <label>236. Liang 2021: Overview of all-trans-retinoic acid (ATRA) and its analogues: structures, activities, and mechanisms in acute promyelocytic leukaemia., Eur. J. Med Chem., 220, DOI: 10.1016/j.ejmech.2021.113451</label>
          <listPosition>236</listPosition>
          <doi>10.1016/j.ejmech.2021.113451</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923798</mtid>
          <link>/api/reference/66923798</link>
          <label>237. Blomhoff 2006: Overview of retinoid metabolism and function., J. Neurobiol., 66, DOI: 10.1002/neu.20242</label>
          <listPosition>237</listPosition>
          <doi>10.1002/neu.20242</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923799</mtid>
          <link>/api/reference/66923799</link>
          <label>238. Zhu 2019: Vitamin A and its derivatives- retinoic acid and retinoid pharmacology., Am. J. Biomed. Sci. Res, 3, DOI: 10.34297/AJBSR.2019.03.000656</label>
          <listPosition>238</listPosition>
          <doi>10.34297/AJBSR.2019.03.000656</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923800</mtid>
          <link>/api/reference/66923800</link>
          <label>239. Shams 1994: Increased interleukin-1 activity in the injured vitamin A-deficient cornea., Cornea, 13, DOI: 10.1097/00003226-199403000-00009</label>
          <listPosition>239</listPosition>
          <doi>10.1097/00003226-199403000-00009</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923801</mtid>
          <link>/api/reference/66923801</link>
          <label>240. Xiong 2014: Effects and mechanisms of vitamin A and vitamin E on the levels of serum leptin and other related cytokines in rats with rheumatoid arthritis., Exp. Ther. Med, 8, DOI: 10.3892/etm.2014.1777</label>
          <listPosition>240</listPosition>
          <doi>10.3892/etm.2014.1777</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923802</mtid>
          <link>/api/reference/66923802</link>
          <label>241. Asgari 2024: Immunomodulatory and anti-inflammatory effects of vitamin A and tryptophan on monocyte-derived dendritic cells stimulated with gliadin in celiac disease patients., Inflammation, DOI: 10.1007/s10753-024-02004-7</label>
          <listPosition>241</listPosition>
          <doi>10.1007/s10753-024-02004-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923803</mtid>
          <link>/api/reference/66923803</link>
          <label>242. Rubin 2017: Metabolic effects of inflammation on vitamin A and carotenoids in humans and animal models., Adv. Nutr., 8, DOI: 10.3945/an.116.014167</label>
          <listPosition>242</listPosition>
          <doi>10.3945/an.116.014167</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923804</mtid>
          <link>/api/reference/66923804</link>
          <label>243. Gholizadeh 2022: Influence of Vitamin A supplementation on inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials., Sci. Rep., 12, DOI: 10.1038/s41598-022-23919-x</label>
          <listPosition>243</listPosition>
          <doi>10.1038/s41598-022-23919-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923805</mtid>
          <link>/api/reference/66923805</link>
          <label>244. Li 2020: Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19., Aging, 12</label>
          <listPosition>244</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923806</mtid>
          <link>/api/reference/66923806</link>
          <label>245. Notarbartolo 2022: Antioxidant effects of dietary supplements on adult COVID-19 patients: why do we not also use them in children., Antioxidants, 11, DOI: 10.3390/antiox11091638</label>
          <listPosition>245</listPosition>
          <doi>10.3390/antiox11091638</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923807</mtid>
          <link>/api/reference/66923807</link>
          <label>246. Somi 2024: Effect of vitamin A supplementation on the outcome severity of COVID-19 in hospitalized patients: a pilot randomized clinical trial., Nutr. Health, 30, DOI: 10.1177/02601060221129144</label>
          <listPosition>246</listPosition>
          <doi>10.1177/02601060221129144</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923808</mtid>
          <link>/api/reference/66923808</link>
          <label>247. da 2023: Retinol levels and severity of patients with COVID-19., Nutrients, 15</label>
          <listPosition>247</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923809</mtid>
          <link>/api/reference/66923809</link>
          <label>248. Wang 2024: Retinol and retinol binding protein 4 levels and COVID-19: a Mendelian randomization study., BMC Pulm. Med, 24</label>
          <listPosition>248</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923810</mtid>
          <link>/api/reference/66923810</link>
          <label>249. West 2000: Meeting requirements for vitamin A., Nutr. Rev., 58</label>
          <listPosition>249</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923811</mtid>
          <link>/api/reference/66923811</link>
          <label>250. Grune 2010: β-carotene is an important vitamin A source for humans., J. Nutr., 140, DOI: 10.3945/jn.109.119024</label>
          <listPosition>250</listPosition>
          <doi>10.3945/jn.109.119024</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923812</mtid>
          <link>/api/reference/66923812</link>
          <label>251. Shoeb 2012: Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages., Free Radic. Biol. Med, 52, DOI: 10.1016/j.freeradbiomed.2011.10.444</label>
          <listPosition>251</listPosition>
          <doi>10.1016/j.freeradbiomed.2011.10.444</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923813</mtid>
          <link>/api/reference/66923813</link>
          <label>252. Raj 2018: Therapeutic potential of benfotiamine and its molecular targets., Eur. Rev. Med Pharm. Sci., 22</label>
          <listPosition>252</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923814</mtid>
          <link>/api/reference/66923814</link>
          <label>253. Haupt 2005: Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomized, controlled pilot study (BEDIP study)., Int J. Clin. Pharm. Ther., 43, DOI: 10.5414/CPP43071</label>
          <listPosition>253</listPosition>
          <doi>10.5414/CPP43071</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923815</mtid>
          <link>/api/reference/66923815</link>
          <label>254. Cameron 2005: Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes., : Ann. N. Y Acad. Sci., DOI: 10.1196/annals.1333.091</label>
          <listPosition>254</listPosition>
          <doi>10.1196/annals.1333.091</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923816</mtid>
          <link>/api/reference/66923816</link>
          <label>255. Menezes 2017: Thiamine and riboflavin inhibit production of cytokines and increase the anti-inflammatory activity of a corticosteroid in a chronic model of inflammation induced by complete Freund’s adjuvant., Pharmacol. Rep., 69, DOI: 10.1016/j.pharep.2017.04.011</label>
          <listPosition>255</listPosition>
          <doi>10.1016/j.pharep.2017.04.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923817</mtid>
          <link>/api/reference/66923817</link>
          <label>256. Zaringhalam 2016: Long-term treatment by vitamin B1 and reduction of serum proinflammatory cytokines, hyperalgesia, and paw edema in adjuvant-induced arthritis., Basic Clin. Neurosci., 7</label>
          <listPosition>256</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923818</mtid>
          <link>/api/reference/66923818</link>
          <label>257. Starling-Soares 2020: Role of the synthetic B1 vitamin sulbutiamine on health., J. Nutr. Metab., 2020, DOI: 10.1155/2020/9349063</label>
          <listPosition>257</listPosition>
          <doi>10.1155/2020/9349063</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923819</mtid>
          <link>/api/reference/66923819</link>
          <label>258. Ghaiad 2023: Regulation of PKC/TLR-4/NF-kB signaling by sulbutiamine improves diabetic nephropathy in rats., Chem. Biol. Inter., 381, DOI: 10.1016/j.cbi.2023.110544</label>
          <listPosition>258</listPosition>
          <doi>10.1016/j.cbi.2023.110544</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923820</mtid>
          <link>/api/reference/66923820</link>
          <label>259. Kiew 2002: Effects of sulbutiamine on diabetic polyneuropathy: an open randomised controlled study in type 2 diabetics., Malays. J. Med Sci., 9</label>
          <listPosition>259</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923821</mtid>
          <link>/api/reference/66923821</link>
          <label>260. Allowitz 2022: Therapeutic potential of vitamin B1derivative benfotiamine from diabetes to COVID-19., Future Med Chem., 14, DOI: 10.4155/fmc-2022-0040</label>
          <listPosition>260</listPosition>
          <doi>10.4155/fmc-2022-0040</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923822</mtid>
          <link>/api/reference/66923822</link>
          <label>261. Pinto 2016: Riboflavin., Adv. Nutr., 7, p. 973, DOI: 10.3945/an.116.012716</label>
          <listPosition>261</listPosition>
          <doi>10.3945/an.116.012716</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923823</mtid>
          <link>/api/reference/66923823</link>
          <label>262. Powers 2003: Riboflavin (vitamin B-2) and health., Am. J. Clin. Nutr., 77, DOI: 10.1093/ajcn/77.6.1352</label>
          <listPosition>262</listPosition>
          <doi>10.1093/ajcn/77.6.1352</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923824</mtid>
          <link>/api/reference/66923824</link>
          <label>263. Carreau 2021: Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies., J. Neurol. Neurosurg. Psychiatry, 92, DOI: 10.1136/jnnp-2020-323304</label>
          <listPosition>263</listPosition>
          <doi>10.1136/jnnp-2020-323304</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923825</mtid>
          <link>/api/reference/66923825</link>
          <label>264. Kemp 1988: 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex., Proc. Natl. Acad. Sci. USA, 85, DOI: 10.1073/pnas.85.17.6547</label>
          <listPosition>264</listPosition>
          <doi>10.1073/pnas.85.17.6547</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923826</mtid>
          <link>/api/reference/66923826</link>
          <label>265. Galambos 2024: Glycine transporter 1 inhibitors minimize the analgesic tolerance to morphine., Int J. Mol. Sci., 25, DOI: 10.3390/ijms252011136</label>
          <listPosition>265</listPosition>
          <doi>10.3390/ijms252011136</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923827</mtid>
          <link>/api/reference/66923827</link>
          <label>266. de Oliveira 2022: Kynurenines in the pathogenesis of peripheral neuropathy during leprosy and COVID-19., Front Cell Infect. Microbiol, 12, DOI: 10.3389/fcimb.2022.815738</label>
          <listPosition>266</listPosition>
          <doi>10.3389/fcimb.2022.815738</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923828</mtid>
          <link>/api/reference/66923828</link>
          <label>267. Mazur-Bialy 2016: Riboflavin reduces pro-inflammatory activation of adipocyte-macrophage co-culture. Potential application of vitamin B2 enrichment for attenuation of insulin resistance and metabolic syndrome development., Molecules, 21, DOI: 10.3390/molecules21121724</label>
          <listPosition>267</listPosition>
          <doi>10.3390/molecules21121724</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923829</mtid>
          <link>/api/reference/66923829</link>
          <label>268. Keil 2020: Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment., Vox Sang., 115, DOI: 10.1111/vox.12937</label>
          <listPosition>268</listPosition>
          <doi>10.1111/vox.12937</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923830</mtid>
          <link>/api/reference/66923830</link>
          <label>269. Landaas 2016: Vitamin levels in adults with ADHD., BJPsych Open, 2, DOI: 10.1192/bjpo.bp.116.003491</label>
          <listPosition>269</listPosition>
          <doi>10.1192/bjpo.bp.116.003491</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923831</mtid>
          <link>/api/reference/66923831</link>
          <label>270. Digby 2012: Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms., Arterioscler. Thromb. Vasc. Biol., 32, DOI: 10.1161/ATVBAHA.111.241836</label>
          <listPosition>270</listPosition>
          <doi>10.1161/ATVBAHA.111.241836</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923832</mtid>
          <link>/api/reference/66923832</link>
          <label>271. Bogan-Brown 2022: Potential efficacy of nutrient supplements for treatment or prevention of COVID-19., J. Diet. Suppl., 19, DOI: 10.1080/19390211.2021.1881686</label>
          <listPosition>271</listPosition>
          <doi>10.1080/19390211.2021.1881686</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923833</mtid>
          <link>/api/reference/66923833</link>
          <label>272. Ungerstedt 2003: Nicotinamide is a potent inhibitor of proinflammatory cytokines., Clin. Exp. Immunol., 131, DOI: 10.1046/j.1365-2249.2003.02031.x</label>
          <listPosition>272</listPosition>
          <doi>10.1046/j.1365-2249.2003.02031.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923834</mtid>
          <link>/api/reference/66923834</link>
          <label>273. Weiss 2015: Nicotinamide: a vitamin able to shift macrophage differentiation toward macrophages with restricted inflammatory features., Innate Immun., 21, DOI: 10.1177/1753425915602545</label>
          <listPosition>273</listPosition>
          <doi>10.1177/1753425915602545</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923835</mtid>
          <link>/api/reference/66923835</link>
          <label>274. Zhang 2023: Assessing the effects of nicotinamide mononucleotide supplementation on pulmonary inflammation in male mice subchronically exposed to ambient particulate matter., Environ. Health Perspect., 131, DOI: 10.1289/EHP12259</label>
          <listPosition>274</listPosition>
          <doi>10.1289/EHP12259</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923836</mtid>
          <link>/api/reference/66923836</link>
          <label>275. Akabane 1995: Nicotinamide Inhibits IRF-1 mRNA induction and prevents IL-1β-induced nitric oxide synthase expression in pancreatic β cells., Biochem Biophys. Res Commun., 215, DOI: 10.1006/bbrc.1995.2496</label>
          <listPosition>275</listPosition>
          <doi>10.1006/bbrc.1995.2496</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923837</mtid>
          <link>/api/reference/66923837</link>
          <label>276. Lee 2019: Supplementation with nicotinamide riboside reduces brain inflammation and improves cognitive function in diabetic mice., Int J. Mol. Sci., 20</label>
          <listPosition>276</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923838</mtid>
          <link>/api/reference/66923838</link>
          <label>277. Jiang 2020: Nicotinamide riboside alleviates alcohol-induced depression-like behaviours in C57BL/6J mice by altering the intestinal microbiota associated with microglial activation and BDNF expression., : Food Funct., DOI: 10.1039/C9FO01780A</label>
          <listPosition>277</listPosition>
          <doi>10.1039/C9FO01780A</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923839</mtid>
          <link>/api/reference/66923839</link>
          <label>278. Kujundžić 2022: COVID-19: are we facing secondary pellagra which cannot simply be cured by vitamin B3?., Int J. Mol. Sci., 23</label>
          <listPosition>278</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923840</mtid>
          <link>/api/reference/66923840</link>
          <label>279. Esam 2022: Molecular docking and dynamics studies of Nicotinamide Riboside as a potential multi-target nutraceutical against SARS-CoV-2 entry, replication, and transcription: A new insight., J. Mol. Struct., 1247, DOI: 10.1016/j.molstruc.2021.131394</label>
          <listPosition>279</listPosition>
          <doi>10.1016/j.molstruc.2021.131394</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923841</mtid>
          <link>/api/reference/66923841</link>
          <label>280. Zhu 2020: RNA-dependent RNA polymerase as a target for COVID-19 drug discovery., SLAS Discov., 25, DOI: 10.1177/2472555220942123</label>
          <listPosition>280</listPosition>
          <doi>10.1177/2472555220942123</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923842</mtid>
          <link>/api/reference/66923842</link>
          <label>281. Valderrábano 2024: Dysregulated nicotinamide adenine dinucleotide metabolome in patients hospitalized with COVID-19., Aging Cell, DOI: 10.1111/acel.14326</label>
          <listPosition>281</listPosition>
          <doi>10.1111/acel.14326</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923843</mtid>
          <link>/api/reference/66923843</link>
          <label>282. Zheng 2022: NAD+ in COVID-19 and viral infections., Trends Immunol., 43, DOI: 10.1016/j.it.2022.02.001</label>
          <listPosition>282</listPosition>
          <doi>10.1016/j.it.2022.02.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923844</mtid>
          <link>/api/reference/66923844</link>
          <label>283. Bencsik 2020: Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: therapeutic options., Br. J. Pharm., 177, DOI: 10.1111/bph.15021</label>
          <listPosition>283</listPosition>
          <doi>10.1111/bph.15021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923845</mtid>
          <link>/api/reference/66923845</link>
          <label>284. Elhassan 2019: Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures., Cell Rep., 28, DOI: 10.1016/j.celrep.2019.07.043</label>
          <listPosition>284</listPosition>
          <doi>10.1016/j.celrep.2019.07.043</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923846</mtid>
          <link>/api/reference/66923846</link>
          <label>285. Papp 2024: The PARP inhibitor rucaparib blocks SARS-CoV-2 virus binding to cells and the immune reaction in models of COVID-19., Br. J. Pharm., DOI: 10.1111/bph.17305</label>
          <listPosition>285</listPosition>
          <doi>10.1111/bph.17305</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923847</mtid>
          <link>/api/reference/66923847</link>
          <label>286. Majolo 2024: Losartan and enalapril maleate differently influence SARS-CoV-2-infected vero cells., Sci. Rep., 14, DOI: 10.1038/s41598-024-76657-7</label>
          <listPosition>286</listPosition>
          <doi>10.1038/s41598-024-76657-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923848</mtid>
          <link>/api/reference/66923848</link>
          <label>287. Zhang 2020: Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19., Circ. Res, 126</label>
          <listPosition>287</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923849</mtid>
          <link>/api/reference/66923849</link>
          <label>288. Komirishetty 2015: 329) PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy., J. Pain., 16, DOI: 10.1016/j.jpain.2015.01.247</label>
          <listPosition>288</listPosition>
          <doi>10.1016/j.jpain.2015.01.247</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923850</mtid>
          <link>/api/reference/66923850</link>
          <label>289. Komirishetty 2016: PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy., Life Sci., 150, DOI: 10.1016/j.lfs.2016.02.085</label>
          <listPosition>289</listPosition>
          <doi>10.1016/j.lfs.2016.02.085</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923851</mtid>
          <link>/api/reference/66923851</link>
          <label>290. Curtin 2020: Poly(ADP-ribose) polymerase inhibition: past, present and future., Nat. Rev. Drug Discov., 19, DOI: 10.1038/s41573-020-0076-6</label>
          <listPosition>290</listPosition>
          <doi>10.1038/s41573-020-0076-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923852</mtid>
          <link>/api/reference/66923852</link>
          <label>291. Hamity 2020: Nicotinamide riboside relieves paclitaxel-induced peripheral neuropathy and enhances suppression of tumor growth in tumor-bearing rats., Pain, 161, DOI: 10.1097/j.pain.0000000000001924</label>
          <listPosition>291</listPosition>
          <doi>10.1097/j.pain.0000000000001924</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923853</mtid>
          <link>/api/reference/66923853</link>
          <label>292. Dai 2022: NAD+ metabolism in peripheral neuropathic pain., Neurochem. Int, 161, DOI: 10.1016/j.neuint.2022.105435</label>
          <listPosition>292</listPosition>
          <doi>10.1016/j.neuint.2022.105435</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923854</mtid>
          <link>/api/reference/66923854</link>
          <label>293. Kort 2010: Subtype-selective Nav1.8 sodium channel blockers: Identification of potent, orally active nicotinamide derivatives., Bioorg. Med Chem. Lett., 20, DOI: 10.1016/j.bmcl.2010.08.121</label>
          <listPosition>293</listPosition>
          <doi>10.1016/j.bmcl.2010.08.121</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923855</mtid>
          <link>/api/reference/66923855</link>
          <label>294. He 2018: Vitamin B5 reduces bacterial growth via regulating innate immunity and adaptive immunity in mice infected with Mycobacterium tuberculosis., Front Immunol., 9, DOI: 10.3389/fimmu.2018.00365</label>
          <listPosition>294</listPosition>
          <doi>10.3389/fimmu.2018.00365</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923856</mtid>
          <link>/api/reference/66923856</link>
          <label>295. Ottenhof 2004: Organisation of the pantothenate (vitamin B5) biosynthesis pathway in higher plants., Plant J., 37, DOI: 10.1046/j.1365-313X.2003.01940.x</label>
          <listPosition>295</listPosition>
          <doi>10.1046/j.1365-313X.2003.01940.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923857</mtid>
          <link>/api/reference/66923857</link>
          <label>296. Jung 2017: The long-term relationship between dietary pantothenic acid (vitamin B5) intake and C-reactive protein concentration in adults aged 40 years and older., Nutr., Metab. Cardiovasc. Dis., 27, DOI: 10.1016/j.numecd.2017.05.008</label>
          <listPosition>296</listPosition>
          <doi>10.1016/j.numecd.2017.05.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923858</mtid>
          <link>/api/reference/66923858</link>
          <label>297. Abou-Hamdan 2023: Potential antiviral effects of pantethine against SARS-CoV-2., Sci. Rep., 13, DOI: 10.1038/s41598-023-29245-0</label>
          <listPosition>297</listPosition>
          <doi>10.1038/s41598-023-29245-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923859</mtid>
          <link>/api/reference/66923859</link>
          <label>298. Hamoudi 2024: Vitamin B5 is a context-dependent dietary regulator of nociception., G3: Genes, Genomes, Genet., DOI: 10.1093/g3journal/jkae174</label>
          <listPosition>298</listPosition>
          <doi>10.1093/g3journal/jkae174</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923860</mtid>
          <link>/api/reference/66923860</link>
          <label>299. Korkmaz 2020: The therapeutic efficacy of dexpanthenol on sciatic nerve injury in a rat model., Br. J. Neurosurg., 34, DOI: 10.1080/02688697.2020.1749984</label>
          <listPosition>299</listPosition>
          <doi>10.1080/02688697.2020.1749984</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923861</mtid>
          <link>/api/reference/66923861</link>
          <label>300. Zhang 2024: The close association of micronutrients with COVID-19., Heliyon, 10</label>
          <listPosition>300</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923862</mtid>
          <link>/api/reference/66923862</link>
          <label>301. Darand 2023: The association between B vitamins and the risk of COVID-19., Br. J. Nutr., 130, DOI: 10.1017/S0007114522003075</label>
          <listPosition>301</listPosition>
          <doi>10.1017/S0007114522003075</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923863</mtid>
          <link>/api/reference/66923863</link>
          <label>302. Huang 2010: Vitamin B6 supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis., Eur. J. Clin. Nutr., 64, DOI: 10.1038/ejcn.2010.107</label>
          <listPosition>302</listPosition>
          <doi>10.1038/ejcn.2010.107</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923864</mtid>
          <link>/api/reference/66923864</link>
          <label>303. Roubenoff 1995: Abnormal vitamin b6 status in rheumatoid cachexia association with spontaneous tumor necrosis factor α production and markers of inflammation., Arthritis Rheum., 38, DOI: 10.1002/art.1780380116</label>
          <listPosition>303</listPosition>
          <doi>10.1002/art.1780380116</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923865</mtid>
          <link>/api/reference/66923865</link>
          <label>304. Chiang 2003: Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis., Am. J. Med., 114, DOI: 10.1016/S0002-9343(02)01528-0</label>
          <listPosition>304</listPosition>
          <doi>10.1016/S0002-9343(02)01528-0</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923866</mtid>
          <link>/api/reference/66923866</link>
          <label>305. Selhub 2013: Dietary vitamin B6 intake modulates colonic inflammation in the IL10-/- model of inflammatory bowel disease., J. Nutr. Biochem., 24, DOI: 10.1016/j.jnutbio.2013.08.005</label>
          <listPosition>305</listPosition>
          <doi>10.1016/j.jnutbio.2013.08.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923867</mtid>
          <link>/api/reference/66923867</link>
          <label>306. Saibeni 2003: Low vitamin B6 plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants., Am. J. Gastroenterol., 98, DOI: 10.1111/j.1572-0241.2003.07160.x</label>
          <listPosition>306</listPosition>
          <doi>10.1111/j.1572-0241.2003.07160.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923868</mtid>
          <link>/api/reference/66923868</link>
          <label>307. Peters 2006: Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial., Alcohol. Alcohol., 41, DOI: 10.1093/alcalc/agl058</label>
          <listPosition>307</listPosition>
          <doi>10.1093/alcalc/agl058</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923869</mtid>
          <link>/api/reference/66923869</link>
          <label>308. Trippe 2016: Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial., Curr. Med Res Opin., 32, DOI: 10.1185/03007995.2015.1103215</label>
          <listPosition>308</listPosition>
          <doi>10.1185/03007995.2015.1103215</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923870</mtid>
          <link>/api/reference/66923870</link>
          <label>309. Okada 2000: Vitamin B6 supplementation can improve peripheral polyneuropathy in patients with chronic renal failure on high-flux haemadialysis and human recombinant erythropoietin., Nephrol. Dial. Transplant., 15, DOI: 10.1093/ndt/15.9.1410</label>
          <listPosition>309</listPosition>
          <doi>10.1093/ndt/15.9.1410</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923871</mtid>
          <link>/api/reference/66923871</link>
          <label>310. Chelban 2019: PDXK mutations cause polyneuropathy responsive to pyridoxal 5’-phosphate supplementation., Ann. Neurol., 86, DOI: 10.1002/ana.25524</label>
          <listPosition>310</listPosition>
          <doi>10.1002/ana.25524</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923872</mtid>
          <link>/api/reference/66923872</link>
          <label>311. Pauls 2021: Polyneuropathy monitoring in Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel., Brain Behav., 11, DOI: 10.1002/brb3.2408</label>
          <listPosition>311</listPosition>
          <doi>10.1002/brb3.2408</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923873</mtid>
          <link>/api/reference/66923873</link>
          <label>312. Aydin Köker 2021: Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience., Neurol. Sci., 42, DOI: 10.1007/s10072-020-04970-w</label>
          <listPosition>312</listPosition>
          <doi>10.1007/s10072-020-04970-w</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923874</mtid>
          <link>/api/reference/66923874</link>
          <label>313. Berger 1992: Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity., Neurology, 42, DOI: 10.1212/WNL.42.7.1367</label>
          <listPosition>313</listPosition>
          <doi>10.1212/WNL.42.7.1367</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923875</mtid>
          <link>/api/reference/66923875</link>
          <label>314. Latov 2016: Abnormal nutritional factors in patients evaluated at a neuropathy center., J. Clin. Neuromuscul. Dis., 17, DOI: 10.1097/CND.0000000000000128</label>
          <listPosition>314</listPosition>
          <doi>10.1097/CND.0000000000000128</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923876</mtid>
          <link>/api/reference/66923876</link>
          <label>315. Wong 2023: Does COVID-19 Infection increase the risk of diabetes? current evidence., Curr. Diab Rep., 23, DOI: 10.1007/s11892-023-01515-1</label>
          <listPosition>315</listPosition>
          <doi>10.1007/s11892-023-01515-1</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923877</mtid>
          <link>/api/reference/66923877</link>
          <label>316. Ueland 2015: Direct and functional biomarkers of vitamin B6 Status., Annu Rev. Nutr., 35, DOI: 10.1146/annurev-nutr-071714-034330</label>
          <listPosition>316</listPosition>
          <doi>10.1146/annurev-nutr-071714-034330</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923878</mtid>
          <link>/api/reference/66923878</link>
          <label>317. Kuroishi 2015: Regulation of immunological and inflammatory functions by biotin., Can. J. Physiol. Pharm., 93, DOI: 10.1139/cjpp-2014-0460</label>
          <listPosition>317</listPosition>
          <doi>10.1139/cjpp-2014-0460</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923879</mtid>
          <link>/api/reference/66923879</link>
          <label>318. Zempleni 2009: Biotin., BioFactors, 35, DOI: 10.1002/biof.8</label>
          <listPosition>318</listPosition>
          <doi>10.1002/biof.8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923880</mtid>
          <link>/api/reference/66923880</link>
          <label>319. León-Del-Rió 2017: Holocarboxylase synthetase: a moonlighting transcriptional coregulator of gene expression and a cytosolic regulator of biotin utilization., Annu Rev. Nutr., 37, DOI: 10.1146/annurev-nutr-042617-104653</label>
          <listPosition>319</listPosition>
          <doi>10.1146/annurev-nutr-042617-104653</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923881</mtid>
          <link>/api/reference/66923881</link>
          <label>320. Bianchi 1990: Identification of an isozymic form of acetyl-CoA carboxylase., J. Biol. Chem., 265, p. 1502, DOI: 10.1016/S0021-9258(19)40045-8</label>
          <listPosition>320</listPosition>
          <doi>10.1016/S0021-9258(19)40045-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923882</mtid>
          <link>/api/reference/66923882</link>
          <label>321. Kim 1997: Regulation of mammalian acetyl-coenzyme A carboxylase., Annu Rev. Nutr., 17, DOI: 10.1146/annurev.nutr.17.1.77</label>
          <listPosition>321</listPosition>
          <doi>10.1146/annurev.nutr.17.1.77</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923883</mtid>
          <link>/api/reference/66923883</link>
          <label>322. Spencer 1993: Brain acetyl-CoA carboxylase: isozymic identification and studies of its regulation during development and altered nutrition., Biochem Biophys. Res Commun., 192, DOI: 10.1006/bbrc.1993.1488</label>
          <listPosition>322</listPosition>
          <doi>10.1006/bbrc.1993.1488</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923884</mtid>
          <link>/api/reference/66923884</link>
          <label>323. Wang 2022: Acetyl-CoA carboxylases and diseases., Front Oncol., 12</label>
          <listPosition>323</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923885</mtid>
          <link>/api/reference/66923885</link>
          <label>324. Abu-Elheiga 2005: Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal., Proc. Natl. Acad. Sci. USA, 102, DOI: 10.1073/pnas.0505714102</label>
          <listPosition>324</listPosition>
          <doi>10.1073/pnas.0505714102</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923886</mtid>
          <link>/api/reference/66923886</link>
          <label>325. Gratacòs-Batlle 2018: Mechanisms of CPT1C-dependent AMPAR trafficking enhancement., Front Mol. Neurosci., 11, DOI: 10.3389/fnmol.2018.00275</label>
          <listPosition>325</listPosition>
          <doi>10.3389/fnmol.2018.00275</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923887</mtid>
          <link>/api/reference/66923887</link>
          <label>326. Casas 2020: Sensing of nutrients by CPT1C controls SAC1 activity to regulate AMPA receptor trafficking., J. Cell Biol., 219, DOI: 10.1083/jcb.201912045</label>
          <listPosition>326</listPosition>
          <doi>10.1083/jcb.201912045</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923888</mtid>
          <link>/api/reference/66923888</link>
          <label>327. Fadó 2021: The return of malonyl-CoA to the brain: cognition and other stories., Prog. Lipid Res, 81, DOI: 10.1016/j.plipres.2020.101071</label>
          <listPosition>327</listPosition>
          <doi>10.1016/j.plipres.2020.101071</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923889</mtid>
          <link>/api/reference/66923889</link>
          <label>328. Cyprian 2023: Metabolic profiling of COVID-19 severity and mortality: a targeted metabolomics approach., J. Immunol., 210, DOI: 10.4049/jimmunol.210.Supp.236.19</label>
          <listPosition>328</listPosition>
          <doi>10.4049/jimmunol.210.Supp.236.19</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923890</mtid>
          <link>/api/reference/66923890</link>
          <label>329. Liang 2024: Spinal nerve transection-induced upregulation of SAP97 via promoting membrane trafficking of GluA1-containing AMPA receptors in the dorsal horn contributes to the pathogenesis of neuropathic pain., Neurobiol. Dis., 194, DOI: 10.1016/j.nbd.2024.106471</label>
          <listPosition>329</listPosition>
          <doi>10.1016/j.nbd.2024.106471</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923891</mtid>
          <link>/api/reference/66923891</link>
          <label>330. Kuroishi 2009: Biotin status affects nickel allergy via regulation of interleukin-1β production in mice., J. Nutr., 139, p. 1031, DOI: 10.3945/jn.108.097543</label>
          <listPosition>330</listPosition>
          <doi>10.3945/jn.108.097543</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923892</mtid>
          <link>/api/reference/66923892</link>
          <label>331. Kuroishi 2008: Biotin deficiency up-regulates TNF-α production in murine macrophages., J. Leukoc. Biol., 83, DOI: 10.1189/jlb.0607428</label>
          <listPosition>331</listPosition>
          <doi>10.1189/jlb.0607428</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923893</mtid>
          <link>/api/reference/66923893</link>
          <label>332. Skupsky 2020: Biotin supplementation ameliorates murine colitis by preventing NF-κB activation., CMGH, 9</label>
          <listPosition>332</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923894</mtid>
          <link>/api/reference/66923894</link>
          <label>333. Demircan 2020: Biotin functionalized self-assembled peptide nanofiber as an adjuvant for immunomodulatory response., Biotechnol. J., 15, DOI: 10.1002/biot.202000100</label>
          <listPosition>333</listPosition>
          <doi>10.1002/biot.202000100</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923895</mtid>
          <link>/api/reference/66923895</link>
          <label>334. A. Dasgupta, S. Khalil, and Amer Wahed, Te chnical Note: Bimodal NegativeInterferenceofBiotinin Roche IL-6 Immunoassay, n.d.</label>
          <listPosition>334</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923896</mtid>
          <link>/api/reference/66923896</link>
          <label>335. Agrawal 2016: Biotin deficiency enhances the inflammatory response of human dendritic cells., Am. J. Physiol. Cell Physiol., 311, DOI: 10.1152/ajpcell.00141.2016</label>
          <listPosition>335</listPosition>
          <doi>10.1152/ajpcell.00141.2016</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923897</mtid>
          <link>/api/reference/66923897</link>
          <label>336. Rodriguez-Melendez 2004: Jurkat cells respond to biotin deficiency with increased nuclear translocation of NF-κB, mediating cell survival., Int. J. Vitam. Nutr. Res., 74, DOI: 10.1024/0300-9831.74.3.209</label>
          <listPosition>336</listPosition>
          <doi>10.1024/0300-9831.74.3.209</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923898</mtid>
          <link>/api/reference/66923898</link>
          <label>337. Um 2019: Pain-relieving effects of mTOR inhibitor in the anterior cingulate cortex of neuropathic rats., Mol. Neurobiol., 56, DOI: 10.1007/s12035-018-1245-z</label>
          <listPosition>337</listPosition>
          <doi>10.1007/s12035-018-1245-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923899</mtid>
          <link>/api/reference/66923899</link>
          <label>338. Mullen 2021: SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition., Nat. Commun., 12, DOI: 10.1038/s41467-021-22166-4</label>
          <listPosition>338</listPosition>
          <doi>10.1038/s41467-021-22166-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923900</mtid>
          <link>/api/reference/66923900</link>
          <label>339. Krall 2021: Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth., Cell Metab., 33, DOI: 10.1016/j.cmet.2021.02.001</label>
          <listPosition>339</listPosition>
          <doi>10.1016/j.cmet.2021.02.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923901</mtid>
          <link>/api/reference/66923901</link>
          <label>340. Obara 2011: Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice., Pain, 152, DOI: 10.1016/j.pain.2011.07.025</label>
          <listPosition>340</listPosition>
          <doi>10.1016/j.pain.2011.07.025</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923902</mtid>
          <link>/api/reference/66923902</link>
          <label>341. Elahi 2018: Biotin Deficiency induces Th1- and Th17-mediated proinflammatory responses in human CD4+ T lymphocytes via activation of the mTOR signaling pathway., J. Immunol., 200, DOI: 10.4049/jimmunol.1701200</label>
          <listPosition>341</listPosition>
          <doi>10.4049/jimmunol.1701200</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923903</mtid>
          <link>/api/reference/66923903</link>
          <label>342. Hayden 2004: Signaling to NF-kappaB.., Genes Dev., 18, DOI: 10.1101/gad.1228704</label>
          <listPosition>342</listPosition>
          <doi>10.1101/gad.1228704</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923904</mtid>
          <link>/api/reference/66923904</link>
          <label>343. Feng 2011: Folic acid inhibits lipopolysaccharide-induced inflammatory response in RAW264.7 macrophages by suppressing MAPKs and NF-κB activation., Inflamm. Res., 60, DOI: 10.1007/s00011-011-0337-2</label>
          <listPosition>343</listPosition>
          <doi>10.1007/s00011-011-0337-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923905</mtid>
          <link>/api/reference/66923905</link>
          <label>344. Schmelzer 2008: Functions of coenzyme Q10 in inflammation and gene expression., : BioFactors, DOI: 10.1002/biof.5520320121</label>
          <listPosition>344</listPosition>
          <doi>10.1002/biof.5520320121</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923906</mtid>
          <link>/api/reference/66923906</link>
          <label>345. Kalliolias 2016: TNF biology, pathogenic mechanisms and emerging therapeutic strategies., Nat. Rev. Rheuma, 12, DOI: 10.1038/nrrheum.2015.169</label>
          <listPosition>345</listPosition>
          <doi>10.1038/nrrheum.2015.169</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923907</mtid>
          <link>/api/reference/66923907</link>
          <label>346. Ni 2025: Long-term folic acid treatment relieves chronic inflammatory pain and pain-induced anxiety by reducing MMP2 expression in rats., Neuropharmacology, 269, DOI: 10.1016/j.neuropharm.2025.110352</label>
          <listPosition>346</listPosition>
          <doi>10.1016/j.neuropharm.2025.110352</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923908</mtid>
          <link>/api/reference/66923908</link>
          <label>347. Samblas 2018: Folic acid improves the inflammatory response in LPS-activated THP-1 macrophages., Mediat. Inflamm., 2018, DOI: 10.1155/2018/1312626</label>
          <listPosition>347</listPosition>
          <doi>10.1155/2018/1312626</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923909</mtid>
          <link>/api/reference/66923909</link>
          <label>348. Huang 2016: Folic acid represses hypoxia-induced inflammation in THP-1 cells through inhibition of the PI3K/Akt/HIF-1α pathway., PLoS One, 11</label>
          <listPosition>348</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923910</mtid>
          <link>/api/reference/66923910</link>
          <label>349. Cianciulli 2016: Folic acid is able to polarize the inflammatory response in LPS activated microglia by regulating multiple signaling pathways., Mediat. Inflamm., 2016, DOI: 10.1155/2016/5240127</label>
          <listPosition>349</listPosition>
          <doi>10.1155/2016/5240127</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923911</mtid>
          <link>/api/reference/66923911</link>
          <label>350. Gysi 2021: Network medicine framework for identifying drug-repurposing opportunities for COVID-19., Proc. Natl. Acad. Sci. USA, 118</label>
          <listPosition>350</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923912</mtid>
          <link>/api/reference/66923912</link>
          <label>351. Zhang 2022: Folic acid restricts SARS-CoV-2 invasion by methylating ACE2., Front Microbiol, 13</label>
          <listPosition>351</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923913</mtid>
          <link>/api/reference/66923913</link>
          <label>352. Škrbić 2023: Folic acid and leucovorin have potential to prevent SARS-CoV-2-virus internalization by interacting with s-glycoprotein/neuropilin-1 receptor complex., Molecules, 28, DOI: 10.3390/molecules28052294</label>
          <listPosition>352</listPosition>
          <doi>10.3390/molecules28052294</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923914</mtid>
          <link>/api/reference/66923914</link>
          <label>353. Zhang 2013: Methylcobalamin: a potential vitamin of pain killer., Neural Plast., 2013, DOI: 10.1155/2013/424651</label>
          <listPosition>353</listPosition>
          <doi>10.1155/2013/424651</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923915</mtid>
          <link>/api/reference/66923915</link>
          <label>354. Chiu 2011: Effic. Saf. intramuscular Inject. methylcobalamin Patients Chronic nonspecific Low. back pain: a Random Control. Trial</label>
          <listPosition>354</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923916</mtid>
          <link>/api/reference/66923916</link>
          <label>355. Waikakul 2000: Methylcobalamin as an adjuvant medication in conservative treatment of lumbar spinal stenosis., J. Med. Assoc. Thail., 83</label>
          <listPosition>355</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923917</mtid>
          <link>/api/reference/66923917</link>
          <label>356. Xu 2016: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn., Mol. Pain., 12, DOI: 10.1177/1744806916657089</label>
          <listPosition>356</listPosition>
          <doi>10.1177/1744806916657089</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923918</mtid>
          <link>/api/reference/66923918</link>
          <label>357. Zhang 2021: Efficacy of mudan granule (combined with methylcobalamin) on type 2 diabetic peripheral neuropathy: study protocol for a double-blind, randomized, placebo-controlled, parallel-arm, multi-center trial., Front Pharm., 12</label>
          <listPosition>357</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923919</mtid>
          <link>/api/reference/66923919</link>
          <label>358. Kuwabara 1999: Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients., Intern. Med., 38, DOI: 10.2169/internalmedicine.38.472</label>
          <listPosition>358</listPosition>
          <doi>10.2169/internalmedicine.38.472</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923920</mtid>
          <link>/api/reference/66923920</link>
          <label>359. Devathasan 1986: Methylcobalamin (CH3B12; Methycobal) in chronic diabetic neuropathy. A double-blind clinical and electrophysiological study., Clin. Trials J., 23</label>
          <listPosition>359</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923921</mtid>
          <link>/api/reference/66923921</link>
          <label>360. Al-Daghri 2016: Association of vitamin B12 with pro-inflammatory cytokines and biochemical markers related to cardiometabolic risk in Saudi subjects., Nutrients, 8, DOI: 10.3390/nu8090460</label>
          <listPosition>360</listPosition>
          <doi>10.3390/nu8090460</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923922</mtid>
          <link>/api/reference/66923922</link>
          <label>361. Domínguez-López 2024: Higher circulating vitamin B12 is associated with lower levels of inflammatory markers in individuals at high cardiovascular risk and in naturally aged mice., J. Sci. Food Agric., 104, DOI: 10.1002/jsfa.12976</label>
          <listPosition>361</listPosition>
          <doi>10.1002/jsfa.12976</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923923</mtid>
          <link>/api/reference/66923923</link>
          <label>362. Joseph Martin 2017: Comparative modulation of levels of oxidative stress in the liver of anti-tuberculosis drug treated wistar rats by vitamin B12, beta-carotene, and spirulina fusiformis: role of NF-κB, iNOS, IL-6, and IL-10., J. Cell Biochem, 118, DOI: 10.1002/jcb.26032</label>
          <listPosition>362</listPosition>
          <doi>10.1002/jcb.26032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923924</mtid>
          <link>/api/reference/66923924</link>
          <label>363. Ahmed Mohammed 2023: Hepatoprotective Effect of Vitamin B12 in Acetaminophen Induce Hepatotoxicity in Male Rats., Arch. Razi Inst., 78</label>
          <listPosition>363</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923925</mtid>
          <link>/api/reference/66923925</link>
          <label>364. Zhou 2017: The efficacy of gastrodin in combination with folate and vitamin B12 on patients with epilepsy after stroke and its effect on HMGB-1, IL-2 and IL-6 serum levels., Exp. Ther. Med, 14</label>
          <listPosition>364</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923926</mtid>
          <link>/api/reference/66923926</link>
          <label>365. Vakilian 2018: Vitamin B12 in association with antipsychotic drugs can modulate the expression of pro-/anti-inflammatory cytokines in alzheimer disease patients., Neuroimmunomodulation, 24</label>
          <listPosition>365</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923927</mtid>
          <link>/api/reference/66923927</link>
          <label>366. G. GÜLBAY, Y. KAYA, Relationship of Vitamin B12 and Vitamin D with IL-4, IL-10, TNF Beta in Obese Patients, Konuralp Tıp Dergisi 15 (2023). 〈https://doi.org/10.18521/ktd.1211939〉., DOI: 10.18521/ktd.1211939</label>
          <listPosition>366</listPosition>
          <doi>10.18521/ktd.1211939</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923928</mtid>
          <link>/api/reference/66923928</link>
          <label>367. Siddiqua 2024: Effects of vitamin B12 supplementation on oxidative stress markers and pro-inflammatory cytokines during pregnancy and postpartum among Bangladeshi mother–child pairs., BMC Nutr., 10, DOI: 10.1186/s40795-023-00785-y</label>
          <listPosition>367</listPosition>
          <doi>10.1186/s40795-023-00785-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923929</mtid>
          <link>/api/reference/66923929</link>
          <label>368. Joseph Martin 2017: J. Cell Biochem, 118, DOI: 10.1002/jcb.26032</label>
          <listPosition>368</listPosition>
          <doi>10.1002/jcb.26032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923930</mtid>
          <link>/api/reference/66923930</link>
          <label>369. Wheatley 2007: Cobalamin in inflammation III - Glutathionylcobalamin and methylcobalamin/adenosylcobalamin coenzymes: the sword in the stone? How cobalamin may directly regulate the nitric oxide synthases., J. Nutr. Environ. Med, 16, DOI: 10.1080/13590840701791863</label>
          <listPosition>369</listPosition>
          <doi>10.1080/13590840701791863</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923931</mtid>
          <link>/api/reference/66923931</link>
          <label>370. Cassiano 2023: Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic markings., Front Immunol., 14, DOI: 10.3389/fimmu.2023.1048790</label>
          <listPosition>370</listPosition>
          <doi>10.3389/fimmu.2023.1048790</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923932</mtid>
          <link>/api/reference/66923932</link>
          <label>371. BUCCELLATO 1999: Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α-mediated., FASEB J., 13, DOI: 10.1096/fasebj.13.2.297</label>
          <listPosition>371</listPosition>
          <doi>10.1096/fasebj.13.2.297</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923933</mtid>
          <link>/api/reference/66923933</link>
          <label>372. Barania Adabi 2023: The association between inflammatory and immune system biomarkers and the dietary inflammatory index in patients with COVID-19., Front Nutr., 10, DOI: 10.3389/fnut.2023.1075061</label>
          <listPosition>372</listPosition>
          <doi>10.3389/fnut.2023.1075061</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923934</mtid>
          <link>/api/reference/66923934</link>
          <label>373. Scalabrino 2008: Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy., Brain Res Rev., 59, DOI: 10.1016/j.brainresrev.2008.05.001</label>
          <listPosition>373</listPosition>
          <doi>10.1016/j.brainresrev.2008.05.001</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923935</mtid>
          <link>/api/reference/66923935</link>
          <label>374. Moatasim 2023: Potent antiviral activity of vitamin B12 against severe acute respiratory syndrome coronavirus 2, middle east respiratory syndrome coronavirus, and human coronavirus 229E., Microorganisms, 11, DOI: 10.3390/microorganisms11112777</label>
          <listPosition>374</listPosition>
          <doi>10.3390/microorganisms11112777</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923936</mtid>
          <link>/api/reference/66923936</link>
          <label>375. Kirchmeyer 2008: All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation., Arthritis Res Ther., 10, DOI: 10.1186/ar2569</label>
          <listPosition>375</listPosition>
          <doi>10.1186/ar2569</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923937</mtid>
          <link>/api/reference/66923937</link>
          <label>376. Wang 2024: Dietary vitamin A modifies the gut microbiota and intestinal tissue transcriptome, impacting intestinal permeability and the release of inflammatory factors, thereby influencing Aβ pathology., Front Nutr., 11</label>
          <listPosition>376</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923938</mtid>
          <link>/api/reference/66923938</link>
          <label>377. Bai 2005: β-carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-κB activation., Exp. Mol. Med, 37, DOI: 10.1038/emm.2005.42</label>
          <listPosition>377</listPosition>
          <doi>10.1038/emm.2005.42</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923939</mtid>
          <link>/api/reference/66923939</link>
          <label>378. Spinas 2015: Crosstalk between vitamin B and immunity., J. Biol. Regul. Homeost. Agents, 29</label>
          <listPosition>378</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923940</mtid>
          <link>/api/reference/66923940</link>
          <label>379. Anthonymuthu 2022: Tumor necrosis factor α impedes colonic thiamin pyrophosphate and free thiamin uptake: involvement of JNK/ERK1/2-mediated pathways., Am. J. Physiol. Cell Physiol., 323, DOI: 10.1152/ajpcell.00458.2022</label>
          <listPosition>379</listPosition>
          <doi>10.1152/ajpcell.00458.2022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923941</mtid>
          <link>/api/reference/66923941</link>
          <label>380. Teran 2022: Neuroprotective effect of thiamine-producing lactic acid bacteria in a murine Parkinsonian model., Food Funct., 13, DOI: 10.1039/D2FO01195F</label>
          <listPosition>380</listPosition>
          <doi>10.1039/D2FO01195F</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923942</mtid>
          <link>/api/reference/66923942</link>
          <label>381. Ozer 2022: Effect of thiamine pyrophosphate on cyclophosphamide-induced oxidative ovarian damage and reproductive dysfunction in female rats., Adv. Clin. Exp. Med., 31, DOI: 10.17219/acem/142535</label>
          <listPosition>381</listPosition>
          <doi>10.17219/acem/142535</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923943</mtid>
          <link>/api/reference/66923943</link>
          <label>382. Pan 2017: Thiamine supplementation facilitates thiamine transporter expression in the rumen epithelium and attenuates high-grain-induced inflammation in low-yielding dairy cows., J. Dairy Sci., 100, DOI: 10.3168/jds.2016-11966</label>
          <listPosition>382</listPosition>
          <doi>10.3168/jds.2016-11966</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923944</mtid>
          <link>/api/reference/66923944</link>
          <label>383. Vatsalya 2021: Efficacy of thiamine and medical management in treating hyperuricemia in AUD Patients with ALD: role of hyperuricemia in liver injury, gut-barrier dysfunction, and inflammation., Clin. Exp. Pharm., 11</label>
          <listPosition>383</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923945</mtid>
          <link>/api/reference/66923945</link>
          <label>384. Toledo Nunes 2019: A pivotal role for thiamine deficiency in the expression of neuroinflammation markers in models of alcohol-related brain damage., Alcohol Clin. Exp. Res, 43, DOI: 10.1111/acer.13946</label>
          <listPosition>384</listPosition>
          <doi>10.1111/acer.13946</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923946</mtid>
          <link>/api/reference/66923946</link>
          <label>385. Yadav 2009: Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1., Invest Ophthalmol. Vis. Sci., 50, DOI: 10.1167/iovs.08-2816</label>
          <listPosition>385</listPosition>
          <doi>10.1167/iovs.08-2816</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923947</mtid>
          <link>/api/reference/66923947</link>
          <label>386. Zhang 2020: Thiamine ameliorates inflammation of the ruminal epithelium of Saanen goats suffering from subacute ruminal acidosis., J. Dairy Sci., 103, DOI: 10.3168/jds.2019-16944</label>
          <listPosition>386</listPosition>
          <doi>10.3168/jds.2019-16944</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923948</mtid>
          <link>/api/reference/66923948</link>
          <label>387. Bozic 2015: Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia., PLoS One, 10, DOI: 10.1371/journal.pone.0118372</label>
          <listPosition>387</listPosition>
          <doi>10.1371/journal.pone.0118372</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923949</mtid>
          <link>/api/reference/66923949</link>
          <label>388. Ramamoorthy 2022: Alzheimer’s disease is associated with disruption in thiamin transport physiology: a potential role for neuroinflammation., Neurobiol. Dis., 171, DOI: 10.1016/j.nbd.2022.105799</label>
          <listPosition>388</listPosition>
          <doi>10.1016/j.nbd.2022.105799</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923950</mtid>
          <link>/api/reference/66923950</link>
          <label>389. Ahn 2020: Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical inflammasomes by the inhibition of caspase-1 activity., Sci. Rep., 10, DOI: 10.1038/s41598-020-76251-7</label>
          <listPosition>389</listPosition>
          <doi>10.1038/s41598-020-76251-7</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923951</mtid>
          <link>/api/reference/66923951</link>
          <label>390. Kodama 2005: Inhibitory mechanisms of highly purified vitamin B2 on the productions of proinflammatory cytokine and NO in endotoxin-induced shock in mice., Life Sci., 78, DOI: 10.1016/j.lfs.2005.04.037</label>
          <listPosition>390</listPosition>
          <doi>10.1016/j.lfs.2005.04.037</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923952</mtid>
          <link>/api/reference/66923952</link>
          <label>391. Mazur-Bialy 2017: Vitamin B2 deficiency enhances the pro-inflammatory activity of adipocyte, consequences for insulin resistance and metabolic syndrome development., Life Sci., 178, DOI: 10.1016/j.lfs.2017.04.010</label>
          <listPosition>391</listPosition>
          <doi>10.1016/j.lfs.2017.04.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923953</mtid>
          <link>/api/reference/66923953</link>
          <label>392. Dey 2016: Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation., J. Inflamm. (U. Kingd. ), 13</label>
          <listPosition>392</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923954</mtid>
          <link>/api/reference/66923954</link>
          <label>393. Akasov 2024: Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity., Biochim Biophys. Acta Gen. Subj., 1868, DOI: 10.1016/j.bbagen.2024.130582</label>
          <listPosition>393</listPosition>
          <doi>10.1016/j.bbagen.2024.130582</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923955</mtid>
          <link>/api/reference/66923955</link>
          <label>394. Anandam 2018: Effect of the proinflammatory cytokine TNF-α on intestinal riboflavin uptake: Inhibition mediated via transcriptional mechanism(s)., Am. J. Physiol. Cell Physiol., 315, DOI: 10.1152/ajpcell.00295.2018</label>
          <listPosition>394</listPosition>
          <doi>10.1152/ajpcell.00295.2018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923956</mtid>
          <link>/api/reference/66923956</link>
          <label>395. Ozaydin 2023: Anti-inflammatory, antioxidant and neuroprotective effects of niacin on mild traumatic brain injury in rats., Turk. Neurosurg., 33</label>
          <listPosition>395</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923957</mtid>
          <link>/api/reference/66923957</link>
          <label>396. Ganji 2015: Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: impact on non-alcoholic fatty liver disease., Metabolism, 64, DOI: 10.1016/j.metabol.2015.05.002</label>
          <listPosition>396</listPosition>
          <doi>10.1016/j.metabol.2015.05.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923958</mtid>
          <link>/api/reference/66923958</link>
          <label>397. Giri 2019: Niacin ameliorates neuro-inflammation in parkinson’s disease via GPR109A., Int J. Mol. Sci., 20, DOI: 10.3390/ijms20184559</label>
          <listPosition>397</listPosition>
          <doi>10.3390/ijms20184559</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923959</mtid>
          <link>/api/reference/66923959</link>
          <label>398. Kwon 2011: Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-κB pathway., Crit. Care Med, 39, DOI: 10.1097/CCM.0b013e3181feeae4</label>
          <listPosition>398</listPosition>
          <doi>10.1097/CCM.0b013e3181feeae4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923960</mtid>
          <link>/api/reference/66923960</link>
          <label>399. Lipszyc 2013: Niacin modulates pro-inflammatory cytokine secretion. A potential mechanism involved in its anti-atherosclerotic effect., Open Cardiovasc Med J., 7, DOI: 10.2174/1874192401307010090</label>
          <listPosition>399</listPosition>
          <doi>10.2174/1874192401307010090</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923961</mtid>
          <link>/api/reference/66923961</link>
          <label>400. Zhou 2014: Niacin attenuates the production of pro-inflammatory cytokines in LPS-induced mouse alveolar macrophages by HCA2 dependent mechanisms., Int Immunopharmacol., 23, DOI: 10.1016/j.intimp.2014.07.006</label>
          <listPosition>400</listPosition>
          <doi>10.1016/j.intimp.2014.07.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923962</mtid>
          <link>/api/reference/66923962</link>
          <label>401. Gheita 2020: The potential role of B5: a stitch in time and switch in cytokine., Phytother. Res., 34, DOI: 10.1002/ptr.6537</label>
          <listPosition>401</listPosition>
          <doi>10.1002/ptr.6537</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923963</mtid>
          <link>/api/reference/66923963</link>
          <label>402. Mikkelsen 2023: High-Dose Vitamin B6 (pyridoxine) displays strong anti-inflammatory properties in lipopolysaccharide-stimulated monocytes., Biomedicines, 11, DOI: 10.3390/biomedicines11092578</label>
          <listPosition>402</listPosition>
          <doi>10.3390/biomedicines11092578</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923964</mtid>
          <link>/api/reference/66923964</link>
          <label>403. Vaccaro 2023: Folate and Vitamin B12 Deficiency Exacerbate Inflammation during Mycobacterium avium paratuberculosis (MAP) Infection., Nutrients, 15, DOI: 10.3390/nu15020261</label>
          <listPosition>403</listPosition>
          <doi>10.3390/nu15020261</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923965</mtid>
          <link>/api/reference/66923965</link>
          <label>404. Liu 2024: Associations between folate intake and knee pain, inflammation mediators and comorbid conditions in patients with symptomatic knee osteoarthritis., BMC Musculoskelet. Disord., 25, p. 973, DOI: 10.1186/s12891-024-08095-5</label>
          <listPosition>404</listPosition>
          <doi>10.1186/s12891-024-08095-5</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923966</mtid>
          <link>/api/reference/66923966</link>
          <label>405. Mitra 2017: Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia., Prog. Neuropsychopharmacol. Biol. Psychiatry, 78, DOI: 10.1016/j.pnpbp.2017.05.005</label>
          <listPosition>405</listPosition>
          <doi>10.1016/j.pnpbp.2017.05.005</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923967</mtid>
          <link>/api/reference/66923967</link>
          <label>406. Harb 2020: The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis., J. Nutr. Biochem., 84, DOI: 10.1016/j.jnutbio.2020.108415</label>
          <listPosition>406</listPosition>
          <doi>10.1016/j.jnutbio.2020.108415</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923968</mtid>
          <link>/api/reference/66923968</link>
          <label>407. Chan 2023: Folate deficiency enhanced inflammation and exacerbated renal fibrosis in high-fat high-fructose diet-fed mice., Nutrients, 15, DOI: 10.3390/nu15163616</label>
          <listPosition>407</listPosition>
          <doi>10.3390/nu15163616</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923969</mtid>
          <link>/api/reference/66923969</link>
          <label>408. Ruff 2023: Folate targeting peptide conjugates for inflammatory response suppression., Curr. Drug Metab., 24, DOI: 10.2174/1389200224666230419090052</label>
          <listPosition>408</listPosition>
          <doi>10.2174/1389200224666230419090052</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923970</mtid>
          <link>/api/reference/66923970</link>
          <label>409. Zargarzadeh 2021: The effects of folic acid supplementation on pro-inflammatory mediators: a systematic review and dose–response meta-analysis of randomized controlled trials., Clin. Ther., 43, DOI: 10.1016/j.clinthera.2021.10.002</label>
          <listPosition>409</listPosition>
          <doi>10.1016/j.clinthera.2021.10.002</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923971</mtid>
          <link>/api/reference/66923971</link>
          <label>410. Ma 2016: Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI., Sci. Rep., 6, DOI: 10.1038/srep37486</label>
          <listPosition>410</listPosition>
          <doi>10.1038/srep37486</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923972</mtid>
          <link>/api/reference/66923972</link>
          <label>411. Steluti 2021: Unmetabolized folic acid is associated with TNF-α, IL-1β and IL-12 concentrations in a population exposed to mandatory food fortification with folic acid: a cross-sectional population-based study in Sao Paulo, Brazil., Eur. J. Nutr., 60, DOI: 10.1007/s00394-020-02307-z</label>
          <listPosition>411</listPosition>
          <doi>10.1007/s00394-020-02307-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923973</mtid>
          <link>/api/reference/66923973</link>
          <label>412. Yang 2024: Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice., Biochem Biophys. Res Commun., 704, DOI: 10.1016/j.bbrc.2024.149668</label>
          <listPosition>412</listPosition>
          <doi>10.1016/j.bbrc.2024.149668</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923974</mtid>
          <link>/api/reference/66923974</link>
          <label>413. Politis 2010: Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production., J. Alzheimer’S. Dis., 19</label>
          <listPosition>413</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923975</mtid>
          <link>/api/reference/66923975</link>
          <label>414. Elliott 2017: An in vitro model of gastric inflammation and treatment with cobalamin., Int J. Inflam., 2017</label>
          <listPosition>414</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923976</mtid>
          <link>/api/reference/66923976</link>
          <label>415. Lykkesfeldt 2025: The pharmacology of vitamin C., Pharm. Rev., 77, DOI: 10.1016/j.pharmr.2025.100043</label>
          <listPosition>415</listPosition>
          <doi>10.1016/j.pharmr.2025.100043</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923977</mtid>
          <link>/api/reference/66923977</link>
          <label>416. Shakoor 2021: Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?., Maturitas, 143, DOI: 10.1016/j.maturitas.2020.08.003</label>
          <listPosition>416</listPosition>
          <doi>10.1016/j.maturitas.2020.08.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923978</mtid>
          <link>/api/reference/66923978</link>
          <label>417. Iddir 2020: Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the covid-19 crisis., Nutrients, 12, DOI: 10.3390/nu12061562</label>
          <listPosition>417</listPosition>
          <doi>10.3390/nu12061562</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923979</mtid>
          <link>/api/reference/66923979</link>
          <label>418. Härtel 2004: Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes., Cytokine, 27, DOI: 10.1016/j.cyto.2004.02.004</label>
          <listPosition>418</listPosition>
          <doi>10.1016/j.cyto.2004.02.004</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923980</mtid>
          <link>/api/reference/66923980</link>
          <label>419. Kumar 2023: Vitamin C improves inflammatory-related redox status in hyperlipidemic rats., Indian J. Clin. Biochem., 38, DOI: 10.1007/s12291-022-01070-8</label>
          <listPosition>419</listPosition>
          <doi>10.1007/s12291-022-01070-8</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923981</mtid>
          <link>/api/reference/66923981</link>
          <label>420. Chang 2016: Therapeutic treatment with ascorbate rescues mice from heat stroke-induced death by attenuating systemic inflammatory response and hypothalamic neuronal damage., Free Radic. Biol. Med, 93, DOI: 10.1016/j.freeradbiomed.2015.12.017</label>
          <listPosition>420</listPosition>
          <doi>10.1016/j.freeradbiomed.2015.12.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923982</mtid>
          <link>/api/reference/66923982</link>
          <label>421. Gholizadeh 2021: Vitamin C reduces interleukin-6 plasma concentration: a systematic review and meta-analysis of randomized clinical trials., Clin. Nutr. Open Sci., 40, DOI: 10.1016/j.nutos.2021.09.003</label>
          <listPosition>421</listPosition>
          <doi>10.1016/j.nutos.2021.09.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923983</mtid>
          <link>/api/reference/66923983</link>
          <label>422. Y.-N. Cui, N. Tian, Y.-H. Luo, J.-J. Zhao, C.-F. Bi, Y. Gou, J. Liu, K. Feng, J.-F. Zhang, Advance Research Perspective, 2024. 〈www.aging-us.comwww.aging-us.com〉.</label>
          <listPosition>422</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923984</mtid>
          <link>/api/reference/66923984</link>
          <label>423. Carr 2017: Vitamin C and immune function., Nutrients, 9, DOI: 10.3390/nu9111211</label>
          <listPosition>423</listPosition>
          <doi>10.3390/nu9111211</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923985</mtid>
          <link>/api/reference/66923985</link>
          <label>424. Ellulu 2015: Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial., Drug Des. Devel Ther., 9</label>
          <listPosition>424</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923986</mtid>
          <link>/api/reference/66923986</link>
          <label>425. Zhang 2021: Pilot trial of high-dose vitamin C in critically ill COVID-19 patients., Ann. Intensive Care, 11, DOI: 10.1186/s13613-020-00792-3</label>
          <listPosition>425</listPosition>
          <doi>10.1186/s13613-020-00792-3</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923987</mtid>
          <link>/api/reference/66923987</link>
          <label>426. Righi 2020: Effects of vitamin C on oxidative stress, inflammation, muscle soreness, and strength following acute exercise: meta-analyses of randomized clinical trials., Eur. J. Nutr., 59, DOI: 10.1007/s00394-020-02215-2</label>
          <listPosition>426</listPosition>
          <doi>10.1007/s00394-020-02215-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923988</mtid>
          <link>/api/reference/66923988</link>
          <label>427. Xia 2021: High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019., Nutrition, 91–92</label>
          <listPosition>427</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923989</mtid>
          <link>/api/reference/66923989</link>
          <label>428. Xia 2021: High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019., Nutrition, 91–92</label>
          <listPosition>428</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923990</mtid>
          <link>/api/reference/66923990</link>
          <label>429. Tiwari 2023: Vitamin D and COVID-19: an update on evidence and potential therapeutic implications., Cureus, DOI: 10.7759/cureus.46121</label>
          <listPosition>429</listPosition>
          <doi>10.7759/cureus.46121</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923991</mtid>
          <link>/api/reference/66923991</link>
          <label>430. Cantorna 2004: Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence., : Exp. Biol. Med, DOI: 10.1177/153537020422901108</label>
          <listPosition>430</listPosition>
          <doi>10.1177/153537020422901108</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923992</mtid>
          <link>/api/reference/66923992</link>
          <label>431. Fenercioglu 2023: The association between serum 25-hydroxyvitamin D3 levels and pro-inflammatory markers in new-onset type 2 diabetes mellitus and prediabetes., Biomolecules, 13, DOI: 10.3390/biom13121778</label>
          <listPosition>431</listPosition>
          <doi>10.3390/biom13121778</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923993</mtid>
          <link>/api/reference/66923993</link>
          <label>432. Ahmad 2023: Association between Average Vitamin D Levels and COVID-19 mortality in 19 European Countries—a population-based study., Nutrients, 15, DOI: 10.3390/nu15224818</label>
          <listPosition>432</listPosition>
          <doi>10.3390/nu15224818</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923994</mtid>
          <link>/api/reference/66923994</link>
          <label>433. Ali 2020: Role of vitamin D in preventing of COVID-19 infection, progression and severity., J. Infect. Public Health, 13, DOI: 10.1016/j.jiph.2020.06.021</label>
          <listPosition>433</listPosition>
          <doi>10.1016/j.jiph.2020.06.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923995</mtid>
          <link>/api/reference/66923995</link>
          <label>434. Annweiler 2020: Vitamin D and survival in COVID-19 patients: a quasi-experimental study., J. Steroid Biochem. Mol. Biol., 204, DOI: 10.1016/j.jsbmb.2020.105771</label>
          <listPosition>434</listPosition>
          <doi>10.1016/j.jsbmb.2020.105771</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923996</mtid>
          <link>/api/reference/66923996</link>
          <label>435. Hastie 2021: Vitamin D and COVID-19 infection and mortality in UK Biobank., Eur. J. Nutr., 60, DOI: 10.1007/s00394-020-02372-4</label>
          <listPosition>435</listPosition>
          <doi>10.1007/s00394-020-02372-4</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923997</mtid>
          <link>/api/reference/66923997</link>
          <label>436. Infante 2022: Low vitamin D status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: an Italian retrospective study., J. Am. Nutr. Assoc., 41</label>
          <listPosition>436</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923998</mtid>
          <link>/api/reference/66923998</link>
          <label>437. Pecina 2021: Vitamin D Status and Severe COVID-19 disease outcomes in hospitalized patients., J. Prim. Care Community Health, 12, DOI: 10.1177/21501327211041206</label>
          <listPosition>437</listPosition>
          <doi>10.1177/21501327211041206</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66923999</mtid>
          <link>/api/reference/66923999</link>
          <label>438. Rastogi 2022: Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)., Post. Med J., 98, DOI: 10.1136/postgradmedj-2020-139065</label>
          <listPosition>438</listPosition>
          <doi>10.1136/postgradmedj-2020-139065</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924000</mtid>
          <link>/api/reference/66924000</link>
          <label>439. Kow 2024: The impact of vitamin D administration on mortality in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials., Inflammopharmacology, DOI: 10.1007/s10787-024-01564-2</label>
          <listPosition>439</listPosition>
          <doi>10.1007/s10787-024-01564-2</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924001</mtid>
          <link>/api/reference/66924001</link>
          <label>440. Contreras-Bolívar 2023: Vitamin D and COVID-19: where are we now?., Post. Med, 135</label>
          <listPosition>440</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924002</mtid>
          <link>/api/reference/66924002</link>
          <label>441. Sartini 2024: Preventive Vitamin D supplementation and risk for COVID-19 infection: a systematic review and meta-analysis., Nutrients, 16</label>
          <listPosition>441</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924003</mtid>
          <link>/api/reference/66924003</link>
          <label>442. Bilezikian 2023: Consensus and controversial aspects of vitamin D and COVID-19., J. Clin. Endocrinol. Metab., 108, DOI: 10.1210/clinem/dgac719</label>
          <listPosition>442</listPosition>
          <doi>10.1210/clinem/dgac719</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924004</mtid>
          <link>/api/reference/66924004</link>
          <label>443. Notz 2022: Vitamin D deficiency in critically ill COVID-19 ARDS patients., Clin. Nutr., 41</label>
          <listPosition>443</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924005</mtid>
          <link>/api/reference/66924005</link>
          <label>444. Grant 2020: Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths., Nutrients, 12</label>
          <listPosition>444</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924006</mtid>
          <link>/api/reference/66924006</link>
          <label>445. Zia 2011: Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D., Am. J. Med. Sci., 341, DOI: 10.1097/MAJ.0b013e3182058864</label>
          <listPosition>445</listPosition>
          <doi>10.1097/MAJ.0b013e3182058864</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924007</mtid>
          <link>/api/reference/66924007</link>
          <label>446. di Filippo 2023: Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization., Endocrine, 80, DOI: 10.1007/s12020-023-03331-9</label>
          <listPosition>446</listPosition>
          <doi>10.1007/s12020-023-03331-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924008</mtid>
          <link>/api/reference/66924008</link>
          <label>447. Khalil 2024: Vitamin D regulates COVID-19 associated severity by suppressing the NLRP3 inflammasome pathway., PLoS One, 19, DOI: 10.1371/journal.pone.0302818</label>
          <listPosition>447</listPosition>
          <doi>10.1371/journal.pone.0302818</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924009</mtid>
          <link>/api/reference/66924009</link>
          <label>448. Cowie 2019: A novel sex-dependent target for the treatment of postoperative pain: the NLRP3 inflammasome., Front Neurol., 10, DOI: 10.3389/fneur.2019.00622</label>
          <listPosition>448</listPosition>
          <doi>10.3389/fneur.2019.00622</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924010</mtid>
          <link>/api/reference/66924010</link>
          <label>449. di Filippo 2023: Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors., J. Clin. Endocrinol. Metab., 108, DOI: 10.1210/clinem/dgad207</label>
          <listPosition>449</listPosition>
          <doi>10.1210/clinem/dgad207</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924011</mtid>
          <link>/api/reference/66924011</link>
          <label>450. di Filippo 2023: Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination., Endocrine, 82, DOI: 10.1007/s12020-023-03481-w</label>
          <listPosition>450</listPosition>
          <doi>10.1007/s12020-023-03481-w</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924012</mtid>
          <link>/api/reference/66924012</link>
          <label>451. Entrenas Castillo 2020: Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study., J. Steroid Biochem. Mol. Biol., 203, DOI: 10.1016/j.jsbmb.2020.105751</label>
          <listPosition>451</listPosition>
          <doi>10.1016/j.jsbmb.2020.105751</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924013</mtid>
          <link>/api/reference/66924013</link>
          <label>452. Jiang 2014: Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy., Free Radic. Biol. Med, 72, DOI: 10.1016/j.freeradbiomed.2014.03.035</label>
          <listPosition>452</listPosition>
          <doi>10.1016/j.freeradbiomed.2014.03.035</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924014</mtid>
          <link>/api/reference/66924014</link>
          <label>453. Singh 2007: Vitamin E: inflammation and atherosclerosis., Vitam. Horm., 76, DOI: 10.1016/S0083-6729(07)76020-X</label>
          <listPosition>453</listPosition>
          <doi>10.1016/S0083-6729(07)76020-X</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924015</mtid>
          <link>/api/reference/66924015</link>
          <label>454. Devaraj 2007: Effect of high-dose α-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease., Am. J. Clin. Nutr., 86, DOI: 10.1093/ajcn/86.5.1392</label>
          <listPosition>454</listPosition>
          <doi>10.1093/ajcn/86.5.1392</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924016</mtid>
          <link>/api/reference/66924016</link>
          <label>455. Devaraj 1999: α-Tocopherol decreases interleukin-1β release from activated human monocytes by inhibition of 5-lipoxygenase., Arterioscler. Thromb. Vasc. Biol., 19, DOI: 10.1161/01.ATV.19.4.1125</label>
          <listPosition>455</listPosition>
          <doi>10.1161/01.ATV.19.4.1125</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924017</mtid>
          <link>/api/reference/66924017</link>
          <label>456. Godbout 2004: α-tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain., J. Neuroimmunol., 149, DOI: 10.1016/j.jneuroim.2003.12.017</label>
          <listPosition>456</listPosition>
          <doi>10.1016/j.jneuroim.2003.12.017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924018</mtid>
          <link>/api/reference/66924018</link>
          <label>457. Keith 2001: A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure., Am. J. Clin. Nutr., 73, DOI: 10.1093/ajcn/73.2.219</label>
          <listPosition>457</listPosition>
          <doi>10.1093/ajcn/73.2.219</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924019</mtid>
          <link>/api/reference/66924019</link>
          <label>458. Devaraj 2008: Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome., Free Radic. Biol. Med, 44, DOI: 10.1016/j.freeradbiomed.2007.12.018</label>
          <listPosition>458</listPosition>
          <doi>10.1016/j.freeradbiomed.2007.12.018</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924020</mtid>
          <link>/api/reference/66924020</link>
          <label>459. Dalgård 2009: Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease., Br. J. Nutr., 101</label>
          <listPosition>459</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924021</mtid>
          <link>/api/reference/66924021</link>
          <label>460. Daud 2013: Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients., Vasc. Health Risk Manag, 9</label>
          <listPosition>460</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924022</mtid>
          <link>/api/reference/66924022</link>
          <label>461. El-Sisi 2013: Atorvastatin improves erectile dysfunction in patients initially irresponsive to sildenafil by the activation of endothelial nitric oxide synthase., Int J. Impot Res, 25, DOI: 10.1038/ijir.2012.46</label>
          <listPosition>461</listPosition>
          <doi>10.1038/ijir.2012.46</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924023</mtid>
          <link>/api/reference/66924023</link>
          <label>462. Mah 2013: γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation., Free Radic. Biol. Med, 65, DOI: 10.1016/j.freeradbiomed.2013.09.016</label>
          <listPosition>462</listPosition>
          <doi>10.1016/j.freeradbiomed.2013.09.016</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924024</mtid>
          <link>/api/reference/66924024</link>
          <label>463. Manning 2013: The effect of lipoic acid and vitamin E therapies in individuals with the metabolic syndrome., Nutr., Metab. Cardiovasc. Dis., 23, DOI: 10.1016/j.numecd.2011.11.006</label>
          <listPosition>463</listPosition>
          <doi>10.1016/j.numecd.2011.11.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924025</mtid>
          <link>/api/reference/66924025</link>
          <label>464. Aryaeian 2014: Effect of conjugated linoleic acid, vitamin E, alone or combined on immunity and inflammatory parameters in adults with active rheumatoid arthritis: a randomized controlled trial., Int J. Prev. Med, 5</label>
          <listPosition>464</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924026</mtid>
          <link>/api/reference/66924026</link>
          <label>465. Khatami 2016: The effects of high-dose vitamin E supplementation on biomarkers of kidney injury, inflammation, and oxidative stress in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial., J. Clin. Lipido, 10, DOI: 10.1016/j.jacl.2016.02.021</label>
          <listPosition>465</listPosition>
          <doi>10.1016/j.jacl.2016.02.021</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924027</mtid>
          <link>/api/reference/66924027</link>
          <label>466. Sohrabi 2016: Intradialytic oral protein supplementation and nutritional and inflammation outcomes in hemodialysis: a randomized controlled trial., Am. J. Kidney Dis., 68, DOI: 10.1053/j.ajkd.2016.02.050</label>
          <listPosition>466</listPosition>
          <doi>10.1053/j.ajkd.2016.02.050</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924028</mtid>
          <link>/api/reference/66924028</link>
          <label>467. Stonehouse 2016: Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: a randomised controlled trial., Atherosclerosis, 254, DOI: 10.1016/j.atherosclerosis.2016.10.027</label>
          <listPosition>467</listPosition>
          <doi>10.1016/j.atherosclerosis.2016.10.027</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924029</mtid>
          <link>/api/reference/66924029</link>
          <label>468. Ekhlasi 2017: Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease., EXCLI J., 16</label>
          <listPosition>468</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924030</mtid>
          <link>/api/reference/66924030</link>
          <label>469. Asbaghi 2020: The effect of vitamin E supplementation on selected inflammatory biomarkers in adults: a systematic review and meta-analysis of randomized clinical trials., Sci. Rep., 10, DOI: 10.1038/s41598-020-73741-6</label>
          <listPosition>469</listPosition>
          <doi>10.1038/s41598-020-73741-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924031</mtid>
          <link>/api/reference/66924031</link>
          <label>470. Andrés 2024: Antioxidant metabolism pathways in vitamins, polyphenols, and selenium: parallels and divergences., Int J. Mol. Sci., 25, DOI: 10.3390/ijms25052600</label>
          <listPosition>470</listPosition>
          <doi>10.3390/ijms25052600</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924032</mtid>
          <link>/api/reference/66924032</link>
          <label>471. Fischer 2004: Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle., J. Physiol., 558, DOI: 10.1113/jphysiol.2004.066779</label>
          <listPosition>471</listPosition>
          <doi>10.1113/jphysiol.2004.066779</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924033</mtid>
          <link>/api/reference/66924033</link>
          <label>472. Dahlbäck 2005: Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases., J. Intern Med, 257, DOI: 10.1111/j.1365-2796.2004.01444.x</label>
          <listPosition>472</listPosition>
          <doi>10.1111/j.1365-2796.2004.01444.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924034</mtid>
          <link>/api/reference/66924034</link>
          <label>473. Vermeer 2012: Vitamin K: The effect on health beyond coagulation - an overview., : Food Nutr. Res, DOI: 10.3402/fnr.v56i0.5329</label>
          <listPosition>473</listPosition>
          <doi>10.3402/fnr.v56i0.5329</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924035</mtid>
          <link>/api/reference/66924035</link>
          <label>474. Collins 1981: Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication., S., Microbiol Rev., 45</label>
          <listPosition>474</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924036</mtid>
          <link>/api/reference/66924036</link>
          <label>475. Beulens 2013: The role of menaquinones (vitamin K2) in human health., Br. J. Nutr., 110, DOI: 10.1017/S0007114513001013</label>
          <listPosition>475</listPosition>
          <doi>10.1017/S0007114513001013</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924037</mtid>
          <link>/api/reference/66924037</link>
          <label>476. Mangge 2022: Dramatic decrease of vitamin K2 subtype menaquinone-7 in COVID-19 patients., Antioxidants, 11, DOI: 10.3390/antiox11071235</label>
          <listPosition>476</listPosition>
          <doi>10.3390/antiox11071235</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924038</mtid>
          <link>/api/reference/66924038</link>
          <label>477. Bus 2021: Relationship between structure and biological activity of various vitamin K forms., Foods, 10, DOI: 10.3390/foods10123136</label>
          <listPosition>477</listPosition>
          <doi>10.3390/foods10123136</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924039</mtid>
          <link>/api/reference/66924039</link>
          <label>478. Ohashi 1995: Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6., J. Biol. Chem., 270, DOI: 10.1074/jbc.270.39.22681</label>
          <listPosition>478</listPosition>
          <doi>10.1074/jbc.270.39.22681</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924040</mtid>
          <link>/api/reference/66924040</link>
          <label>479. Goudarzi 2016: Gas6 promotes oligodendrogenesis and myelination in the adult central nervous system and after lysolecithin-induced demyelination., ASN Neuro, 8, DOI: 10.1177/1759091416668430</label>
          <listPosition>479</listPosition>
          <doi>10.1177/1759091416668430</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924041</mtid>
          <link>/api/reference/66924041</link>
          <label>480. Hafizi 2006: Gas6 and protein S: Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily., FEBS J., 273, DOI: 10.1111/j.1742-4658.2006.05529.x</label>
          <listPosition>480</listPosition>
          <doi>10.1111/j.1742-4658.2006.05529.x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924042</mtid>
          <link>/api/reference/66924042</link>
          <label>481. Lu 2001: Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family., Science (1979), 293</label>
          <listPosition>481</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924043</mtid>
          <link>/api/reference/66924043</link>
          <label>482. Lemke 2013: Biology of the TAM receptors., Cold Spring Harb. Perspect. Biol., 5, DOI: 10.1101/cshperspect.a009076</label>
          <listPosition>482</listPosition>
          <doi>10.1101/cshperspect.a009076</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924044</mtid>
          <link>/api/reference/66924044</link>
          <label>483. Goudarzi 2020: Gas6 induces myelination through anti-inflammatory IL-10 and TGF-β upregulation in white matter and glia., Cells, 9, DOI: 10.3390/cells9081779</label>
          <listPosition>483</listPosition>
          <doi>10.3390/cells9081779</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924045</mtid>
          <link>/api/reference/66924045</link>
          <label>484. Rothlin 2007: TAM receptors are pleiotropic inhibitors of the innate immune response., Cell, 131, DOI: 10.1016/j.cell.2007.10.034</label>
          <listPosition>484</listPosition>
          <doi>10.1016/j.cell.2007.10.034</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924046</mtid>
          <link>/api/reference/66924046</link>
          <label>485. Xie 2024: Vitamin K: infection, inflammation, and auto-immunity., J. Inflamm. Res, 17, DOI: 10.2147/JIR.S445806</label>
          <listPosition>485</listPosition>
          <doi>10.2147/JIR.S445806</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924047</mtid>
          <link>/api/reference/66924047</link>
          <label>486. Ohsaki 2010: Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor αB through the repression of IKKα/β phosphorylation., J. Nutr. Biochem., 21, DOI: 10.1016/j.jnutbio.2009.09.011</label>
          <listPosition>486</listPosition>
          <doi>10.1016/j.jnutbio.2009.09.011</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924048</mtid>
          <link>/api/reference/66924048</link>
          <label>487. Linneberg 2021: The association of low vitamin k status with mortality in a cohort of 138 hospitalized patients with covid-19., Nutrients, 13, DOI: 10.3390/nu13061985</label>
          <listPosition>487</listPosition>
          <doi>10.3390/nu13061985</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924049</mtid>
          <link>/api/reference/66924049</link>
          <label>488. Dofferhoff 2021: Reduced Vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019., Clin. Infect. Dis., 73, DOI: 10.1093/cid/ciaa1258</label>
          <listPosition>488</listPosition>
          <doi>10.1093/cid/ciaa1258</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924050</mtid>
          <link>/api/reference/66924050</link>
          <label>489. Okabe 2024: Vitamin K2 Protects Against SARS-CoV-2 Envelope Protein-Induced Cytotoxicity in Chronic Myeloid Leukemia Cells and Enhances Imatinib Activity., Int J. Mol. Sci., 25, DOI: 10.3390/ijms252111800</label>
          <listPosition>489</listPosition>
          <doi>10.3390/ijms252111800</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924051</mtid>
          <link>/api/reference/66924051</link>
          <label>490. Zhan 2023: Protective role of vitamin K3 on SARS-CoV-2 structural protein-induced inflammation and cell death., Pharmaceuticals, 16, DOI: 10.3390/ph16081101</label>
          <listPosition>490</listPosition>
          <doi>10.3390/ph16081101</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924052</mtid>
          <link>/api/reference/66924052</link>
          <label>491. Atieh 2025: Vitamins K2 and D3 improve long COVID, fungal translocation, and inflammation: randomized controlled trial., Nutrients, 17, DOI: 10.3390/nu17020304</label>
          <listPosition>491</listPosition>
          <doi>10.3390/nu17020304</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924053</mtid>
          <link>/api/reference/66924053</link>
          <label>492. Wang 2021: The multifaceted roles of TAM receptors during viral infection., Virol. Sin., 36, DOI: 10.1007/s12250-020-00264-9</label>
          <listPosition>492</listPosition>
          <doi>10.1007/s12250-020-00264-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924054</mtid>
          <link>/api/reference/66924054</link>
          <label>493. Sun 2010: Sertoli cell-initiated testicular innate immune response through Toll-like receptor-3 activation is negatively regulated by Tyro3, Axl, and Mer receptors., Endocrinology, 151, DOI: 10.1210/en.2009-1498</label>
          <listPosition>493</listPosition>
          <doi>10.1210/en.2009-1498</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924055</mtid>
          <link>/api/reference/66924055</link>
          <label>494. Wang 2021: AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells., Cell Res, 31, DOI: 10.1038/s41422-020-00460-y</label>
          <listPosition>494</listPosition>
          <doi>10.1038/s41422-020-00460-y</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924056</mtid>
          <link>/api/reference/66924056</link>
          <label>495. Martín-Rojas 2020: COVID-19 coagulopathy: an in-depth analysis of the coagulation system., Eur. J. Haematol., 105, DOI: 10.1111/ejh.13501</label>
          <listPosition>495</listPosition>
          <doi>10.1111/ejh.13501</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924057</mtid>
          <link>/api/reference/66924057</link>
          <label>496. Angelillo-Scherrer 2001: Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis., Nat. Med, 7, DOI: 10.1038/84667</label>
          <listPosition>496</listPosition>
          <doi>10.1038/84667</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924058</mtid>
          <link>/api/reference/66924058</link>
          <label>497. Laurance 2012: Growth arrest-specific gene 6 (gas6) and vascular hemostasis., Adv. Nutr., 3, DOI: 10.3945/an.111.001826</label>
          <listPosition>497</listPosition>
          <doi>10.3945/an.111.001826</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924059</mtid>
          <link>/api/reference/66924059</link>
          <label>498. Balogh 2005: Analysis of Gas6 in human platelets and plasma., Arterioscler. Thromb. Vasc. Biol., 25, DOI: 10.1161/01.ATV.0000163845.07146.48</label>
          <listPosition>498</listPosition>
          <doi>10.1161/01.ATV.0000163845.07146.48</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924060</mtid>
          <link>/api/reference/66924060</link>
          <label>499. Lee 2012: Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-κB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury., J. Leukoc. Biol., 91, DOI: 10.1189/jlb.0611289</label>
          <listPosition>499</listPosition>
          <doi>10.1189/jlb.0611289</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924061</mtid>
          <link>/api/reference/66924061</link>
          <label>500. Lemke 2020: Blood clots and TAM receptor signalling in COVID-19 pathogenesis., Nat. Rev. Immunol., 20, DOI: 10.1038/s41577-020-0354-x</label>
          <listPosition>500</listPosition>
          <doi>10.1038/s41577-020-0354-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924062</mtid>
          <link>/api/reference/66924062</link>
          <label>501. Lew 2014: Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities., Elife, 3, DOI: 10.7554/eLife.03385</label>
          <listPosition>501</listPosition>
          <doi>10.7554/eLife.03385</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924063</mtid>
          <link>/api/reference/66924063</link>
          <label>502. Tonello 2022: Baseline Plasma Gas6 protein elevation predicts adverse outcomes in hospitalized COVID-19 patients., Dis. Markers, 2022, DOI: 10.1155/2022/1568352</label>
          <listPosition>502</listPosition>
          <doi>10.1155/2022/1568352</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924064</mtid>
          <link>/api/reference/66924064</link>
          <label>503. Schött 2021: Vitamin K effects on gas6 and soluble axl receptors in intensive care patients: an observational screening study., Nutrients, 13, DOI: 10.3390/nu13114101</label>
          <listPosition>503</listPosition>
          <doi>10.3390/nu13114101</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924065</mtid>
          <link>/api/reference/66924065</link>
          <label>504. Moretti 2015: TNF-α-induced depressive-like phenotype and p38MAPK activation are abolished by ascorbic acid treatment., Eur. Neuropsychopharmacol., 25, DOI: 10.1016/j.euroneuro.2015.03.006</label>
          <listPosition>504</listPosition>
          <doi>10.1016/j.euroneuro.2015.03.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924066</mtid>
          <link>/api/reference/66924066</link>
          <label>505. Schmidt 2022: Ascorbic acid attenuates activation and cytokine production in sepsis-like monocytes., J. Leukoc. Biol., 112, DOI: 10.1002/JLB.4AB0521-243R</label>
          <listPosition>505</listPosition>
          <doi>10.1002/JLB.4AB0521-243R</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924067</mtid>
          <link>/api/reference/66924067</link>
          <label>506. Pala 2022: Vitamin C (Ascorbic acid) protects from neuropathy caused by cisplatin, through enhanced heat shock protein-70 and reduced oxidant effect., Rev. Assoc. Med Bras., 68, DOI: 10.1590/1806-9282.20220032</label>
          <listPosition>506</listPosition>
          <doi>10.1590/1806-9282.20220032</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924068</mtid>
          <link>/api/reference/66924068</link>
          <label>507. Luo 2022: Vitamin C protects against hypoxia, inflammation, and ER stress in primary human preadipocytes and adipocytes., Mol. Cell Endocrinol., 556, DOI: 10.1016/j.mce.2022.111740</label>
          <listPosition>507</listPosition>
          <doi>10.1016/j.mce.2022.111740</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924069</mtid>
          <link>/api/reference/66924069</link>
          <label>508. Akolkar 2017: Vitamin C mitigates oxidative/nitrosative stress and inflammation in Doxorubicin-Induced cardiomyopathy., Am. J. Physiol. Heart Circ. Physiol., 313, DOI: 10.1152/ajpheart.00253.2017</label>
          <listPosition>508</listPosition>
          <doi>10.1152/ajpheart.00253.2017</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924070</mtid>
          <link>/api/reference/66924070</link>
          <label>509. Bozkurt 2023: Comparison of effects of quercetin and ascorbic acid on infl ammatory cytokines and antioxidant biomarkers in infant rats using an experimental sepsis model., Bratisl. Med. J., 124, p. 768, DOI: 10.4149/BLL_2023_118</label>
          <listPosition>509</listPosition>
          <doi>10.4149/BLL_2023_118</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924071</mtid>
          <link>/api/reference/66924071</link>
          <label>510. Barker 2009: Modulation of inflammation by vitamin E and C supplementation prior to anterior cruciate ligament surgery., Free Radic. Biol. Med, 46, DOI: 10.1016/j.freeradbiomed.2008.11.006</label>
          <listPosition>510</listPosition>
          <doi>10.1016/j.freeradbiomed.2008.11.006</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924072</mtid>
          <link>/api/reference/66924072</link>
          <label>511. Diomede 2020: A novel role of ascorbic acid in anti-inflammatory pathway and ROS generation in HEMA treated dental pulp stem cells., Materials, 13</label>
          <listPosition>511</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924073</mtid>
          <link>/api/reference/66924073</link>
          <label>512. Chen 2022: Vitamin D3 decreases TNF-α-induced inflammation in lung epithelial cells through a reduction in mitochondrial fission and mitophagy., Cell Biol. Toxicol., 38, DOI: 10.1007/s10565-021-09629-6</label>
          <listPosition>512</listPosition>
          <doi>10.1007/s10565-021-09629-6</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924074</mtid>
          <link>/api/reference/66924074</link>
          <label>513. Labudzynskyi 2016: Role of vitamin D3 in regulation of interleukin-6 and osteopontin expression in liver of diabetic mice., Eur. Rev. Med Pharm. Sci.</label>
          <listPosition>513</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924075</mtid>
          <link>/api/reference/66924075</link>
          <label>514. Wang 2013: 25-Hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice., J. Steroid Biochem. Mol. Biol., 135, DOI: 10.1016/j.jsbmb.2013.01.008</label>
          <listPosition>514</listPosition>
          <doi>10.1016/j.jsbmb.2013.01.008</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924076</mtid>
          <link>/api/reference/66924076</link>
          <label>515. Moslemi 2022: Efficacy of vitamin D supplementation as an adjunct therapy for improving inflammatory and oxidative stress biomarkers: An umbrella meta-analysis., Pharm. Res, 186, DOI: 10.1016/j.phrs.2022.106484</label>
          <listPosition>515</listPosition>
          <doi>10.1016/j.phrs.2022.106484</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924077</mtid>
          <link>/api/reference/66924077</link>
          <label>516. Hashemi 2018: Anti-inflammatory effects of dietary Vitamin D 3 in patients with multiple sclerosis., Neurol. Genet, 4, DOI: 10.1212/NXG.0000000000000278</label>
          <listPosition>516</listPosition>
          <doi>10.1212/NXG.0000000000000278</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924078</mtid>
          <link>/api/reference/66924078</link>
          <label>517. Adegoke 2017: Relationship between serum 25-hydroxyvitamin D and inflammatory cytokines in paediatric sickle cell disease., Cytokine, 96, DOI: 10.1016/j.cyto.2017.03.010</label>
          <listPosition>517</listPosition>
          <doi>10.1016/j.cyto.2017.03.010</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924079</mtid>
          <link>/api/reference/66924079</link>
          <label>518. Sharifi 2019: Effect of single-dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo-controlled trial., APMIS, 127, DOI: 10.1111/apm.12982</label>
          <listPosition>518</listPosition>
          <doi>10.1111/apm.12982</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924080</mtid>
          <link>/api/reference/66924080</link>
          <label>519. Miroliaee 2018: The study of vitamin D administration effect on CRP and Interleukin-6 as prognostic biomarkers of ventilator associated pneumonia., J. Crit. Care, 44, DOI: 10.1016/j.jcrc.2017.08.040</label>
          <listPosition>519</listPosition>
          <doi>10.1016/j.jcrc.2017.08.040</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924081</mtid>
          <link>/api/reference/66924081</link>
          <label>520. Subramanian 2017: Vitamin D promotes pneumococcal killing and modulates inflammatory responses in primary human neutrophils., J. Innate Immun., 9, DOI: 10.1159/000455969</label>
          <listPosition>520</listPosition>
          <doi>10.1159/000455969</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924082</mtid>
          <link>/api/reference/66924082</link>
          <label>521. Jain 2020: Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers., Sci. Rep., 10, DOI: 10.1038/s41598-020-77093-z</label>
          <listPosition>521</listPosition>
          <doi>10.1038/s41598-020-77093-z</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924083</mtid>
          <link>/api/reference/66924083</link>
          <label>522. Singh 2005: Vitamin E, oxidative stress, and inflammation., Annu Rev. Nutr., 25, DOI: 10.1146/annurev.nutr.24.012003.132446</label>
          <listPosition>522</listPosition>
          <doi>10.1146/annurev.nutr.24.012003.132446</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924084</mtid>
          <link>/api/reference/66924084</link>
          <label>523. Lee 2024: α-Tocopherol and γ-tocopherol decrease inflammatory response and insulin resistance during the interaction of adipocytes and macrophages., Nutr. Res Pr., 18, p. 761, DOI: 10.4162/nrp.2024.18.6.761</label>
          <listPosition>523</listPosition>
          <doi>10.4162/nrp.2024.18.6.761</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924085</mtid>
          <link>/api/reference/66924085</link>
          <label>524. Meydani 2004: Vitamin E modulation of cardiovascular disease., : Ann. N. Y Acad. Sci., DOI: 10.1196/annals.1331.027</label>
          <listPosition>524</listPosition>
          <doi>10.1196/annals.1331.027</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924086</mtid>
          <link>/api/reference/66924086</link>
          <label>525. Moreira 2022: Alpha-tocopherol-loaded polycaprolactone nanoparticles improve the inflammation and systemic oxidative stress of arthritic rats., J. Tradit. Complement Med, 12, DOI: 10.1016/j.jtcme.2021.12.003</label>
          <listPosition>525</listPosition>
          <doi>10.1016/j.jtcme.2021.12.003</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924087</mtid>
          <link>/api/reference/66924087</link>
          <label>526. Sadikan 2023: Tocotrienol-rich fraction reduces retinal inflammation and angiogenesis in rats with streptozotocin-induced diabetes., BMC Complement Med Ther., 23, DOI: 10.1186/s12906-023-04005-9</label>
          <listPosition>526</listPosition>
          <doi>10.1186/s12906-023-04005-9</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924088</mtid>
          <link>/api/reference/66924088</link>
          <label>527. Kiyose 2021: Effect of δ-tocopherol on mice adipose tissues and mice adipocytes induced inflammation., J. Oleo Sci., 70, DOI: 10.5650/jos.ess21124</label>
          <listPosition>527</listPosition>
          <doi>10.5650/jos.ess21124</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924089</mtid>
          <link>/api/reference/66924089</link>
          <label>528. Singh 2004: Anti-inflammatory effects of α-tocopherol, in., Ann. N. Y Acad. Sci., DOI: 10.1196/annals.1331.019</label>
          <listPosition>528</listPosition>
          <doi>10.1196/annals.1331.019</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924090</mtid>
          <link>/api/reference/66924090</link>
          <label>529. Shea 2014: Associations between vitamin k status and haemostatic and inflammatory biomarkers in community-dwelling adults: the multi-ethnic study of atherosclerosis., Thromb. Haemost., 112</label>
          <listPosition>529</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924091</mtid>
          <link>/api/reference/66924091</link>
          <label>530. Ohsaki 2006: Vitamin K suppresses lipopolysaccharide-induced inflammation in the rat., Biosci. Biotechnol. Biochem, 70, DOI: 10.1271/bbb.70.926</label>
          <listPosition>530</listPosition>
          <doi>10.1271/bbb.70.926</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924092</mtid>
          <link>/api/reference/66924092</link>
          <label>531. Reddi 1995: Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin k) compounds., Cytokine, 7, DOI: 10.1006/cyto.1995.0034</label>
          <listPosition>531</listPosition>
          <doi>10.1006/cyto.1995.0034</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924093</mtid>
          <link>/api/reference/66924093</link>
          <label>532. Ibarrola-Jurado 2012: Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease., Am. J. Clin. Nutr., 96, DOI: 10.3945/ajcn.111.033498</label>
          <listPosition>532</listPosition>
          <doi>10.3945/ajcn.111.033498</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924094</mtid>
          <link>/api/reference/66924094</link>
          <label>533. Dihingia 2018: Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose., J. Nutr. Biochem., 52, DOI: 10.1016/j.jnutbio.2017.09.022</label>
          <listPosition>533</listPosition>
          <doi>10.1016/j.jnutbio.2017.09.022</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924095</mtid>
          <link>/api/reference/66924095</link>
          <label>534. Saputra 2019: Menaquinone-4 suppresses lipopolysaccharide-induced inflammation in MG6 mouse microglia-derived cells by inhibiting the NF-κB signaling pathway., Int J. Mol. Sci., 20, DOI: 10.3390/ijms20092317</label>
          <listPosition>534</listPosition>
          <doi>10.3390/ijms20092317</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924096</mtid>
          <link>/api/reference/66924096</link>
          <label>535. Shiraishi 2016: Vitamin K deficiency leads to exacerbation of murine dextran sulfate sodium-induced colitis., J. Gastroenterol., 51, DOI: 10.1007/s00535-015-1112-x</label>
          <listPosition>535</listPosition>
          <doi>10.1007/s00535-015-1112-x</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924097</mtid>
          <link>/api/reference/66924097</link>
          <label>536. Pan 2016: Inhibition of TNF-α, IL-1α, and IL-1β by pretreatment of human monocyte-derived macrophages with menaquinone-7 and cell activation with TLR agonists in vitro., J. Med Food, 19, DOI: 10.1089/jmf.2016.0030</label>
          <listPosition>536</listPosition>
          <doi>10.1089/jmf.2016.0030</doi>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
        <reference>
          <otype>Reference</otype>
          <mtid>66924098</mtid>
          <link>/api/reference/66924098</link>
          <label>537. Shea 2008: Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham offspring study., Am. J. Epidemiol., 167</label>
          <listPosition>537</listPosition>
          <published>false</published>
          <snippet>true</snippet>
        </reference>
      </references>
      <link>/api/publication/36252484</link>
      <label>Al-Khrasani Mahmoud et al. Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?. (2025) BIOMEDICINE &amp; PHARMACOTHERAPY 0753-3322 1950-6007 189</label><template>&lt;div class=&quot;JournalArticle Publication short-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10015484&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10015484&quot; target=&quot;_blank&quot;&gt;Al-Khrasani, Mahmoud ✉&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10090082&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10090082&quot; target=&quot;_blank&quot;&gt;Essmat, Nariman&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10096971&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10096971&quot; target=&quot;_blank&quot;&gt;Boldizsár, Imre&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10075565&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10075565&quot; target=&quot;_blank&quot;&gt;Varga, Bence Tamás&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10101816&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10101816&quot; target=&quot;_blank&quot;&gt;Chalabiani, Yashar&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10090125&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10090125&quot; target=&quot;_blank&quot;&gt;Abbood, Sarah Kadhim&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10052997&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10052997&quot; target=&quot;_blank&quot;&gt;Ernyey, Aliz Judit&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10015480&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10015480&quot; target=&quot;_blank&quot;&gt;Király, Kornél&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10065644&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10065644&quot; target=&quot;_blank&quot;&gt;Máté, Attila&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; ; &lt;span class=&quot;author-name&quot; mtid=&quot;10000721&quot;&gt; &lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000721&quot; target=&quot;_blank&quot;&gt;Riba, Pál&lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-type&quot;&gt; &lt;/span&gt; et al. &lt;/div &gt;&lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;36252484&quot; mtid=&quot;36252484&quot; target=&quot;_blank&quot;&gt;Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?&lt;/a&gt;&lt;/div&gt; &lt;div class=&quot;pub-info&quot;&gt; &lt;span class=&quot;journal-title&quot;&gt;BIOMEDICINE &amp; PHARMACOTHERAPY&lt;/span&gt; &lt;span class=&quot;journal-volume&quot;&gt;189&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper: 118346 , 38 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2025)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-end&quot;&gt;&lt;div class=&quot;identifier-list&quot;&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.biopha.2025.118346&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.biopha.2025.118346&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;221337&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/221337&quot;&gt; REAL &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;105010506187&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105010506187&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;40664036&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40664036&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402&quot; target=&quot;_blank&quot; href=&quot;https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;short-pub-prop-list&quot;&gt; &lt;span class=&quot;deleted-record&quot;&gt;Központi kezelésű&lt;/span&gt; &lt;span class=&quot;short-pub-mtid&quot;&gt; Közlemény:36252484 &lt;/span&gt; &lt;span class=&quot;status-holder&quot;&gt;&lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt;&lt;/span&gt; &lt;span class=&quot;pub-core&quot;&gt;Forrás Idéző &lt;/span&gt; &lt;span class=&quot;pub-type&quot;&gt;Folyóiratcikk (Összefoglaló cikk ) &lt;/span&gt; &lt;!-- &amp;&amp; !record.category.scientific --&gt; &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 7&lt;/span&gt; | Független: 5 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 7 | Scopus jelölt:&amp;nbsp;7 | WoS/Scopus jelölt:&amp;nbsp;7 | DOI jelölt:&amp;nbsp;7 &lt;/div&gt; &lt;/div&gt; &lt;/div&gt; &lt;/div&gt;</template><template2>&lt;div class=&quot;JournalArticle Publication long-list&quot;&gt; &lt;div class=&quot;authors&quot;&gt; &lt;img title=&quot;Forrásközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-core-icon.png&quot;&gt; &lt;img title=&quot;Idézőközlemény&quot; style=&quot;float: left&quot; src=&quot;/frontend/resources/grid/publication-citation-icon.png&quot;&gt; &lt;div class=&quot;autype autype0&quot;&gt; &lt;span class=&quot;author-name&quot; mtid=&quot;10015484&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10015484&quot; target=&quot;_blank&quot;&gt;Al-Khrasani Mahmoud ✉ (&lt;span class=&quot;authorship-author-name&quot;&gt;Al-Khrasani Mahmoud&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10090082&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10090082&quot; target=&quot;_blank&quot;&gt;Essmat Nariman (&lt;span class=&quot;authorship-author-name&quot;&gt;Gomaa Nariman Essmat Mohamed Abdeltawab&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; In vivo and in vitro pain assessment&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10096971&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10096971&quot; target=&quot;_blank&quot;&gt;Boldizsár Imre (&lt;span class=&quot;authorship-author-name&quot;&gt;Boldizsár Jr Imre&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10075565&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10075565&quot; target=&quot;_blank&quot;&gt;Varga Bence Tamás (&lt;span class=&quot;authorship-author-name&quot;&gt;Varga Bence Tamás&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10101816&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10101816&quot; target=&quot;_blank&quot;&gt;Chalabiani Yashar (&lt;span class=&quot;authorship-author-name&quot;&gt;Chalabiani Yashar&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; neuropsychopharmacology&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10090125&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10090125&quot; target=&quot;_blank&quot;&gt;Abbood Sarah Kadhim (&lt;span class=&quot;authorship-author-name&quot;&gt;Abbood Sarah Kadhim&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; In vivo AND In vitro pain assessment&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10052997&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10052997&quot; target=&quot;_blank&quot;&gt;Ernyey Aliz Judit (&lt;span class=&quot;authorship-author-name&quot;&gt;Ernyey Alíz Judit&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10015480&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10015480&quot; target=&quot;_blank&quot;&gt;Király Kornél (&lt;span class=&quot;authorship-author-name&quot;&gt;Király Kornél P&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10065644&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10065644&quot; target=&quot;_blank&quot;&gt;Máté Attila (&lt;span class=&quot;authorship-author-name&quot;&gt;Máté Attila&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Alvásmedicina, diabetes&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10000721&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000721&quot; target=&quot;_blank&quot;&gt;Riba Pál (&lt;span class=&quot;authorship-author-name&quot;&gt;Riba Pál&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia, opioid fájdalomcsillapítás&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10006033&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10006033&quot; target=&quot;_blank&quot;&gt;Timár Julia (&lt;span class=&quot;authorship-author-name&quot;&gt;Timár Júlia&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10009109&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10009109&quot; target=&quot;_blank&quot;&gt;Gyertyán István (&lt;span class=&quot;authorship-author-name&quot;&gt;Gyertyán István&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Viselkedésfarmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10011448&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10011448&quot; target=&quot;_blank&quot;&gt;Miklya Ildikó (&lt;span class=&quot;authorship-author-name&quot;&gt;Miklya Ildikó&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Neuropszichofarmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; &gt;Parenti Carmela &lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; &gt;Pasquinucci Lorella &lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10057401&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10057401&quot; target=&quot;_blank&quot;&gt;Ágg Bence (&lt;span class=&quot;authorship-author-name&quot;&gt;Ágg Bence&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10005121&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10005121&quot; target=&quot;_blank&quot;&gt;Fürst Susanna (&lt;span class=&quot;authorship-author-name&quot;&gt;Fürst Zsuzsanna&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10010125&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10010125&quot; target=&quot;_blank&quot;&gt;Ferdinandy Péter (&lt;span class=&quot;authorship-author-name&quot;&gt;Ferdinandy Péter&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia, molekuláris medicina&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10000023&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000023&quot; target=&quot;_blank&quot;&gt;Vizi E. Sylvester (&lt;span class=&quot;authorship-author-name&quot;&gt;Vizi E. Szilveszter&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Neurofarmakológia, neurokémia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;HUN-REN Kísérleti Orvostudományi Kutatóintézet&quot;&gt;HRN KOKI&lt;/span&gt;/Molekuláris Farmakológia Kutatócsoport; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet&lt;/span&gt; ;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;span class=&quot;author-name&quot; mtid=&quot;10000022&quot;&gt;&lt;a href=&quot;/gui2/?type=authors&amp;mode=browse&amp;sel=10000022&quot; target=&quot;_blank&quot;&gt;Harsing Laszlo G. (&lt;span class=&quot;authorship-author-name&quot;&gt;Hársing László Gábor&lt;/span&gt; &lt;span class=&quot;authorAux-mtmt&quot;&gt; Farmakológia&lt;/span&gt;) &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;author-affil&quot;&gt;&lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Általános Orvostudományi Kar&quot;&gt;AOK&lt;/span&gt;/&lt;span title=&quot;Intézet&quot;&gt;I&lt;/span&gt;/Farmakológiai és Farmakoterápiás Intézet; &lt;span title=&quot;Semmelweis Egyetem&quot;&gt;SE&lt;/span&gt;/&lt;span title=&quot;Központi Szervezeti Egységek (beleértve az Egyéb Szervezeti Egységeket)&quot;&gt;KSZE&lt;/span&gt;/Farmakológiai és Gyógyszerkutatás-fejlesztési Központ&lt;/span&gt; &lt;/div&gt; &lt;/div&gt; &lt;div class=&quot;title&quot;&gt;&lt;a href=&quot;/gui2/?mode=browse&amp;params=publication;36252484&quot; target=&quot;_blank&quot;&gt;Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?&lt;/a&gt;&lt;/div&gt; &lt;div&gt; &lt;span class=&quot;journal-title&quot;&gt;BIOMEDICINE &amp; PHARMACOTHERAPY&lt;/span&gt; &lt;span class=&quot;journal-issn&quot;&gt;(&lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/0753-3322&quot;&gt;0753-3322&lt;/a&gt; &lt;a target=&quot;_blank&quot; href=&quot;https://portal.issn.org/resource/ISSN/1950-6007&quot;&gt;1950-6007&lt;/a&gt;)&lt;/span&gt;: &lt;span class=&quot;journal-volume&quot;&gt;189&lt;/span&gt; &lt;span class=&quot;page&quot;&gt; Paper 118346. 38 p. &lt;/span&gt; &lt;span class=&quot;year&quot;&gt;(2025)&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;pub-footer&quot;&gt;  &lt;span class=&quot;language&quot; xmlns=&quot;http://www.w3.org/1999/html&quot;&gt;Nyelv: Angol | &lt;/span&gt; &lt;span class=&quot;identifiers&quot;&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;10.1016/j.biopha.2025.118346&quot; target=&quot;_blank&quot; href=&quot;https://doi.org/10.1016/j.biopha.2025.118346&quot;&gt; DOI &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_GOLD&quot; title=&quot; Gold &quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;221337&quot; target=&quot;_blank&quot; href=&quot;https://real.mtak.hu/221337&quot;&gt; REAL &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;105010506187&quot; target=&quot;_blank&quot; href=&quot;http://www.scopus.com/record/display.url?origin=inward&amp;eid=2-s2.0-105010506187&quot;&gt; Scopus &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;40664036&quot; target=&quot;_blank&quot; href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=40664036&amp;dopt=Abstract&quot;&gt; PubMed &lt;/a&gt; &lt;/span&gt; &lt;span class=&quot;id identifier oa_none&quot; title=&quot;none&quot;&gt; &lt;a style=&quot;color:blue&quot; title=&quot;https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402&quot; target=&quot;_blank&quot; href=&quot;https://linkinghub.elsevier.com/retrieve/pii/S0753332225005402&quot;&gt; Egyéb URL &lt;/a&gt; &lt;/span&gt; &lt;/span&gt; &lt;OnlyViewableByAuthor&gt;&lt;div class=&quot;ratings&quot;&gt; &lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Medicine (miscellaneous)&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt; &lt;div class=&quot;journal-subject&quot;&gt;Folyóirat szakterülete: Scopus - Pharmacology&amp;nbsp;&amp;nbsp;&amp;nbsp;SJR indikátor:&amp;nbsp;D1&lt;/div&gt; &lt;div class=&quot;journal-subject&quot;&gt;Norvég listás folyóirat&lt;/div&gt; &lt;/div&gt;&lt;/OnlyViewableByAuthor&gt; &lt;div class=&quot;publication-citation&quot; style=&quot;margin-left: 0.5cm;&quot;&gt; &lt;span title=&quot;Nyilvános idézőközlemények összesen, említések nélkül&quot; class=&quot;citingPub-count&quot;&gt;Nyilvános idéző összesen: 7&lt;/span&gt; | Független: 5 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 7 | Scopus jelölt:&amp;nbsp;7 | WoS/Scopus jelölt:&amp;nbsp;7 | DOI jelölt:&amp;nbsp;7 &lt;/div&gt;  &lt;div class=&quot;publication-citation&quot;&gt; &lt;a target=&quot;_blank&quot; href=&quot;/api/publication?cond=citations.related;eq;36252484&amp;sort=publishedYear,desc&amp;sort=title&quot;&gt; Idézett közlemények száma: 9 &lt;/a&gt; &lt;/div&gt; &lt;div class=&quot;mtid&quot;&gt;&lt;span class=&quot;long-pub-mtid&quot;&gt;Közlemény: 36252484&lt;/span&gt; | &lt;span class=&quot;status-data status-VALIDATED&quot;&gt; Egyeztetett &lt;/span&gt; Forrás Idéző | &lt;span class=&quot;type-subtype&quot;&gt;Folyóiratcikk ( Összefoglaló cikk ) &lt;/span&gt; | &lt;span class=&quot;pub-category&quot;&gt;Tudományos&lt;/span&gt; | &lt;span class=&quot;publication-sourceOfData&quot;&gt;Scopus&lt;/span&gt; &lt;/div&gt; &lt;div class=&quot;funder&quot;&gt; (TKP2021-EGA-25), (RRF-2.3.1-21-2022-00003), Nemzeti Kardiovaszkuláris Laboratórium(RRF-2.3.1-21-2022-00003) Támogató: NKFIH &lt;/div&gt; &lt;div class=&quot;lastModified&quot;&gt;Utolsó módosítás: 2026.07.10. 10:31 Gere Tamásné (SE_KK_Admin5_GT, admin) &lt;/div&gt; &lt;div class=&quot;lockedBy&quot;&gt;Központi kezelésű 2026.05.20. 09:50 Lévayné Deseő Katalin (MTMT Központi admin) &lt;/div&gt; &lt;/div&gt;&lt;/div&gt;</template2>
    </publication>
  </content>
</myciteResult>
